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E1 - Integrating HIV inpatient and
outpatient services, HIV-TB, HIV-STI,
non-communicable disorders and other
relevant diseases
MOAE0102
Family health days: an innovative approach to providing
integrated health services for HIV and non-communicable
diseases among adults and children in hard-to-reach areas
of Lesotho
A. Tiam1, O. Oyebanji1, J. Nkonyana2, A. Ahimbisibwe1, M. Putsoane1,
M. Mokone1, M. Nyabela1, A. Isavwa1, M. Tsoeu1, M. Foso1 and
L. Buhendwa1
1Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), Clinical
Services, Maseru, Lesotho. 2MOHSW-Lesotho, DDC, Maseru
Lesotho
Presenting author email: atiam@pedaids.org
Background: Due to Lesotho’s high adult HIV prevalence (23%),
considerable resources have been allocated to the HIV/AIDS
response, while resources for non-communicable diseases have
lagged. Since November 2011, the Elizabeth Glaser Pediatric
AIDS Foundation (EGPAF) has supported Lesotho Ministry of Health
to roll out Family Health Days (FHDs), an innovative strategy to
increase community access to integrated health services, with a
focus on hard-to-reach areas where immunization coverage, HIV
service uptake, and screening and treatment for chronic diseases
are low.
Methods: Services were provided at mobile service delivery
points from 17th October to 25th November 2011. Delivery
points located in rural setting were staffed by multi-disciplinary
teams of doctors, nurses, community workers, nutritionists,
AIDS officers, and pharmacists (30-40 health professionals
present).
Results: During this campaign, 8,396 adults were tested for HIV
(67.3% female; 32.6% male). In all, 588 (7%) tested HIV-positive
(6.7% female; 7.1% male). Among those testing HIV-positive,
68.5% (403) received CD4 testing and 36.6% were enrolled into
HIV care at their nearest clinics. A total of 324 ART defaulters were
identified and linked back to care. Follow-up with referral facilities
showed 100% of patients (defaulters and newly enrolled) linked to
care were enrolled at a facility. Standard immunizations were
administered to 990 children. 4,454 adults (24.7% male; 75.3%
female) were screened for hypertension, and of those screened,
24.2% had elevated blood pressure and were linked to care centers.
Addtitionally, 3,045 adults had blood sugar tests (27.0% males; 73.0%
females); 3.1% had elevated blood sugar and were linked to care
facilities.
Conclusion: Offering integrated services within hard-to-reach com-
munities can increase access to a variety of critical health services,
including those for non-communicable diseases, and can link ART
clients lost to follow-up back to facilities. This approach will be scaled
up throughout Lesotho as a strategy to reach all populations in the
country.
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Integrated community HIV testing campaigns: leveraging
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Uganda. 4School of Public Health, University of California, Berkeley,
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Medicine, School of Medicine, Makerere University College of
Health Sciences, Kampala, Uganda. 7Department of Medicine,
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Background: The high burden of undiagnosed HIV in sub-Saharan
Africa limits treatment and prevention efforts. Community-based HIV
testing campaigns can address this challenge and provide an
untapped opportunity to identify non-communicable diseases
(NCDs). We tested the feasibility and diagnostic yield of integrating
NCD and communicable diseases into a rapid HIV testing and referral
campaign for all residents of a rural Ugandan parish.
Methods: A five-day, multi-disease campaign, offering diagnostic,
preventive, treatment and referral services, was performed in
May 2011. Services included point-of-care screening for HIV,
malaria, TB, hypertension and diabetes. Finger-prick diagnostics
eliminated the need for phlebotomy. HIV-infected adults met
clinic staff and peer counselors on-site; those with CD45100/mL
underwent intensive counseling and rapid referral for antiretro-
viral therapy (ART). Community participation, case-finding
yield, and linkage to care three months post-campaign were
analyzed.
Results: Of 6,300 residents, 2,323/3,150 (74%) adults and 2,020/
3,150 (69%) children participated. An estimated 95% and 52% of
adult female and male residents participated respectively. Adult HIV
prevalence was 7.8%, with 46% of HIV-infected adults newly
diagnosed. Thirty-nine percent of new HIV diagnoses linked to care.
In a pilot subgroup with CD45100, 83% linked and started ART
within 10 days. Malaria was identified in 10% of children, and
hypertension and diabetes in 28% and 3.5% of adults screened,
respectively. Sixty-five percent of hypertensives and 23% of diabetics
were new diagnoses, of which 43% and 61% linked to care,
respectively. Screening identified suspected TB in 87% of HIV-
infected and 19% of HIV-uninfected adults; 52% percent of HIV-
uninfected TB suspects linked to care.
Conclusion: In an integrated campaign engaging 74% of adult
residents, we identified a high burden of undiagnosed HIV,
hypertension and diabetes. Improving male attendance and optimiz-
ing linkage to care require new approaches. The campaign demon-
strates the feasibility of integrating hypertension, diabetes and
communicable diseases into HIV initiatives.
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E3 - Effect of HIV funding/programming
on sexual and reproductive health (SRH)
services
WEPDE0101
Managing change in performance-based project funding: a
case study of PPFN Rapid Emergency Scale Up Plan to
increase HCT/FP/STIs integrated services
G. Hounkanrin1, Y. Melkamu1, I.M. Ibrahim2, I. Ogo2, O. Opeyemi2
and D. Toki2
1International Planned Parenthood Federation, Africa Region,
Nairobi, Kenya. 2Planned Parenthood Federation of Nigeria (PPFN),
Abuja, Nigeria
Presenting author email: imibrahim@ppfn.org
Background: Planned Parenthood Federation of Nigeria (PPFN) is
implementing the Global Fund Round 9 project as Principal
Recipient. In 2011, PPFN was challenged with lack of HCT RTK, FP
and STI commodities resulting in poor performance.
In creating change to optimise PPFN performance, the Rapid
Emergency Scale Up Plan was developed to meet the backlog of
unmet targets in three weeks; the Kotter’s 8 step change mode as
theoretical model. The plan addresses HCT and provision of
integrated SRH/HIV services through FP/STI services to capture HCT
missed opportunities.
This abstract therefore seeks to document lesson learnt through the
plan surpassing PPFN HCT services.
Methods: PPFN designed a plan showing targets linked to each clinic.
A cumulative target for all clinics within a cluster was assigned to
PPFN staff in each of the 35 states. This was replicated by region.
To determine if each staff would meet its targets, Kotter’s 8 step
models was applied.
PPFN had the following targets for 2011: provide service in 486
health facilities and ensure that and 225,800 HCT clients were
provided with FP and STI services.
Results: By using FP/STIs services as entry point, PPFN met its target
by 110% for HCT services, 213% for FP/STIs services with 88% of
facilities providing services
Conclusion: The paper indicates integration of services as a way to
meet client’s needs in a challenging environment and therefore
increases performance while optimizing resources.
E4 - Integration of SRH and HIV services:
Delivery models and costs
WEPDE0102
Reaching key populations in SRH/HIV integration:
recommendations from a global intervention review to
identify strategies to increase the responsiveness and
relevance of integrated programming to the sexual and
reproductive health and rights (SRHR) needs of high-risk
groups, including sex workers, MSM, transgenders, IDUs
and PLHIV
S. Grote1, S. Middleton-Lee2, J. Robertson1 and S. Mehta1
1India HIV/AIDS Alliance, New Delhi, India. 2Independent Consultant,
Brighton, United Kingdom
Presenting author email: sunitagrote@gmail.com
Background: While policy and implementation support for SRHR/HIV
integration is increasing, significant questions and uncertainties
remain about what such programming means in practice. This is
particularly the case in concentrated HIV epidemics, where little is
still known about what integration should look like for key
populations, including sex workers, men who have sex with men
(MSM), transgenders, injection drug users (IDUs) and people living
with HIV (PLHIV). While integration is a desirable goal in the long-run
particularly for clinical services, joining programs and systems that
are not ready could compromise quality and access for these groups
that already face difficulty in obtaining appropriate services for both
HIV and SRH needs.
Methods: India HIV/AIDS Alliance undertook a global review of
over 160 resources available on the websites of selected national
and international organisations, including NGOs, technical support
agencies and UN agencies. The resources included case studies,
mappings, toolkits, policy briefings and program reports.
Results: The review identified the most common challenges in
designing and implementing SRH/HIV integrated programs for key
populations. These included stigma and discrimination, low levels of
demand, lack of rights-based approaches, low attention to gender
inequality, low understanding of key populations’ specific SRH needs,
lack of capacity and sensitivity among service providers, lack of
strong referral systems and inadequate resources for additional
interventions. The review highlighted key steps that organisations
can take to successfully integrate SRHR and HIV in their responses for
key populations.
Conclusion: While SRH/HIV integrated programs present an
important opportunity to respond to the unmet needs of key
populations, integration that is premature, overly rapid or too
large-scale risks compromising rather than enhancing key popula-
tions’ access to high quality HIV and SRH services. Good practice
principles, including gender equality, human rights-based ap-
proaches, meaningful involvement of communities, for work with




Implementation of VMMC efficiency elements in four sub-
Saharan countries: service delivery methods and provider
attitudes
J. Bertrand1, D. Rech2, E. Njeuhmeli3, D. Castor3, S. Frade2,
M. Loolpapit4, M. Machaku5, W. Mavhu6 and L. Perry1
1Tulane School of Public Health and Tropical Medicine, Tulane
SPHTM, New Orleans, United States. 2CHAPS, Johannesburg, South
Africa. 3USAID, Washington, United States. 4FHI360/Kenya, Nairobi,
Kenya. 5Jhpiego/Tanzania, Dar es Salaam, United Republic of
Tanzania. 6ZAPP, Harare, Zimbabwe
Presenting author email: bertrand@tulane.edu
Background: The Systematic Monitoring of the Male Circum-
cision Scale-up (SYMMACS) is designed to track voluntary male
circumcision (VMMC) service delivery in Kenya, South Africa,
Tanzania, and Zimbabwe. The study measured adoption of six
elements to increase efficiency in the delivery of clinical VMMC
services, including:
Methods: Data collection took place at 14-30 VMMC sites per country
(73 sites total) from April-December 2011. It included observation of
the clinical facilities, observation of VMMC procedures, interviews
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with VMMC providers and the in-charge officer, and compilation of
service statistics.
. Surgical method
. Task shifting (allowing non-physicians to perform
VMMC)
. Task-sharing (allowing non-physicians to conduct as-
pects of VMMC)
. Rotation among multiple bays in the operating
theater
. Bundling of supplies and tools
. Use of electrocautery instead of ligating sutures
Results: The results are useful for monitoring service delivery in each
country and conducting cross country comparisons. The data shows
considerable variation by country on 5 of the 6 elements, the
exception being nearly universal use of the forceps-guided method
(see Table 1). The study revealed stark differences on task-shifting,
both in terms of actual practice and provider attitudes toward it. For
example, in Zimbabwe, while no providers report using task-shifting,
86.5% say they would implement the practice given the choice.
Countries also differed in the use of multiple beds per provider
(rotation) during VMMC, with100% of providers in Zimbabwe
reported using multiple beds, compared to 38% percent in Kenya,
reflecting a different service delivery model. Provider reported use
of electrocautery ranged from 5.4% in Tanzania to 88.6% in
South Africa.
Conclusion: The decision to adopt these elements is generally based
on national policies. However, the review of these practices across
four countries demonstrates alternative methods of service delivery,
and is intended to incite potential changes to these policies in the
name of increasing efficiency.
E9 - Models of delivery, including
promotion of acceptance, uptake and
costs
MOPDE0102
Determinants of VMMC provider burnout in four sub-
Saharan countries
J. Bertrand1, D. Rech2, E. Njeuhmeli3, D. Castor3, S. Frade2,
M. Loolpapit4, M. Machaku5, W. Mavhu6 and L. Perry1
1Tulane SPHTM, Global Health Systems and Development, New
Orleans, United States. 2CHAPS, Johannesburg, South Africa. 3USAID,
Washington, United States. 4FHI360/Kenya, Nairobi, Kenya. 5Jhpiego/
Tanzania, Dar es Salaam, United Republic of Tanzania. 6ZAPP, Harare,
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Presenting author email: dino@chaps.org.za
Background: The Systematic Monitoring of the Male Circumcision
Scale-up (SYMMACS) is designed to track voluntary male circumci-
sion (VMMC) service delivery in Kenya, South Africa, Tanzania, and
Zimbabwe. The study measured adoption of six elements to increase
efficiency in the delivery of clinical VMMC services, including:
. Surgical method (e.g., forceps-guided)
. Task shifting (allowing non-physicians to perform
VMMC)
. Task-sharing (allowing non-physicians to conduct as-
pects of VMMC)
. Rotation among multiple bays in the operating theater
. Bundling of supplies and tools
. Use of electrocautery instead of ligating sutures
Methods: Data collection took place at 1430 VMMC sites per
country (73 sites total) from April-December 2011. It included
observation of the clinical facilities, observation of VMMC proce-
dures, interviews with VMMC providers and the in-charge officer,
and compilation of service statistics. A total of 357 providers
reported on their attitudes towards their jobs and on the pervasive-
ness of burnout in the field of VMMC.
Results: The results are useful for monitoring service delivery in each
country and conducting cross country comparisons. The data shows
varied levels of burnout and job satisfaction among providers across
countries (see Table 1 and Table 2).
The various survey instruments allow for an analysis of which
program, site and provider level factors may contribute to increased
If given the choice, providers reported that they would

























1. Multiple beds per provider 36.7 27.1 82.9 14.3 73.1 25.8 100.0 0.0
2. Bundled surgical supplies (purchased as a kit) 0.0 40.0 88.6 9.5 24.7 32.3 100.0 0.0
Bundling of surgical instruments and supplies by clinic staff 97.6 0.0 7.6 19.0 73.1 20.4 0.0 9.5
3. Task shifting: allowing adequately trained nurses and or
clinical officers to perform the entire MC procedure
98.8 1.2 13.3 57.1 73.1 24.7 0.0 86.5
4. Task sharing: allowing secondary providers to administer
local anesthesia
38.8 21.2 85.7 13.3 73.1 23.7 68.9 27.0
Task sharing: allowing secondary providers to complete
interrupted sutures
41.2 17.6 81.9 16.2 73.1 23.7 59.5 32.4
5. Use of forceps guided surgical method 100.0 0.0 91.4 8.6 74.2 24.7 98.6 1.4
6. Electrocautery/diathermy 14.1 41.2 88.6 11.4 5.4 15.1 78.4 16.2
Implementation of efficiency measures in VMMC: act.
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burnout. This paper presents results on: type of site (mobile/ static/
outreach), site volume, provider cadre, education and additional
training, time in field, full/part-time status, and variety of tasks
performed. For example, preliminary analyses from Zimbabwe
indicated that physicians experience higher levels of burnout than
their nurse colleagues.
Conclusion: The review of these practices across the four countries
will shed light on alternative methods of staffing and service delivery
that contribute to lower levels of burnout among VMMC providers.
The results could inform policies and program planning for VMMC as
well as other clinical HIV services.
MOPDE0106
A comparative analysis of two high-volume male medical
circumcision (MMC) operational models with similar service
delivery outcomes in different settings within Gauteng and
KwaZulu-Natal provinces in South Africa: urban Centre for
HIV/AIDS Prevention Studies (CHAPS) versus rural-SACTWU
Worker Health Program (SWHP)
N. Soboil1, J. Cockburn1, D. Rech2 and D. Taljaard2
1SACTWU,Worker Health Program, Cape Town, South Africa. 2CHAPS,
Johannesburg, South Africa
Presenting author email: nikki@swtzn.co.za
Background: In 2010 South Africa initiated rapid scale up of MMC
services nationally. In support of the service delivery, CHAPS
operates a ‘‘specialized fixed’’ VMMC programme in a large urban
setting in Johannesburg, Gauteng. SWHP operates a ‘‘roving’’ VMMC
programme in the rural district of Uthukela, KwaZulu-Natal. Both
programmes have achieved similar uptake of MMC services using
different operational models, with each achieving the highest
number of MMCs nationally within their applicable settings.
Methods: A comparative analysis was conducted of CHAPS’ ‘‘fixed
site’’ and SWHP’s ‘‘roving team’’ over a one year period to analyse
unique attributes of each, namely: social mobilisation; staff and
capital resources; extent of partnerships with district Departments
of Health (DOH), service quality, and cost comparisons between
models.
Results: Social mobilisation activities were similar but customised to
address local customs and preferences. There was variation in
staffing and capital expenditure due to CHAPS’ initial capital outlay
for a fixed site and its permanent team of 27 versus SWHP’s skeleton
team of 12 with no investment in facilities. Both programmes have
strong partnerships with their district DOHs, although SWHP
benefited from more support in terms of interim staffing and
provision of surgical consumables. This contributed to variances in
expenditure and cost per MMC by programme. Adverse events and
service quality were comparable, but roving services required greater
time and resources in tracking client follow up than fixed services.
Table 1.
Conclusion: This comparative analysis shows models need to be
customised to address the requirements of each target population
group and their geographic settings. In urban settings, fixed sites,
drawing on large dense surrounding populations, maintain good
daily numbers and follow up rates. In rural settings, the roving
model, with significant government support, is economical and
effective in reaching targets and covering communities spanning
large areas.










% reporting to have noticed any provider fatigue/burnout among colleagues
when they perform MC full-time as a primary work activity
Yes, frequently 8.2 14.3 0.0 9.5
Yes, occasionally 80.0 26.7 8.6 24.3
Yes, but very rarely 7.1 15.2 16.1 32.4
No, not at all 4.7 41.0 74.2 29.7
Don?t know 0.0 2.9 1.1 4.1
Table 2. VMMC provider personal job satisfaction a
% of providers who report to strongly agree or agree with the following









 Performing (or assisting in performing) male circumcision is a personally
fulfilling job.
87.1 82.8 100.0 81.1
 I personally have begun to experience work fatigue or burnout from
performing (or assisting in performing) male circumcision repeatedly.
70.6 36.2 53.8 27.0
Description CHAPS SWHP
Capital Expenditure 550 000 153 000
Salaries & Wages 5 135 222 3 256 688
Awareness Campaigns 163 680 26 400
Surgical Kits & Supplies 2 774 000 1 778 000
Training 6 000 93 300
Transport & Travel 37 084 123 646
Operating Overheads 1 254 416 544 631
Cost per 12 000 MMC procedures per
annum
9 920 402 5 975 665
Cost per MMC Procedure (SA Rands) R 827 R 498
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MOPDE0107
We too are shareholders: why women must be
meaningfully involved in the rollout of medical male
circumcision in Africa
K. Agot, S. Ohaga, B. Ayieko, E. Omanga and M. Kabare
Impact Research & Development Organization, Kisumu, Kenya
Presenting author email: kawango@impact-rdo.org
Background: Evidence is mixed on the benefit of medical male
circumcision (MMC) for women. Questions remain whether there is
direct benefit in reducing HIV acquisition among women; whether
men put women at risk due to early resumption of sex; whether
mass rollout of MMC leads to risk compensation in ways that
compromise women’s ability to negotiate condom use; and whether
MMC increases patriarchal behaviors such as gender-based violence.
We present data from various studies to address these questions and
make the case for women’s shareholding position in MMC.
Methods: We reviewed over 30 published and ongoing studies on
MMC for evidence on early resumption of sex, risk compensation,
benefits of MMC to women, and women’s views of and reactions to
MMC rollout in different African countries.
Results: About 10 studies have returned the verdict of no risk
compensation among circumcised men. In addition, there are few
but scientifically solid evidence emerging showing up to 47% direct
benefit of MMC in reducing HIV transmission to women, particularly
when sex is not resumed early. However, four studies show
consistent evidence of early resumption of sex before wound
healing, ranging from 24-42% overall, 63-76% among married/
cohabiting men, and 12-48% among HIV-positive men. About 15
studies indicate that women support MMC though misconceptions
are still common, with up to 77% unaware of the need for sexual
abstinence. Some believe that scale-up of MMC translates into
reduced risk hence less need for safe sex.
Conclusion: With the current scale up of MMC for HIV prevention in
14 African countries, there is no evidence of risk compensation;
however, early resumption of sex and women’s low risk perception
because their partners are circumcised may undermine the benefits
of MMC to women. MMC programs should target women with
correct and complete information and advocate for their involve-
ment in partners’ decisions on circumcision.
E15 - Managing HIV supply chain
challenges with limited resources
THPDE0101
Lessons from the rapid response of Namibia’s supply chain
when antiretroviral treatment guidelines changed to
tenofovir-based first-line regimen
J. Lates1, B. Ongeri2, A. Wolde2, E. Sagwa2 and D. Mabirizi2
1Division: Pharmaceutical Services, Ministry of Health and Social
Services, Windhoek, Namibia. 2Supply Chain Management System
(SCMS), Windhoek, Namibia
Presenting author email: jennie_lates@yahoo.co.uk
Background: Namibia’s antiretroviral treatment (ART) programme
has expanded rapidly, enrolling 68,000 adult patients on treatment
by December 2009, with 35% taking stavudine-based regimens. In
2010 the Ministry of Health & Social Services (MoHSS) adapted WHO
recommendations and began implementing new ART guidelines that
changed ART eligibility criteria and preferred first line regimens. Thus,
MoHSS enlisted the support of the Supply Chain Management
System (SCMS) to analyse the supply chain implications of the
changes and provide support for a smooth transition.
Methods: Using MS Excel(r) spreadsheets, SCMS modelled implica-
tions of increasing the CD4 threshold for ART initiation and changing
to tenofovir-based first line regimens. Backed by Namibian Govern-
ment funding commitment, CMS accelerated internal procurement
processes to avail tenofovir-based formulations, reviewed stock
control parameters to manage reduced demand for stavudine and
expanded ARV storage capacity to cope with the increased volumes
of ARVs. Monitoring systems were intensified including quarterly
tracking of trends in consumption and treatment regimens.
Results: Within 8 months, CMS had managed to accumulate
adequate quantities of tenofovir formulations, clearing the way for
the national roll-out of the new ART guidelines starting September
2010. As a result, over 34% of the approximately 90,000 adults on
ART were taking tenofovir-based regimens one year later. In addition,
a potential wastage of about US$ 950,000 worth of stavudine
formulations was prevented and stock outs of tenofovir formulations
avoided.
Interventions to optimise existing storage space at CMS created an
additional 328 pallet locations, a 74% increase in racked storage
capacity in five rooms for ARVs and general pharmaceuticals.
Conclusion: A rapid response was achievable due to the Namibian
government’s commitment and the agility of the supply chain. Timely
availability of information through robust monitoring systems
established to capture changing consumption patterns informed
procurement planning and minimised the risks associated with
change in ART guidelines.
THPDE0102
Cote d’Ivoire in crisis: supply chain strategies averted
treatment interruption
M. Touhon1, A. Pringle2, C. Sheridan2 and J.B. Evi3
1Supply Chain Management System (SCMS), Abidjan, Cote D’Ivoire.
2Supply Chain Management System (SCMS), Arlington, United States.
3MSH/SCMS, Abidjan, Cote D’Ivoire
Presenting author email: bevi@ci.pfscm.org
Background: Crisis followed the October 2010 Presidential elections
in Cote d’Ivoire. International sanctions were applied, the banking
system collapsed, security deteriorated and internal displacement
prevented access to healthcare. SCMS, a PEPFAR program adminis-
tered by USAID, adapted the national HIV/AIDS supply chain
strategies to respond to changing conditions and to avoid treatment
interruption
Methods: From the outset, SCMS established a crisis-committee
whose daily calls between the field and Washington focused on
information sharing with the Ministry of Health (MOH), Mission, USG
team, Implementing Partners (IPs) and international donors.
SCMS jointly reviewed supply plans and stock-status reports with
international donors and IPs and adjusted planned orders to meet
urgent national demands. Under threat of air, land and sea border
closings, SCMS re-routed all deliveries though its’ Regional Distri-
bution Center (RDC) in Accra, Ghana. The RDCs, in turn, pulsed com-
modities into the country as demand required and security permitted.
Meanwhile, in country, the MOH provided patients with two months
treatment instead of the usual one. The distribution mechanisms,
however, were disrupted and SCMS together with IPs created an
interim distribution plan in which IPs picked up their products and
distributed them to sites.
Results: Deliveries continued throughout the crisis; no health facility
experienced a stockout of critical products and treatment interrup-
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tion was averted. Donor collaboration ensured planned deliveries
met patient needs. The RDC in neighboring Ghana provided flexibility
to maximize in-country stock levels, arrange last-minute flights and
make urgent deliveries. On-the-ground collaboration with the MOH
and IPs ensured medicines were not only available at service delivery
points, but in the patients’ hand.
Conclusion: By creatively leveraging in-country knowledge, regional
resources and procurement volumes of supplies, ARVs and other
critical products reached patients throughout the crisis.
THPDE0103
Use of simple, low cost innovations to improve availability
of HIV-related commodities at public hospitals in Uganda
H. Kizito1, G. Tugume1 and L. Jaramillo2
1USAID Strengthening Uganda’s Systems for Treating AIDS Nationally
(SUSTAIN) Project, University Research Co., LLC (URC), Kampala,
Uganda. 2International Development Group, University Research Co.,
LLC (URC), Bethesda, United States
Presenting author email: ljaramillo@urc-chs.com
Background: Currently, HIV/AIDS care support from donors is shifting
from direct service delivery to systems strengthening of country-
owned programs. However, frequent stock-outs of HIV supplies
occur, as, in many cases, the systems for supply of HIV- and non-HIV-
related commodities remain separate, and health facilities do not
order for HIV commodities when required. The Strengthening
Uganda’s Systems for Treating AIDS Nationally (SUSTAIN) Project
worked closely with and supported 17 public hospitals in Uganda to
harmonize ordering for commodities from the governments’ Na-
tional Medical Stores to improve availability and service delivery.
Methods: SUSTAIN utilized four low-cost interventions to strengthen
supply chain management systems: identification of focal persons
responsible for submission of commodity orders to the national
stores; training of the order focal persons in ART logistics manage-
ment followed by onsite coaching and mentoring; telephone text
message reminders to the focal persons one week prior to order
deadlines; and development of an order checklist to harmonize
submission of HIV- and non-HIV-related commodities.
Results: From January to October 2011, average ordering rates for all
commodities improved from 46% to 71%. Improvements were noted
in order submission rates for HIV-related commodities: from 29% to
81% for ARVs, 24% to 69% for PMTCT commodities, and 22% to 63%
for HIV test kits. 54% of facilities harmonized submission of orders
for all commodities, an improvement from 12% in January 2011.
Improved submission of orders resulted in increased availability of
HIV-related commodities and quality of care.
Conclusion: Improving availability of commodities and supplies
available through the national system can be achieved by supporting
hospitals to utilize low cost, simple innovations to improve ordering
rates.
THPDE0105
Overcoming challenges in supply chain management amidst
rapid scale-up of antiretroviral services
V.S. Mulema1, S. Kabogoza1, D. Tumuhairwe1, L. Mumbe2, R. Kimuli1
and A. Mugume1
1JSI Research & Training Institute, Inc. (JSI)/Strengthening TB and
HIV&AIDS Responses in East Central Uganda (STAR-EC), Jinja,
Uganda. 2Ministry of Health, AIDS Control Programme, Kampala,
Uganda
Presenting author email: skabogoza@starecuganda.org
Background: Fragile health commodity supply chain systems have
long been a factor inhibiting universal access to care and treatment
in ART programs. Weaknesses in the various components of the
logistics cycle contribute to non-dependable and irregular supply of
quality products at service delivery points which causes poor health-
seeking behaviour, treatment interruption and poor adherence and
therefore treatment failure and resistance.
Methods: In June 2010, STAR-EC, a five year USAID-funded project
implemented by JSI, initiated training and mentorship of health
workers in pediatric ART, logistics management of opportunistic
infection medicines and stores management to build capacity for
quantification. District focal persons were facilitated to support the
sites to submit orders to the national suppliers. Storage was
improved through the provision of medicine cabinets and pallets.
Destruction of expired commodities was done in high priority health
centres to generate space for increasing quantities of products.
STAR-EC later supported the collection of these supplies from the
facilities to the district stores for destruction by MoH. Data
management was improved through the printing and distribution
of logistics management information tools that encouraged the use
of more optimal formulations. During periods of stock outs, buffer
commodities were provided and collaboration with other partners
mitigated non-availability at facilities. Consistent communication
with national stores to determine availability of supplies and support
to facilities to make and retrieve emergency orders was provided.
Results: The ordering rate for ARVs increased from 46% to 96% and
was maintained as shown in Figure 1. Consequently, the availability
of products improved which led to increase in number of clients
enrolled onto ART as shown in the Figure 2.
Figure 1. Ordering Rate for ARVs.
Figure 2. Annual Enrolment of Clients on ART.
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Conclusion: Improved availability of commodities at health facilities
and consequently, sustained expansion of ART programs can be
achieved by with a holistic approach towards all the elements of the
logistics cycle.
THPDE0106
Mind the gap: evaluating internal controls in HIV supply
chains across sub-Saharan Africa
J. Kohler1 and A. Revathi2
1Deloitte Consulting LLP, Washington, United States. 2Deloitte
Consulting, LLP, Arlington, United States
Presenting author email: julkohler@deloitte.com
Background: With USAID and Global Fund support, Deloitte
Consulting LLP assessed existence and effectiveness of internal
controls for government and non-governmental pharmaceutical
supply chains in selected African countries. Within these countries,
Deloitte traced inventory movements and volumes of selected ARVs,
RTKs, and other commodities from the point of entry along the
supply chain to end-user consumption.
Methods: The Deloitte team assessed a variety of sites, including
central, provincial, and district warehouses; rural health posts;
government, mission, and private hospitals; points of entry; and
transportation companies. Site sampling methodology weighted
provinces and districts by expected risk areas for diversion, popula-
tion size, number of sites, and volume of medicine dispensed.
ARVs, RTKs and other commodities (e.g., anti-malarials, essential
medicines, ITNs) were traced. Assessments incorporated a structured
questionnaire, documentation sampling and review, and end-to-end
reconciliation of inventory movements across each level of the
supply chain. The evaluation focused on eight areas to determine
control strength: Control Environment, Monitoring and Evaluation,
Port Arrival and Customs Clearing, Transportation, Receiving, Sto-
rage, Distribution, and People. Scores were rolled up to province and
country level in these eight areas to yield a final risk score for each
country’s supply chain.
Results: Assessed supply chains were generally found to be in the
second quartile of maturity (with a score between 25 and 50 of 100
points), indicating overall weakness in internal controls. Amongst
assessed countries, trends were inconsistent at the central, provincial
or district levels. Common to all countries, sub-district facilities had
very weak controls, leading to greater losses compared to upstream
facilities.
Conclusion: Country governments and donors must improve doc-
umentation practices, particularly at the lowest level of the supply
chain for ARV and RTK consumption. Strengthening sub-district
facility controls will decrease stock-outs, diversion, and loss due to
expiry, increasing available resources for health programming and
improving patient outcomes.
E17 - Developing/implementing chronic
disease programmes in resource-limited
settings
MOAE0104
Cardiovascular disease risk factor profiles of HIV-positive
clients: findings from a pilot program to integrate CVD
screening into HIV services at a secondary health facility in
Kano, North-Western Nigeria
U. Gwarzo1, T. Maji1, S. Isa-Dutse1, Y. Ahmed1, K. Obayagbona1,
E. Okechukwu2, S. Odafe1, H. Khamofu1, K. Torpey1 and O. Chabikuli1
1FHI360 (Family Health International), Abuja, Nigeria. 2USAID Nigeria,
Abuja, Nigeria
Presenting author email: ugwarzo@ghain.org
Background: There is a clear and growing body of evidence for
increased prevalence of cardiovascular disease (CVD) in HIV patients
as a result of viral effects or of antiretroviral medications (ART). This
pilot was implemented to assess the feasibility of integrating routine
screening of cardiovascular risk factors in an HIV clinic setting in
order to inform programmatic approaches.
Methods: HIV-positive clients enrolled in the facility between May
2010 and August 2011 (12,177 clients) were targeted for clinical CVD
screening. Those found with specified CVD risk factors were referred
for laboratory evaluation of their fasting blood sugar and lipid profile.
In addition, behavioral and biomedical interventions were provided,
including referrals to an on-site cardiac clinic for clients with a ten-
year CVD risk of developing a fatal or non-fatal cardiovascular event
of ]20% (WHO/ISH AFR-D CVD risk assessment charts). Follow-up
annual and biannual CVD risk assessments were also scheduled for
clients withB20% and ]20% ten-year CVD risks respectively.
Results: From May 2010 to August 2011 a total of 1,033 HIV positive
clients aged between 17 and 70 years were randomly selected for
screening; 82.7% were receiving ART. Of those screened, 205 (19.8%)
were identified with one or more CVD risk factors and sent for
laboratory evaluation; 42% of whom had a CVD risk ofB20%, and
2.4% a CVD risk of ]20%. The most common risk factors identified
were age (25.7%), male sex (25.9%), high BMI (21.8%), and
hypertension (15.2%). Although all risk factors were more prevalent
in those receiving ART, there was no statistically significant difference
with the ART-naive. Mean serum total cholesterol levels were found
to increase as duration on ART increased.
Conclusion: We conclude that integration of screening for cardio-
vascular diseases in ART clinic settings is feasible and essential in
order to improve the life expectancy of HIV-positive individuals.
MOAE0105
Integrating cervical cancer prevention services into mobile
HIV counseling and testing services to reach more women
with life-saving cancer interventions
E. Mulenga1, C. Chisoko2, Y. Mulenga1 and C. Makoane3
1PCI, Lusaka, Zambia. 2Zambia Defence Force, Lusaka, Zambia. 3PCI,
Washington, United States
Background: Zambia has the world’s second highest annual cervical
cancer incidence and mortality rates[1] coupled with one of the
world’s highest HIV prevalence rates at 14.3%.[2] Research has
shown an association between HIV infection and a high incidence of
invasive cervical cancer with rapid progression. In the Zambia
military population where the seroprevalence rate is estimated to
be two times higher than the national rate, women are at greater
risk of cervical cancer and HIV co-infection.
Methods: PCI and the Zambia Defence Force (ZDF) adopted the
‘‘screen-and-treat’’ model of the Cervical Cancer Prevention Program
in Zambia (CCPPZ) and integrated it into an existing ZDF mobile HIV
counseling and testing (CT) unit. The pilot was implemented in 14
ZDF units using existing health facilities and equipment. ZDF nurses
were trained on the CCPPZ protocols and used an opt-out approach
to enroll women accessing mobile CT services. Nurses screened
consenting women using visual inspection with acetic acid (VIA) and
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provided same-visit treatment using cryotherapy (‘‘screen-and-
treat’’).
Results: A total of 839 women accessed mobile CT services;
560 women (67%), median age 35, consented to being screened.
Of the 560 screened, 16% (88/560) were found with abnormal
cervical lesions of which 11% (62/560) were eligible for on-site
cryotherapy and were treated immediately while 5% (26/560)
were referred to the Gynecologic Cancer Prevention Unit at
University Teaching Hospital and of these 92% (24/26) completed
the referral. The prevalence of HIV among women screened was 20%
(113/560).
Conclusion: The high proportion of women (67%) that accepted
screening for cervical cancer and the high proportion of women
completing the referral, show that existing HIV prevention interven-
tions provide a springboard for rapidly reaching women with timely,
life-saving and easily adaptable cervical cancer prevention and
treatment programs such as ‘‘screen and treat’’.
[1] GLOBOCAN 2008
[2] Zambia Demographic and Health Survey (2007)
MOAE0305
Sustainable financing for national responses through use of
locally mobilised resources: a case of the AIDS levy in
Zimbabwe
R. Yekeye1, A. Manenji2 and D.T. Magure1
1National AIDS Council of ZImbabwe, Programmes, Harare,
Zimbabwe. 2National AIDS Council of Zimbabwe, Finance, Harare,
Zimbabwe
Background: Zimbabwe is one of the countries with the highest
HIV prevalence (13.75%) in the world. It has a strong policy and
strategic framework and a National AIDS Trust Fund (NATF) created
through an Act of Parliament. All employed individuals and
companies in Zimbabwe pay 3% of their taxable income on monthly
and quarterly for former and later respectively. The money support
the national response to HIV and AIDS and the fund has emerged as
an innovative and potentially sustainable internal response resour-
cing approach.
Methods: The study was conducted in Zimbabwe and used a
combination of secondary literature, key informant interviews
(Ministry of Health, NAC, Private Sector and Public Service autho-
rities), focus group discussions (beneficiaries) and observations
(Health facilities).
Results: The NATF is an innovative approach for a self financed/
sustained HIV and AIDS response in Zimbabwe. Currently 25% of all
people on ART are supported by the fund apart from financing some
interventions under prevention, advocacy and monitoring and
evaluation. Assisted the country achieve Global Fund grant targets
though funding the acceleration of implementation. Strengthened
and improved effectiveness of NAC’s coordinating capacity. Fund’s
full potential yet to be realised as the informal sector (with
estimated 80% of the employable population) is not contributing
and the economy operating 40% of its capacity. NATF is a regional
best practice and four countries Tanzania, Botswana, Kenya and
Zambia have visited Zimbabwe to learn about the levy.
Conclusion: The NATF demonstrates potential countries have to
generate internal resources to sustain their responses. In the context
of diminishing the external global financial support, countries need
innovative approaches to avoid reversing response gains. Countries
with large informal sectors need to ensure contribution by these as
they also benefit from services and commodities. The success of this
approach rests on genuine political commitment and private sector
collaboration.
E21 - Using mobile phones/other
methods to track patient and for
programme data
WEAE0302
Monthly monitoring at a small NGO: mobile phones versus
paper
K. Regan1,2, D. Seo1,3, E. Churchman1,4, J. Kiwango1, S. Gervas1 and
L. Whiddon1
1Support for International Change (SIC), Arusha, United Republic of
Tanzania. 2University of Maryland, College Park, Education Policy
Studies, College Park, United States. 3University of Michigan, William
Davidson Institute, Ann Arbor, United States. 4Emory University,
Hubert Department of Global Health, Atlanta, United States
Presenting author email: kati@sichange.org
Background: For a small NGO supporting a community health worker
program in rural villages, ensuring accurate timely data collection is
difficult. Paper based systems are time-consuming to collect and
often provide incomplete data. A simple, cost-effective monitoring
system using mobile phones can speed up data collection and
provide better data. This project aimed to use electronic reporting to
better capture the quality of support (social, family, personal)
provided by community health workers.
Methods: The project adapted paper-based monthly reporting tools
already in use for implementation on the mobile phone platform
using open access Frontline software. 38 CHWs (21% of the total
number) were selected from a diverse set of locations. Staff built buy
in from participating CHWs for the new technology and trained them
on the system. Data was collected through SMS to a central
database. CHWs received an initial sum of phone credit and were
reimbursed based on the number of messages received, regardless
of accuracy. To assess the comparative benefit of the system,
SIC measured the collection and accuracy of CHWs using paper
surveys.
Results: One month after initiation, participating CHWs had sent
monthly patient information by text for 37.2% of their clients with
9.8% of messages having data errors. For paper, at one month, the
percentage of monthly patient reports collected was 6%. At three
months, a higher percentage of paper reports (78.7%) had been
collected than electronic (45.0%). Paper surveys were two and a half
times as likely to have missing information.
Conclusion: The mobile phone system has a clear advantage in
timeliness of data. Over time, however, consistency with mobile
phone reporting declined because of difficulties with reimburse-
ments and challenges with system maintenance Next steps are
adjusting the reimbursement system and evaluating whether the
system is better suited for use in ongoing reporting, annual
evaluation or not at all.
WEAE0304
Mobile telemedicine for improved community-level
clinical decision making, referrals and medical
information transmission and storage: a pilot study in
Nairobi, Kenya
J. Cohn1 and K. Xiong2
1University of Pennsylvania School of Medicine, Department of
Medicine, Philadelphia, United States. 2Moi University, Nairobi,
Kenya
Presenting author email: jecohn6@gmail.com
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Background: Shortages of health professionals in low-income
countries make task shifting to community health workers (CHWs)
crucial to AIDS care and treatment. Multiple studies of CHW
utilization reveal poor linkages to the formal health sector, lack of
clinical decision making support in the field and weak integration of
information gathered at the community level with the national
health information system.
Methods: A pilot study was performed at a public HIV clinic in
Nairobi that provided CHWs with a mobile telephone system
(ClinipakMobile) loaded with surveys that support appropriate
clinical decision making and link to an electronic patient information
database. Each CHW underwent a one-day training on use of
ClinipakMobile and used ClinipakMobile at home visits with clients
living with HIV. Variables assessed were: ability of the CHW to use
ClinipakMobile based on standardized role-play assessments, CHW
satisfaction surveys, ability of the server to store clinical data, and
patient-based outcomes assessed by an end-of-study chart review of
CHW referrals.
Results: Seventeen CHWs participated. The CHWs quickly learned
and retained skills in using ClinipakMobile across three time points
(week 0, 3 and 6) and expressed great satisfaction. The database
maintained function and integrity with only one down-time period of
24 hours. CHW patient interviews using ClinipakMobile recorded
multiple ‘‘red flag’’ answers for antiretroviral non-adherence (21%),
side effects (30%) and opportunistic infection symptoms (33%)
resulting in 30% of patients receiving ClinipakMobile-recommended
referrals to the health facility. The chart review revealed these
problems were infrequently noted by clinicians at follow-up visits.
Conclusion: ClinipakMobile is an easy-to-use mhealth tool to
improve CHW functioning to care for PLWHA. Busy clinicians may
not note important clinical ‘‘red flag’’ that CHWs record at home
visits. In the future, patient information gathered on ClinipakMobile
should be downloaded from the server daily and given directly to
clinicians to improve care during clinic visits.
FRAE0104
An automated platform for delivery of CD4 results to SMS-
enabled antenatal clinic printers, Botswana
A. Veres1, S. Dryden-Peterson2, E. van Widenfelt3, P. Motshegwa3,
M. Mine4, S. Moyo3, K. Keapoletswe4, A. Avalos4, M. Mmalane3,
R. Shapiro5 and S. Lockman2
1Harvard University, Faculty of Arts and Sciences, Cambridge, United
States. 2Brigham and Women’s Hospital, Division of Infectious
Diseases, Boston, United States. 3Botswana Harvard AIDS Institute,
Gaborone, Botswana. 4Botswana Ministry of Health, Department of
HIV/AIDS Prevention and Care, Gaborone, Botswana. 5Beth Israel
Deaconess Medical Center, Boston, United States
Presenting author email: scott_peterson@post.harvard.edu
Background: CD4 determination and is a key step in the prevention
of mother-to-child transmission cascade. However, timely access to
centrally-processed CD4 results remains a challenge for antenatal
clinics in resource-limited settings.
Methods: As part of an interventional study to improve antenatal
access to HAART, we developed an automated platform to wirelessly
communicate CD4 results to portable SMS-enabled thermal printers
(iBacsTel) in referral antenatal clinics. The system, authored in Python
over a MySQL database using Django, directly collects results from
flow cytometer (FACSCalibur) output files and integrates demo-
graphics and validation status from electronic records. The system
then sends validated results via a SMS gateway (Kannel) to printers in
referring antenatal clinics. Clinic receipt is confirmed centrally via
SMS. A monitoring platform (see Figure 1) permits quick central
assessment of clinic printer status, laboratory delays, deviations from
expected testing patterns (e.g. due to supply outages, staffing
shortages), and identification of women with low CD4 counts.
We deployed the system in 16 clinics around Gaborone, Botswana
(2 clinics added per month) between August 2011 and February 2012.
Results: Antenatal CD4 results for 367 women have been transmitted
and confirmed, including 92 women qualifying for HAART (CD4
B250 cells/mL). Pre-intervention delivery, largely via hand delivery
of printed results, was estimated at 21 days. After an initial
adaptation phase, the mean number of days from phlebotomy to
confirmed clinic result receipt improved to 3.0 days (95% CI 2.13.9
days, Figure 2). Improvements in both laboratory and results
transmission times have resulted from real-time identification of
laboratory delays, software modifications, and preemptive manage-
ment of printer airtime periods. Clinicians report satisfaction, noting
substantial improvements in reliability and timeliness.
Conclusion: Direct transmission of CD4 results to antenatal practi-
tioners is feasible and reduces time to result receipt. The system
permits central monitoring of clinic and lab performance and
prioritization of pregnant women with low CD4.
TULBE02
Implementation of a wireless GPRS-based monitoring
system for point-of-care CD4 testing at rural primary health
facilities in Mozambique
Figure 1. Display from two of the monitoring platform screens,
displaying specimen details, validation/transmission status, and
clinic status.
Figure 2. Turn-around time for CD4 result delivery to antenatal
clinics.
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J. Quevedo1
1Clinton Health Access Initiative, Maputo, Mozambique. 2Instituto
Nacional de Saúde, Maputo, Mozambique
Presenting author email: jquevedo@clintonhealthaccess.org
Background: Point-of-care CD4 testing (POC CD4) is being imple-
mented in many countries to improve access to CD4 and HIV
services, especially in decentralized rural and remote areas. However,
the implementation of POC CD4 faces challenges due to the
difficulties of monitoring testing quality, operator performance,
instrument breakdowns and supply stock-outs in remote sites.
Methods: At 10 health centers in Sofala Province, Mozambique we
implemented twelve POC CD4 devices enabled with GPRS modems
capable of transmitting test data to a central database via local
mobile phone network. A web-based software interface was
customized to allow provincial and national-level supervisors to
access the following data from each device: (i) device functionality;
(ii) daily test volume; (iii) error type and frequency; and (iv)
frequency and performance of daily quality control runs (Figures 1
and 2).
Results: Data from the twelve POC CD4 devices representing a total
of 336 testing days and 3,109 CD4 tests (with 620 quality control
runs) were aggregated and reported by the interface. The system
identified 376 error events, including 19 quality control failures
(Levey-Jennings2 standard deviations), 4 failures to run daily
controls before testing, 45 operator test errors, 6 possible device
malfunction events, and 21 instances of attempted use of expired
reagents. These events prompted follow-up corrective action by
supervisors more quickly than with previous paper-based reporting
methods.
Conclusion: This is the first description of a remote wireless
monitoring system to track performance of POC diagnostic tests
for HIV in resource-limited settings. This GPRS-based system can
improve the management of POC diagnostics by capturing real-time
events that might otherwise go unnoticed. This enables detailed
management of the quality and performance of POC CD4 testing in
remote areas and rapid response to resolve problems and provide
Figure 2.
Figure 1.
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additional training or support. This system also has applications in
monitoring patient- and population-level epidemiological trends.
E25 - Strategies to increase HIV testing,
and to promote linkage and retention in
care
WEAE0202
A laboratory-based approach to reduce loss to follow-up of
HIV-positive clients
C.O. Nwuba1, T. Dagunduro1, C. Umenyi1, B. Peters2, F. Afolayan3 and
O. Abolarin4
1Management Sciences for Health, Prevention Organizational
Systems, AIDS, Care and Treatment, Ilorin, Nigeria. 2Children
Specialist Hospital, Laboratory Unit, Ilorin, Nigeria. 3General Hospital,
Laboratory Unit, Omuaran, Nigeria. 4Specialist Hospital, Laboratory
Unit, Offa, Nigeria
Presenting author email: cnwuba@msh.org
Background: In Nigeria, the progressive loss of patients at every
stage in antiretroviral therapy (ART) programs especially at the point
of uptake of CD4 monitoring poses a threat to the achievement of
treatment targets. Long waiting time coupled with the burden of
traveling long distances for blood draw and receipt of CD4 results has
led to attrition in the number of clients who test positive to HIV
versus the number who eventually commence ART.
Methods: In order to increase uptake of CD4 monitoring and reduce
loss to follow up (LTFU) at three USAID/MSH supported HIV care and
treatment clinics, the following interventions were instituted.
1. Task shifting to data clerks to fill laboratory request forms for CD4
monitoring instead of clinicians who complain of heavy workload.
2. Strengthened escort services from the point of enrollment to the
laboratory to ensure that clients access laboratory investigations on
the same day.
3. Task shifting to laboratory technicians on the use of automated
CD4 equipments after consistent onsite training and supervision.
4. Established point of care sample collection for CD4 estimation.
5. We commenced daily CD4 investigations (Monday to Friday)
ensuring that clients attending clinics from long distances access CD4
monitoring on any day of the week.
6. Commenced 24 hours turnaround time for release of CD4 result to
ensure rapid initiation of eligible clients on ART.
Results: After 12 months, number of clients accessing CD4
investigations increased from 53.8% to 93.3% while number of
clients LTFU reduced from 58.7% to 10.7%. Turnaround time for CD4
results decreased from 7 days to 24 hours. Average client waiting
time reduced from 4 hours to 1hour 30mins.
Conclusion: Strengthening laboratory systems helps increase uptake
of CD4 investigations, shorten client waiting time and ultimately
reduces LTFU especially among clients attending clinics from hard to
reach communities with difficult terrains.
WEAE0301
The distribution and use of cell phones to mothers of HIV-
positive infants identified by the Haiti National Early Infant
Diagnosis of HIV program (EID): a model for increasing
adherence?
N. Segaren1, T. Lewis1, O. Desinor2, E. Simeon1 and N. Segaren3
1Caris Foundation, Port au Prince, Haiti. 2USAID, PAP, Haiti. 3Chelsea
& Westminster Hospital, London, United Kingdom
Background: The Caris Foundation in partnership with the Voila
Foundation provides cell phones to mothers of HIV-positive infants
identified via the Haiti National EID program. Mothers without
access to cell phones are difficult to communicate with; Caris EID
teams contact families to increase clinic attendance, improve
treatment adherence and monitor children’s health.
Methods: New phones were distributed to mothers of HIV-positive
infants identified by the EID program. The program started in
May 2010 and is ongoing. The cell phones were donated by Voila, a
national cell service provider in Haiti. It was explained that the
purpose of the phone was for monitoring the child and the mother
would be contacted regularly by members of the Caris team/site
providers. Each mother gave signed consent. Caris coordinators call
mothers who have phones (donated or pre-existing) approximately
weekly to discuss appointments, drugs and their children’s health
status.
Results: Over 70% of the phones used to monitor families were still
active in Feb 2012. Of the 76 families with functional cell phones, all
76 children were adherent to treatment as defined as attending 6
out of the last 6 hospital appointments given (monthly). All the
women felt positive about being called by the Caris teams and 99%










































Cell phone distribution figures.
Questions Responses
Why were you given a phone?
(50 of the 70 women who were
given a phone were contactable
by the donated phone)
To check my child is healthy/ok
45/50 (90%) To remind me of my
appointments 37/50 (74%) To
contact someone if I my child is
sick/ needs help 30/50 (60%)
What do you feel when you are
called by the team? (108 respon-
dents)
Positive Feelings 108(100%)
Neutral Feelings 0 (0%) Negative
Feelings 0 (0%)
Does being contacted by the
team help you? (108 respon-
dents)
Yes 107 (99.1%) No 1 (0.9%)
If being called is helpful-why?
(108 respondants)
Appointment Reminder 86 (80%)
Medication Reminder 68 (63%) To
help me when my child is ill 55
(51%)
What are the problems you
have with your phone? (108
respondants)
Lack of money to buy minutes 81
(75%) Difficulty in finding a place
to charge the phone 43 (40%) Poor
phone reception 27 (25%) Fear of
phone being stolen 23 (21%)
Cell phone questionnaire, Haiti.
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Conclusion: The distribution of cell phones to families of HIV-positive
children identified with the EID program in Haiti has helped our
teams monitor the progress of children. Approximately 20% of PCR
positive children identified are lost to follow up within the first year
and contact by phone can help. Phones are available for approxi-
mately 20USD in Haiti; the program is not prohibitively expensive.
30% of the phones were non-functional/stolen within 21 months of
the project. The use of mobile phones, combined with an active
community tracing program has benefitted the Haiti EID program.
MOPDE0203
Risk factors for late-stage HIV disease presentation at initial
HIV diagnosis in Durban, South Africa
P. Drain1, E. Losina2, S. Chetty3, J. Giddy3, D. Ross4, J. Katz5,
S. Coleman6, L. Bogart7, K. Freedberg2, R. Walensky2 and B. Ingrid1
1Massachusetts General Hospital, Boston, United States. 2Harvard
Center for AIDS Research, Boston, United States. 3McCord Hospital,
Durban, South Africa. 4St. Mary’s Hospital, Durban, South Africa.
5Brigham & Women’s Hospital, Boston, United States. 6Boston
University School of Public Health, Boston, United States. 7Children’s
Hospital Boston, Boston, United States
Presenting author email: pkdrain@gmail.com
Background: Despite expanded access to HIV testing, most newly-
diagnosed South Africans present with severe immunosuppression.
We sought to determine the risk factors for presentation with late-
stage HIV disease and the perceived barriers to presenting earlier for
care.
Methods: We enrolled and surveyed adults prior to HIV testing at
four outpatient clinics in urban and peri-urban areas of Durban from
August 2010 to November 2011. Late-stage HIV disease was defined
as a CD4 countB100 cells/mm3. We used multivariate logistic
regression models to determine the effects of sex, emotional health,
social support, distance from the clinic, employment, perceived
barriers to receiving healthcare, and foregoing healthcare to use
money for food, clothing, or housing (‘‘competing needs to
healthcare’’) on presentation for care with late-stage HIV disease.
Results: Among 3,669 adults screened, 830 (22.6%) were enrolled,
newly-diagnosed HIV-infected, and obtained a CD4 result. Among
those, 279 (33.6%) presented with late-stage HIV disease. In multi-
variate analyses, participants who lived 5 kilometers away (OR 2.8,
95% CI 1.74.7), had reported competing needs to healthcare (OR
1.7, 95% CI 1.22.4), were male (OR 1.7, 95% CI 1.22.3), worked
outside the home (OR 1.5, 95% CI 1.12.1), perceived health service
delivery barriers (OR 1.5, 95% CI 1.12.1), and had poor emotional
health (OR 1.4, 95% CI 1.01.9) had higher odds of late-stage HIV
disease presentation.
Conclusion: In Durban, South Africa, the strongest independent risk
factors for presentation with late-stage HIV disease were living
further from the clinic, being male, and having competing needs to
healthcare. Self-reported barriers related to personal illness, costs of
care, and poor perceived service delivery were also significantly
associated with late-stage disease presentation. Future studies
should examine whether use of mobile units and financial assistance
may reduce presentation with late-stage HIV disease in resource-
poor settings.
THPDE0301
Towards universal awareness of HIV status: a systematic
review on uptake of home-based HIV testing in sub-Saharan
Africa
K. Sabapathy1,2, R. Van den Bergh3, S. Fidler2, R. Hayes1 and
N. Ford4,5
1London School of Hygiene and Tropical Medicine, London, United
Kingdom. 2Imperial College, London, United Kingdom. 3Medecins
Sans Frontieres, Brussels, Belgium. 4Medecins Sans Frontieres,
London, United Kingdom. 5University of Cape Town, Cape Town,
South Africa
Presenting author email: kalpana.sabapathy@gmail.com
Background: Improving access to HIV testing is recognized as a key
priority in scaling up HIV treatment and prevention services. Home-
based testing (HBT) as an approach to delivering wide-scale HIV
testing is explored in this study.
Methods: A systematic review and random effects meta-analysis of
published studies reporting on uptake of HBT in sub-Saharan Africa
since 2000 were conducted to assess the proportion of individuals
accepting HBT and receiving their test result. Three electronic
databases were searched.
Results: Our initial search yielded 1199 articles, 114 were reviewed
as full-text articles and 19 publications involving 21 studies
(N524,787 offered HBT) were included for final review. The studies
came from 5 countries: Uganda, Malawi, Kenya, South Africa,
Zambia.
Figure 1. Proportion accepting HBT.
Figure 2. Prop receiving HBT of all those offered.
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The proportion of people who accepted HBT (N474,516) ranged
from 58.1% to 100%, with a pooled proportion of 83.8% (95%
CI: 80.986.6%) (Figure 1). Heterogeneity was high (t20.13). Sixteen
studies reported on the number of people who received the result of
HBT (N432,835). The proportion of individuals receiving their
results out of all those offered testing ranged from 24.9% to 99.7%
with a pooled proportion of 77.4% (95% CI: 74.080.7%), (t2 0.12)
(Figure 2). HIV prevalence ranged from 2.9%36.5%. New diagnosis
of HIV following HBT ranged from 4079% of those testing positive.
Forty-eight percent of those offered testing were men and they were
just as likely to accept HBT as women (pooled odds
ratio 0.84 (95% CI: 0.561.26)(t20.33). The proportion of individuals
previously tested for HIV among those offered a test ranged
from 566%. No evidence was reported of negative consequences
of HBT.
Conclusion: Home based voluntary counselling and testing has the
potential to dramatically increase awareness of HIV status in
previously undiagnosed men and women in sub-Saharan Africa.
HBT is a gateway to accessing care early and the benefits for
individual and public health, both for treatment and prevention,
make it an invaluable tool in the fight against HIV.
THPDE0302
Thinking outside the docs: expanding access to HIV testing
services through the delivery of HIV testing at the
Department of Motor Vehicles in Washington, D.C.
A. Fulwood Wood, D. Parris, F. Terrell Hamilton and S. Brockington
Family & Medical Counseling Service, Inc., Washington, United States
Presenting author email: afulwood@fmcsinc.org
Background:Washington DC has an estimated HIV prevalence rate of
3.2% and only 50% may be aware of their infection. Using large
volume public service venues may promote HIV testing and directly
increase access to HIV testing, thereby increasing the number of
residents who know their HIV status. Family and Medical Counseling
Service, Inc. (FMCS) implemented a novel program to provide HIV
testing at the Department of Motor Vehicles (DMV) which provides
driver’s license and automobile tag services to over 150,000
residents annually.
Methods: Dedicated project staff discuss the importance of routine
HIV testing and offer the test to everyone awaiting DMV services.
Rapid HIV testing is conducted in a private office inside the DMV, and
all who test positive are immediately referred to care and support
services. We present data describing the HIV testing outcomes from
the program. We also asked a sample of 406 persons who didn’t test
about their reason for refusal.
Results: From October 2010 to February 2012, 108,188 individuals
were offered an HIV test, 8,152 (8%) accepted, 6,788 (83%) were
tested, and 34 (0.5%) were positive. The most common reasons for
refusal were ‘‘already had a test in the past six months’’ (138/406,
30%) and ‘‘do not feel I’m at risk’’ (76/406, 17%). Twenty-three
percent (n1,566) of those tested had never been tested before;
the majority of whom were aged 1324.
Conclusion: Conducting HIV testing in high volume non-clinical
settings, such as the DMV, is a feasible strategy to engage individuals
in HIV counseling and testing services, including those who have
never tested before. Expansion of this program model to similar
public service sites may be necessary to increase access to HIV
testing services, encourage routine screening and increase the







































The national HIV counselling and testing campaign and
treatment expansion in South Africa: a return on
investments in combination prevention
T. Mbengashe1, Z. Nevhutalu2, M. Chipimo3, T. Chidarikire1 and
L. Diseko1
1National Department of Health, HIV Cluster, Pretoria,
South Africa. 2South Africa National AIDS Council,
Pretoria, South Africa. 3UNAIDS, Pretoria Country Office,
Pretoria, South Africa
Background: South Africa has an estimated 5.6 million people living
with HIV, representing a quarter of the disease burden in sub-Sahara
Africa and one fifth of the global disease burden. The National HCT
Campaign was launched in April 2010 and ended in June 2011,
coordinated by the National Nerve Centre.
Methods: The Campaign was launched at national, provincial
and district levels and targeted everyone between the ages of
1260 years, not exclusive of younger or older persons. Confidenti-
ality and informed consent was required to test and every site was
linked to a referral facility providing ART, care and support. HCT
was done at health facilities, work places and community outreach
sites.
Results: South Africa committed a significant budget of US$3.5
billion to support the HCT Campaign and Treatment Expansion.
By June 2011 a record 13,269,746 HIV tests were conducted and
2,155,312 (16%) people tested positive of whom 48% had CD4
counts above 350. Over 400,000 patients were initiated on ART, of
whom 57,000 were pregnant women. National Laboratory DNA
PCR results indicated that mother to child transmission rates at 8
weeks reduced to 5% compared to 11% in 2009. Over 8 million
Figure 3. Sub-group analyses of proportions accept.
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people were screened for TB and 185 million male condoms and
524,000 female condoms were distributed. 237 males were medically
circumcised, exceeding the Campaign target of 100,000. The
procurement system achieved a 53% ARV price reduction through
competitive tenders and 3,686 (80%) health facilities were capaci-
tated to deliver ART through task shifting and training of 10,542
nurses.
Conclusion: South Africa has succeeded in implementing a massive
HCT campaign linked to a comprehensive HIV prevention model that
optimizes treatment for prevention and reduction of new HIV
infections. The Campaign created a shift from testing for treatment
to testing for prevention and promoted combination prevention to
turn the AIDS epidemic tide for South Africa.
THPDE0306
Announcing a new method of HIV testing: the planning of
robust home testing for HIV combined with internet
counseling
J. van der Helm1, F. Zuure1, H. Fennema2, U. Davidovich1, M. Prins1,3
and on behalf of the HIVTest@Home study group
1Health Service Amsterdam, HIV/STI Research, Amsterdam,
Netherlands. 2Health Service Amsterdam, Amsterdam, Netherlands.
3Academic Medical Center, University of Amsterdam, Amsterdam,
Netherlands
Presenting author email: jvdhelm@ggd.amsterdam.nl
Background: Recent estimates indicate that 40% of the HIV
infections in the Netherlands are undiagnosed. Earlier diagnosis of
HIV will improve individual health outcomes and reduce further
spread. Self tests for HIV have become available, which allow
individuals to test at home without involvement of health care
professionals. Although self tests may help to increase HIV test
uptake, there are concerns about test quality, counseling and medical
follow up. The Amsterdam Public Health Service has initiated
the HivTest@Home project to develop and evaluate a service that
provides reliable HIV self tests using oral fluid in combination with an
Internet counseling strategy for individuals at high risk for HIV,
especially MSM and migrants from HIV endemic countries.
Methods: A website and logistic infrastructure will be developed that
provides an intake with personal advice about HIV self testing, and
enable individuals to purchase the HIV self test we provide online.
With the test, they will receive a code to access a pre-test trajectory
including step-by-step instructions, counseling, and low-threshold
contact options with health care professionals. For those who test
positive, a follow-up procedure will be developed to motivate them to
access regular health care for confirmation testing and referral to an
HIV clinic.
Results: The service will be launched in 2013, accompanied by a
media campaign targeting high risk groups. We aim to distribute
2,000 tests within a 12-month period, assuming an HIV prevalence of
newly diagnosed individuals of 2.5-5.0%. Using data collected online
from participants, web statistics, interviews with participants, and
clinical follow-up data, we will evaluate the feasibility and accept-
ability of the service and its effectiveness in identifying undiagnosed
HIV infections.
Conclusion: If feasible and effective this new method can create
another reliable low-threshold testing option for different risk
populations -an option hardly needed to break the cycle of low-
testing numbers.
E26 - Co-designing and implementing
programmes at national and regional
scale
TULBE03
HIV treatment as prevention: driving health system
development and improved health outcomes in British
Columbia
C. Panessa1,W. O’Briain2, G. McGowan2, J. Montaner3 and P. Kendall4
1British Columbia Ministry of Health, Population and Public Health,
Vancouver, Canada. 2British Columbia Ministry of Health, Population
and Public Health, Victoria, Canada. 3BC Centre for Excellence in HIV/
AIDS, Vancouver, Canada. 4Office of the Provincial Health Officer,
Figure 1. Dramatic Increase in HIV testing in Vancouver*one of the two STOP HIV pilot areas*compared non-pilot areas. [Increases in HIV
Testing].
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Ministry of Health, Victoria, Canada
Presenting author email: ciro.panessa@gov.bc.ca
Background: Jurisdictions use a mix of horizontal and vertical
approaches to achieve health system reform. Horizontal approaches
like British Columbia’s Innovation and Change Agenda aim to
strengthen the overall health system, while vertical strategies,
supported by specialized provincial structures, address specific
health issues. Both approaches have drawbacks, so public health
leaders such as Jaime Sepúlveda and Julio Frenk have described a
third way, ‘‘the diagonal approach’’: explicit intervention priorities,
with cost effectiveness and improved reach and engagement
embedded as foundational principles, can generate positive dis-
ease-specific outcomes for individuals and populations, while dealing
with generic health system issues such as human resource develop-
ment and quality assurance.
Methods: BC is using an explicit HIV Treatment as Prevention (TasP)
pilot, Seek and Treat to Optimally Prevent HIV (STOP HIV), as a
diagonal approach to drive innovation and strategic change in BC’s
health system. Emphasis has been placed on several outcomes:
improved screening; increased diagnoses due to improved screening;
and increased linkage to care/treatment. Several discrete initiatives
have been deployed to enhance health system capacity to reach
(‘‘Seek’’) and sustainably engage (‘‘Treat’’) vulnerable groups in an
overall program of care.
Results: STOP HIV is driving health system change. Latest data is
confirming that British Columbians’ in the pilot areas are being
better engaged leading to increased HIV testing, diagnoses, treat-
ment and reduced AIDS mortality*see Figures [13].
Conclusion: STOP HIV is a real-world implementation of HIV TasP,
aimed at reducing HIV/AIDS-related morbidity and mortality, as well
as new HIV diagnoses, and as a result containing associated health
system costs. The initiative has become a driver of diagonal health
care reform*and by engaging the most vulnerable and hard to
reach, contributes to reducing health inequalities.
Figure 2. Reversal in new diagnosis trends in Vancouver*one of the two STOP HIV pilot areas*compared to non-pilot areas [Increases in
HIV Diagnoses].
Figure 3. Increasing trend in treatment starts in the two STOP HIV pilot areas (Vancouver Coastel Health and Northern Health) compared to
the rest of the province [Increases in Treatment].
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WEPDE0105
’Less is more’: assessing the effectiveness of a HIV
prevention program for long distance trucker drivers
in India after a re-designing in implementation
structure
V.R. Tirumalasetti1, B. Mahapatra2, S. Juneja1 and I. Singh1
1TCI Foundation, HIV/AIDS Communicatios, Delhi, India. 2Population
Council, New Delhi, India
Presenting author email: vasudha.tcif@tcil.com
Background: A large scale HIV prevention programs among long
distance trucker drivers was started in 2003 across 36 Transhipment
locations (TSLs) alongside the national highways. Program was
re-designed in the year 2006 by reducing number intervention
locations to 17 high performing TSLs. The current research assesses
the effectiveness of program after the re-design process.
Methods: Program monitoring data over seven years and two rounds
of cross-sectional behavioral survey conducted in January 2008
(N1402) and July 2009 (N1407) were used. Indicators on
program outreach and service utilization were examined. Multi-
variate logistic regression models were used to assess if the increase
from first survey to next was significant.
Results: Coverage of program increased from 43535 in 2004 to
311667 in 2010, though there was a decline in number of TSLs. Along
with this, there was a significant increase in number of truckers
utilizing clinical services. Analysis from survey data showed
that there was a seven-fold increase in clinic visit in last 12 months
from 2008 to 2009 (21% vs. 63%, PB 0.001). Significant level
of increase was also observed in percent of truckers who watched
street plays, participation in health exhibitions. Furthermore,
increase from round-1 to round-4 was significant in the following
indicators: received condom (13% to 22%, PB 0.001), one-
one counseling (15% to 21%, PB 0.01). Treatment seeking for
sexually transmitted infection (STI)-related symptoms from STI
clinics also increased six times during this time (16% vs. 50%,
PB0.001).
Conclusion: The re-designing of the intervention has increased the
program coverage and service utilization. Implementing truckers
program in limited number of high-impact locations after proper
planning can help in saturating the coverage and optimum utilization
of the available resources.
E27 - Capacitating public health systems
to deliver HIV care at scale
TULBE04
Changes in population-level HIV RNA distribution one year
after implementation of key components of an HIV ?test
and treat? strategy in rural Uganda
V. Jain1,2, D. Kwarisiima2,3, T. Liegler1, T. Clark1,2, G. Chamie1,2,
J. Kabami2, D. Black1,2, G. Amanyire2,3, D. Byonanebye2,3, E. Geng1,2,
H. Thirumurthy2,4, M. Petersen2,5, E. Charlebois2,6, M. Kamya2,7,
D. Havlir1,2 and and the SEARCH Collaboration
1University of California San Francisco, HIV/AIDS Division, San
Francisco General Hospital, San Francisco, United States. 2Makerere
University-UCSF Research Collaboration, Kampala, Uganda. 3Mulago-
Mbarara Joint AIDS Program, Mbarara, Uganda. 4Gillings School of
Global Public Health, University of North Carolina, Chapel Hill, United
States. 5School of Public Health, University of California, Berkeley,
Division of Biostatistics, Berkeley, United States. 6Center for AIDS
Prevention Studies (CAPS), University of California San Francisco
San Francisco, United States. 7Makerere University School of
Medicine, Kampala, Uganda
Presenting author email: vivek.jain@ucsf.edu
Background: ‘Test-and-treat’ programs combining expanded HIV
diagnosis, linkage to care, and ART delivery are under considera-
tion, but real-world experience is lacking. During 2011, in rural
southwestern Uganda, implementation of ART eligibility to CD4B
350/uL began. Concomitantly, we (A) conducted a community-wide
HIV testing/linkage-to-care campaign, and (B) offered ART to adults
with CD4]350 via a research study (EARLI: NCT01479634). One
year later, we conducted a second health campaign and examined
the population distribution of HIV RNA levels.
Methods: During weeklong campaigns in May 2011 and 2012, all
Kakyerere Parish residents were offered HIV testing (Determine,
Inverness) in multi-disease diagnosis and linkage ‘‘health fairs’’. In
HIV individuals, HIV RNA levels were measured by a validated
fingerprick blood collection method and RT-PCR (Abbott). We
assessed population HIV RNA levels by computing (1) the proportion
of persons with an undetectable VL, (2) the median VL, and (3) the
mean log(VL) among HIV persons.
Results: After community mobilization, 4,343 and 4,872 persons
attended the 2011 and 2012 campaigns, respectively. We estimated
69% and 71% community participation based on census data from
2011 and 2012, respectively. Adult HIV prevalence (]18yrs.)
was 7.8% in 2011 (179/2,282 adults) and 9.4% in 2012 (210/2271
adults). Prevalence was 18.6% on the final day of the health
fair located at the parish trading center, and 8.2% across prior days
(pB 0.001). A substantially higher proportion of HIV individuals
had an undetectable HIV RNA level in 2012 vs. 2011 (55% vs. 37%),
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a165/179 adults tested had a VL completed.
2011 and 2012 HIV Testing Campaigns.
Conclusion: In this ongoing study, we demonstrate that key
components of a test-and-treat strategy are feasible in a resource-
limited setting. One year after implementing intensified community-
based HIV testing and linkage, with ART eligibility regardless of CD4
count, over half of HIV persons attending a health campaign had
undetectable HIV RNA.
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E29 - International funding for HIV scale-
up: following the money
MOAE0306
Funding universal access to antiretroviral treatment
through a ‘Global Health Charge’ on alcohol and tobacco
consumption: feasibility in the 20 countries with the largest
HIV epidemics
A. Hill1 and W. Sawyer2
1Liverpool University, Pharmacology and Therapeutics, London,
United Kingdom. 2MetaVirology Ltd, Statistics, London, United
Kingdom
Presenting author email: microhaart@aol.com
Background: Current funding levels from PEPFAR/Global Fund may
be too low to ensure Universal Access to antiretrovirals (ARVs) in the
long-term. Additional, sustainable sources of funding are required.
Methods: For the 20 countries with the largest HIV epidemics, the
additional costs required to achieve Universal Access were calcu-
lated, using WHO 2011 estimates of patient numbers requiring ARV
treatment, combined with Clinton Foundation prices of ARVs, and
PEPFAR estimates of cost of care/diagnostics. WHO estimates of
adult population size, annual alcohol and tobacco consumption
(commercially supplied) were used to estimate annual revenues from
a ‘‘Global Health Charge’’ of 1 US cent per 10mL unit of alcohol, and
10c per 20 cigarettes.
Results: In the 20 countries with largest HIV epidemics, 5.2/11.3
million eligible patients were receiving antiretrovirals (coverage
46%). The minimum cost of care was $861 per patient-year
(antiretrovirals, $406, medical $300, diagnostics $155). Ten of the
20 countries (Botswana, Brazil, China, India, Nigeria, Thailand, Russia,
Uganda, Ukraine and Vietnam), could fund 100% of Universal Access
costs from National revenue using the ‘‘Global Health Charge’’: $2.57
of the total $17.97 billion of revenue collected per year would cover
treatment of 3.0 million eligible patients in these countries. In the
other 10 countries (Cameroun, Cote d’Ivoire, DR Congo, Kenya,
Malawi, Mozambique, Tanzania, South Africa, Zambia, Zimbabwe)
$937 million could be collected annually with the Global Health
Charge: sufficient to treat 1.1 million eligible patients (35% of the
additional $2.67 billion budget required for Universal Access).
Conclusion: A ‘‘Global Health Charge’’ of 1 US cent per unit of
alcohol, and 10 cents per 20 cigarettes, collected and spent at a
National level, would be sufficient to fund an additional 4.1 million
patients per year with antiretroviral treatment and care; Universal
Access could be acheived in 10 of the 20 countries with this
system.
E31 - Impact of health insurance
schemes, co-payments and out-of-
pocket payments on access, adherence
and outcomes
MOPDE0201
Time and money: the costs of utilizing HIV and TB treatment
and care in rural KwaZulu-Natal
N.Z. Chimbindi1,2, M.-L. Newell1,3 and T. Bärnighausen1,4
1Africa Centre for Health and Population Studies, Research/Scientific,
Mtubatuba, South Africa. 2University of Witwatersrand, School of
Public Health, Johannesburg, South Africa. 3University College
London, Institute of Child Health, London, United Kingdom. 4Harvard
School of Public Health, Global Health and Population, Boston,
United States
Presenting author email: nchimbindi@africacentre.ac.za
Background: HIV and TB treatment is provided free of charge in the
public sector in South Africa. However, patients may lose time and
incur expenses due to utilizing these services. We measure time and
financial costs of utilizing HIV and TB services, and examine in how
far they lead to financial distress (patients’ self-report of either
borrowing money or selling assets to finance healthcare).
Methods: We randomly selected patients in a two-stage-sampling
scheme and collected data in patient exit interviews: 300 patients on
antiretroviral treatment (ART), 200 enrolled in a pre-ART programme,
and 300 receiving TB treatment in rural KwaZulu-Natal, South Africa.
We assess factors associated with financial distress in multiple
regressions, controlling for sex, age and employment.
Results:Most patients utilizing healthcare were women: 79% (in pre-
ART), 62% (ART), 53% (TB). The average times patients spent utilizing
care at the last clinic visit was: 3.5 (pre-ART), 2.8 (ART), and 1.1 hours
(TB). The average total costs of utilizing healthcare during the last
visit were: 15 (pre-ART), 25 (ART), and 20 South African Rand (ZAR)
(TB). Transport was the single largest cost component in all three
patient categories. 39% (ART), 31% (pre-ART), and 41% (TB) of
patients reported financial distress due to healthcare utilization.
For each additional hour spent utilizing healthcare, the odds of
financial distress increased by 3% (pre-ART), 21% (ART) and 64%
(TB). For every additional 10 ZAR spent on utilizing healthcare, the
odds of financial distress increased by 25% (pre-ART), 9% (ART), and
6% (TB).
Conclusion: In this poor, rural community, very high proportions
of patients utilizing HIV or TB services report financial distress
due to healthcare utilization. Frequent, free transport to HIV
and TB clinics would likely substantially reduce the time and
financial burdens of healthcare, as well as the prevalence of financial
distress.
E33 - Social protection
MOPDE0205
Economic spillover effects of ART on rural South African
households
J. Bor1,2, T. Bärnighausen1,2, F. Tanser2 and M.-L. Newell3
1Harvard School of Public Health, Global Health and Population,
Boston, United States. 2Africa Centre for Health and
Population Studies, University of KwaZulu-Natal, Mtubatuba
South Africa. 3Centre for Paediatric Epidemiology and Biostatistics,
University College of London Institute of Child Health, London,
United Kingdom
Presenting author email: jbor@hsph.harvard.edu
Background: ART rollout may have important indirect effects on
households and communities. We assess household spillover effects
of ART on economic outcomes, in a region of rural South Africa with
high HIV prevalence.
Methods: Longitudinal socioeconomic data from a large population
surveillance system (n100,000) were linked with clinical records
from the government ART program serving the area (n6964). We
first describe the extent of household-level exposure to ART among
residents in the community. We then employ panel data techniques
to evaluate the impact of ART on household assets, food insecurity,
and perceived financial status; household composition; and the labor
market participation and school enrollment of other household
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members. We assess trends in these economic outcomes, relative to
the dates when household members accessed the ART program and/
or initiated ART. As a point of contrast, we examine similar trends
relative to dates of death due to HIV in the era before the public
sector ART rollout.
Results: By 2010, two-fifths of area residents lived with someone
who had sought care in the government ART program. Prior to
widespread availability of ART, households in the region experiencing
an HIV-related death faced large economic costs. In contrast, we find
little evidence that households of ART initiators experience sig-
nificant economic hardship due to HIV illness.
Conclusion: South Africa?s public sector ART rollout has provided
substantial social protection for households against the economic
costs formerly associated with HIV illness and death. Through
indirect exposure to ART via household living arrangements, large
populations now enjoy the economic benefits of ART.
E34 - Cost-effectiveness of optimizing
diagnostics and monitoring tools
TUAE0101
Cost-effectiveness of lateral-flow urine LAM for TB diagnosis
in HIV-positive South African adults
D. Sun1, S. Dorman2,3, M. Shah2,3, Y. Manabe3,4 and D. Dowdy1,3
1Johns Hopkins Bloomberg School of Public Health, Epidemiology,
Baltimore, United States. 2Johns Hopkins School of Medicine,
Medicine, Baltimore, United States. 3Center for Tuberculosis
Research, Baltimore, United States. 4Infectious Diseases Institute,
Kampala, Uganda
Presenting author email: sandydisun@gmail.com
Background: Improved diagnosis of tuberculosis (TB) is a high
priority in people living with HIV/AIDS. A lateral flow assay is
now available for point-of-care detection of lipoarabinomannan
(LAM, a cell wall component of Mycobacterium tuberculosis) in
urine. This assay improves sensitivity of TB diagnosis in highly
immunocompromised individuals, but its cost-effectiveness is
uncertain.
Methods: We incorporated data from a clinical evaluation of
lateral-flow urine LAM into a decision-analytic cost-effectiveness
model. Our study cohort consisted of hospitalized, HIV-infected
South African adults with CD4 T-cell countsB100 cells/mL,
clinical consideration of TB diagnosis, and access to sputum smear
microscopy. Our primary outcome was the incremental cost-effec-
tiveness ratio (ICER), expressed in 2011 US dollars per disability-
adjusted life year (DALY) averted from the perspective of a public-
sector TB control program. Key assumptions are shown in Table 1.
We adopted a lifetime time horizon with 3% discounting and
performed both sensitivity analysis and probabilistic uncertainty
analysis.
Results: For every 1000 patients tested, adding lateral-flow urine
LAM to microscopy generated 80 incremental appropriate TB
treatments and averted 58 DALYs, at a cost of $1400 (95%
uncertainty range: $716$5773) per DALY averted (Table 2). The
majority of incremental costs reflected TB treatment. Incremental
cost-effectiveness was most sensitive to assay specificity, cost of TB
treatment, life expectancy after TB cure, and cohort TB prevalence
(Figure 1 and Figure 2). The probability of acceptability was 99.1% at
a per-DALY willingness-to-pay threshold equal to per-capita gross
domestic product ($11,000) and 85.3% at a threshold of $2000
(Figure 3).
Conclusion: Lateral-flow detection of urinary LAM is potentially cost-
effective for TB diagnosis in severely immunocompromised
South African adults. Cost-effectiveness can be maximized by
deploying this assay in populations with high TB prevalence,
adopting treatment thresholds that optimize specificity, and
Scenario Cohort Size TB Cases TB Cases Treated
Non-TB Cases







1000 380 262 130 170 495 $306,000
Smear Plus
Urine LAM
1000 380 342 155 110 437 $387,000 $1400
Cost Effectiveness of Lateral-Flow Urine LAM.
Name Value Sensitivity Range Reference
TB prevalence 0.38 0.120.5 Study data
LAM sensitivity 0.66 0.31 Study data
LAM specificity 0.95 0.71 Study data
Sputum smear sensitivity 0.345 0.20.5 IJTLD 2011; 15:287295
LAM cost $3.50 $1$30 IJTLD 2011; 15:287295
Treatment cost, per person $870 $500$2000 WHO 2011
Probability of empiric therapy: TB cases who test negative 0.53 00.75 BMC Public Health 2011; 11:127
Probability of empiric therapy: people without TB who test negative 0.21 00.5 AIDS 2007; 21:20432050
Life expectancy following TB cure (CD4 T-cell count B100 cells/mL) 1.45 110 Actuarial Society of South Africa 2008
Key Parameter Values.
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promptly delivering antiretroviral therapy to extend patients’ life
expectancy following cure.
TUAE0105
Routine HIV screening in Portugal: clinical impact and
cost-effectiveness
Y. Yazdanpanah1, J. Perelman2, J. Alves2, K. Mansinho3,
M.A. Dilorenzo4, J.-E. Park4, E. Losina5,6,7, R.P. Walensky4,5,
F. Noubary4, H. Barros8, K.A. Freedberg4,6,7 and A.D. Paltiel9
1Hospital Bichat Claude Bernard, Paris, France. 2National School
of Public Health, Nova University of Lisbon, Lisbon, Portugal.
3Hospital Center Lisboa Ocidental, Lisbon, Portugal. 4Massachusetts
General Hospital, Boston, United States. 5Brigham and Women’s
Hospital, Boston, United States. 6Harvard Medical School
Boston, United States. 7Boston University School of Public
Health, Boston, United States. 8Institute of Public Health,
Porto University, Porto, Portugal. 9Yale University, New Haven
United States
Presenting author email: yazdan.yazdanpanah@bch.aphp.fr
Background: We sought to forecast the clinical impact and cost-
effectiveness of routine HIV screening in Portugal, where the burden
of disease remains high.
Methods: We used a computer model of HIV detection and
treatment, coupled with Portuguese national clinical and economic
data, to estimate life expectancy (LE), cost, and the incremental cost-
effectiveness ratios (ICERs) of alternative HIV screening strategies.We
compared current HIV detection practices in Portugal to routine HIV
screening in adults aged 1869. We considered a variety of target
populations with differing levels of HIV risk and several testing
strategies including the current strategy, one-time screening,
screening every five years, screening every three years, and annual
screening (Table 1). Baseline input values included: undiagnosed HIV
prevalence (0.16%), annual incidence (0.020%), mean age (42 years),
mean CD4 at care initiation (292 cells/mL), test acceptance (63%),
linkage to care (78%), HIV test cost (_5.40), and an annual discount
rate (5%). We conducted extensive sensitivity analyses on these
values.
Tornado Diagram: One-Way Sensitivity Analyses.
Preferred Strategy, Willingness to Pay$11,000.
Cost-Effectiveness Acceptability Curve.
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Results: One-time testing increased discounted HIV-infected LE from
15.426 to 15.652 LYs and undiscounted HIV-infected LE from 36.117
to 36.597 LYs, as compared to current detection practice (Table 1).
One-time testing yielded greater increases in HIV-infected LE and was
more cost-effective in regions with greater HIV risk (Table 2, Lisbon,
Undiagnosed HIV Prevalence0.29%, Annual Incidence0.037%),
compared to regions with lower HIV risk (Table 3, Guarda,
Undiagnosed HIV Prevalence0.03%, Annual Incidence0.004%).
In Lisbon, the cost-effectiveness ratio of screening every three years
was 48,200 _/QALY and the cost-effectiveness ratio of annual
screening was 76,300 _/QALY.
Conclusion: One-time, routine, voluntary HIV screening in the
Portuguese general population meets accepted international stan-
dards of cost-effectiveness. One-time screening is more attractive in
regions with higher undiagnosed HIV prevalence and even more
frequent screening may be justified in these regions given their
higher incidence rates.
TUPDE0201
Cost effectiveness evaluation of alternative monitoring
strategies for antiretroviral therapy in low-resource settings:
monitoring of HIV viral loads, CD4 cell counts and clinical
assessments versus clinical monitoring alone (STRATALL
ANRS 12110/ESTHER trial in Cameroon)
S. Boyer1,2,3, L. March1,2,3, C. Kouanfack4, G. Laborde-Balen5,
P. Marino1,2, A. Aghokeng6,7, E. Mpoudi-Ngole7, S. Koulla-Shiro4,8,
E. Delaporte6,9, M.P. Carrieri1,2,3, B. Spire1,2,3, C. Laurent6,
J.-P. Moatti1,2,3 and Stratall ANRS 12110/ESTHER Study Group
1INSERM, U912 (SESSTIM), Marseille, France. 2Aix Marseille
Universit, IRD, UMR-S912, Marseille, France. 3ORS PACA,
Observatoire Rgional de la Sant Provence Alpes Cte d’Azur, Marseille,
France. 4Central Hospital, UMI 233, Yaound, Cameroon. 5UMI 233
Yaound, Cameroon, French Ministry of Foreign Affairs, Yaound,
Cameroon. 6Institut de Recherche pour le Dveloppement (IRD),
Table 1. National base case results
HIV-INFECTED POPULATION GENERAL POPULATION
Undiscounted Discounted Undiscounted Discounted
Screening strategy LYs LYs QALYs Costs (Euros) LYs LYs QALYs Costs (Euros) ICER (Euros/QALY)
Current screening practice 36.117 15.426 14.549 76,930 38.216 16.097 16.089 720 *
One-time screening 36.597 15.652 14.752 83,500 38.221 16.099 16.091 780 36,500
Screening every 5 yrs 37.128 15.778 14.871 88,530 38.226 16.101 16.092 840 dom*
Screening every 3 yrs 37.381 15.850 14.940 91,320 38.227 16.101 16.093 870 57,200
Annual screening 37.896 16.011 15.090 97,980 38.233 16.103 16.094 980 91,700
*dom‘‘weakly dominated.’’ Costs more and confers fewer QALYs than an alternative strategy.
**DOM‘‘strongly dominated.’’ Costs more and is less effective than an alternative strategy.
Table 2. Lisbon region base case results
HIV-INFECTED POPULATION GENERAL POPULATION
Undiscounted Discounted Undiscounted Discounted
Screening strategy LYs LYs QALYs Costs (Euros) LYs LYs QALYs Costs (Euros) ICER (Euros/QALY)
Current screening practice 36.077 15.416 14.538 77,020 38.152 16.083 16.068 1,300 *
One-time screening 36.560 15.646 14.744 83,710 38.161 16.086 16.071 1,410 34,900
Screening every 5 yrs 37.092 15.772 14.863 88,740 38.170 16.089 16.073 1,510 47,900
Screening every 3 yrs 37.350 15.843 14.931 91,550 38.174 16.090 16.074 1,560 48,200
Annual screening 37.871 16.002 15.079 98,190 38.184 16.092 16.076 1,720 76,300
Table 3. Guarda region base case results
HIV-INFECTED POPULATION GENERAL POPULATION
Undiscounted Discounted Undiscounted Discounted
Screening strategy LYs LYs QALYs Costs (Euros) LYs LYs QALYs Costs (Euros) ICER (Euros/QALY)
Current screening practice 36.176 15.435 14.559 76,750 38.280 16.112 16.111 140 *
One-time screening 36.622 15.662 14.764 83,320 38.280 16.113 16.111 150 62,800
Screening every 5 yrs 37.158 15.786 14.881 88,380 38.282 16.113 16.111 170 dom*
Screening every 3 yrs 37.416 15.860 14.953 91,090 38.282 16.113 16.111 180 97,800
Annual screening 37.934 16.010 15.091 97,860 38.282 16.113 16.111 240 DOM**
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Background: Since the introduction of antiretroviral therapy (ART) in
low-resource settings the use of laboratory monitoring for HIV
infection has been the subject of great debate. This study aimed to
assess the cost and cost-effectiveness of clinical plus laboratory
monitoring (LAB) compared with clinical monitoring alone (CLIN).
Methods: A randomized non-inferiority trial was performed in nine
rural district hospitals in Cameroon. HIV-infected, ART-naive adults
with WHO stage 3-4 disease were enrolled and followed-up for 2
years. Participants were randomly assigned to CLIN (quarterly clinical
monitoring) or LAB (six-monthly HIV viral loads and CD4 cell counts
plus quarterly clinical monitoring) by a computer-generated list.
Clinical outcomes and related-costs were calculated among patients
followed-up for at least six months excluding the period unrelated to
ART monitoring. Incremental cost-effectiveness ratios (ICER; US$ per
life-years saved) were computed based on two HIV-RNA test costs
(Abbot molecular technology, $67 and in house ANRS test, $35). One-
way and multivariate sensitivity analyses were performed.
Results: Analyses were conducted among 188 and 197 patients in
the LAB and CLIN groups respectively. With the Abbott test, results
per 100 individuals showed that LAB compared with CLIN increased
costs by $49,800 and saved 10.6 life-years (ICER$4678 per life-year
saved). With the ANRS test, the incremental cost is $34,900 per 100
individuals, i.e. an ICER of $3276 per life-year saved. 50 000 trial
Monte Carlo simulation showed ICERs (IQR) from $3536-$5136 and
$2553-$3642 per life-year saved with the first and second tests
respectively. Considering a cost-effectiveness threshold of $3800 (i.e.
three times the Cameroonian capita gross domestic product), LAB is
cost-effective when the cost of HIV-RNA plus CD4 cell count are
lower than $75.
Conclusion: Monitoring of HIV viral load and CD4 cell count to guide
switching to second-line ART is cost-effective in resource-limited
settings when using less costly generic tests.
E36 - Cost-effectiveness of management
of health care systems
TUAE0102
Cost-effectiveness of strategies to promote identification of
HIV cases: economic analysis of a controlled trial in China
G. Zeng1, F. Lu2, K. Khoshnood3 and Z. Wu2
1Chinese Center for Disease Control and Prevention, Beijing, China.
2National Center for AIDS/STD Control and Prevention, Chinese
Center for Disease Control and Prevention, Beijing, China. 3Yale
University, New Haven, United States
Presenting author email: hxydzg@163.com
Background: Expanding HIV testing in healthcare settings needs
more economic evidence in China with concentrated HIV epidemic.
This study was aimed to examine the costs and benefits of strategies
to improve HIV testing and promote case finding.
Methods: Cost-effectiveness analysis based on a Markov model was
applied to compare three HIV testing strategies for patients in
outpatient departments: Strategy Atargeted testing based on risk
behavior and symptoms, Strategy Bnon-targeted testing all male
adult patients with blood withdrawn for any clinical reasons, Strategy
Cnon-targeted testing all adult patients with blood withdrawn.
Unidentified HIV prevalence, number of testing, number of newly
identified cases, and related costs were derived from a controlled
trial, which compared the effectiveness of strategies above in areas
with concentrated epidemic in China. Long-term costs and health
outcomes were derived from the literature. Incremental cost utility
was evaluated from a societal perspective using a lifetime horizon.
The benefit from reduced HIV transmission was not considered.
Results: With 0.3% of the undiagnosed outpatient HIV prevalence in
study areas, the cost per new HIV infection identified was $146.1,
$258.4 and $350.9 under strategy A, B, C, respectively. Strategy A
resulted in per-patient lifetime discounted costs of $11,349 and
benefits of 6.21 quality-adjusted life-year (QALY) gained. Strategy B
increased mean QALY by 0.018, with an incremental cost-effective-
ness of ?5,710/QALY, and Strategy C increased mean QALY by
0.017 than strategy B, with an incremental cost-effectiveness of
$6,592/QALY. Sensitivity analysis showed that even if the undiag-
nosed HIV prevalence was as low as 0.113%, annual implementation
of strategy C would still be cost-effective, with a cost of $14,059
to save a QALY, which was just 3 times of GDP per capital in
China.
Conclusion: In concentrated epidemic area, non-targeted HIV testing
in healthcare setting is cost-effectiveness and justified for sustainable
investment.
E37 - Cost-effectiveness of programmes
building individual, community and
institutional capacity
TUAE0103
Cost-effectiveness of test and treat prevention in a high HIV
prevalence U.S. city
F. Escaleira1,2, R. Birger3, T. Hallett4, B. Grenfell3, S. Hodder1 and
A. Sinha5
1New Jersey Medical School, UMDNJ, Medicine, Division of Infectious
Diseases, Newark, United States. 2UMDNJ School of Public Health,
Piscataway, United States. 3Princeton University, Ecology and
Evolutionary Biology, Princeton, United States. 4Department of
Infectious Disease Epidemiology, Imperial College London, London,
United Kingdom. 5New Jersey Medical School, UMDNJ, Preventive
Medicine and Community Health, Newark, United States
Background: Progress in reducing HIV incidence in the US epidemic
has stalled in recent years. Modeling studies suggest that test-and-
treat interventions could powerfully control some HIV epidemics.
Using mathematical modeling, we assess cost-effectiveness of test-
and-treat strategies in the HIV epidemic in Newark, NJ, one of the
most severe in the U.S.
Methods: A compartmental model was developed representing
populations at HIV-risk in Newark with transmission through sex
and intravenous drug use. The model was calibrated to NJ data on
annual prevalent cases by acquisition mode, 20022009. Three
interventions (In) were considered: In1 increased HIV testing cover-
age; In2 provided In1 and case management; In3 provided In2 and
universal antiretroviral therapy. In current practice, at-risk subjects
were assumed tested once every four years. Expanded testing
resulted in the testing frequency doubling. Health resource use
and unit costs were estimated, testing and HIV-related outpatient
costs calculated, and inpatient and emergency department costs
abstracted from the literature. A health care system perspective, 3%
discount rate, and ten-year program time horizon were used. Costs
are in U.S. dollars (USD) 2011.
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Results: At the start, 220,500 individuals were HIV-uninfected but
at-risk and 16,550 were HIV-infected. Annually, In1, In2, and In3
averted a median of 142, 581, 658 incident cases and 162, 826, and
901 HIV-related deaths respectively. Ten-year costs, cases/ deaths
averted are presented (Table 1). ICERs per death averted for In1,
In2, and In3 were $146,800, $28,000 and $143,100 respectively.
In1 is less efficient than a blend of current practice and In2. If such
a blend were implementable, then In1 would be eliminated
and ICERs for In2 and In3 would be $62,800 and $143,100
respectively.
Conclusion: Test-and-treat strategies, particularly testing combined
with case management / universal ART, may substantially
decrease HIV transmission in this high prevalence area, prevent
HIV-related deaths, and do so in a cost-effective fashion.
TUPDE0103
Value for money of structural interventions: going beyond
HIV-only cost-effectiveness analysis
M. Remme1, A. Vassall1, B. Lutz2 and C. Watts1
1London School of Hygiene & Tropical Medicine, Global Health &
Development, London, United Kingdom. 2UNDP, New York, United
States
Presenting author email: michelle.remme@lshtm.ac.uk
Background: The UNAIDS Investment Framework highlights ‘’critical
enablers’‘ that influence the success of HIV programmes; and
synergies with other development sectors. Although the need to
address the structural drivers of HIV vulnerability is well recognised,
there is a danger that these interventions are not prioritised in HIV
budgets, given the limited body of evidence on their cost-effective-
ness. A key challenge to economists evaluating such interventions is
how to assess the wide range of costs and consequences of these
comprehensive structural interventions. We use two methods to
estimate the cost-effectiveness of a conditional cash transfer in
Malawi to keep girls in school.
Methods: We model national costs based on full coverage of girls of
secondary school age (1519 years) living on less than US$1.25 a
day. Based on trial evidence, we model a 64% reduction in HIV
incidence among the target group to estimate economic benefits.We
use two economic evaluation approaches, one that apportions the
total costs of the intervention according to the HIV-related propor-
tion of total economic benefit and another based on the WHO cost-
effectiveness threshold.
Results: We find that about 30% of estimated economic benefits in
Malawi are related to HIV. The trial estimated a cost per infection
averted (IA) of US$12,500, which we translate into a cost per DALY of
US$711. Allocating total costs according to the proportion of HIV-
related economic benefit reduces the cost per IA to US$3,750 and
the cost per DALY to US$213. Alternatively, if the HIV programme
wishes to achieve cost-effectiveness at the WHO threshold of GDP
per capita (US$310) then it would achieve value for money by
funding 44% of total costs.
Conclusion: HIV programmes are recommended to allocate funds to
structural interventions based on proven effectiveness and according
to the threshold at which the intervention becomes cost-effective
from an HIV perspective, rather than estimating conventional cost-
effectiveness ratios.
E38 - Effects of adult and paediatric HIV
treatment on earned and family income
MOPDE0204
Impact of antiretroviral therapy (ART) on socio-economic
status and productivity of HIV-positive individuals/
households in a private setting in India
F. Visnegarwala1,2, A. Nalli2, R. Babu2, S. Satish2, L. Pradeep2 and
G. Alexander2
1Indian Institute of Health Management and Research, Public Health,
Bangalore, India. 2Action Service and Hope for AIDS (ASHA)
Foundation, Research, Bangalore, India
Presenting author email: fehmidav@gmail.com
Background: PLHA have decreased economic productivity both due
to direct and indirect causes. Data from developed countries have
shown that at the societal level, high costs ARTare offset by increased
productivity. However, these data have to be substantiated in
developing countries where the expenditure for ART largely borne
by individuals.We hypothesized that post-ART the SES would improve
regardless of the baseline SES and will be sustained over time.
Methods: We performed a comprehensive SES evaluation pre/post
ART initiation using an ambispective cohort study design. Indian
household-specific SES validated tool’’ (Aggarwal OP 2005), with
score of B15 being indigent to 76 being affluent was used
prospectively, along with clinical, ART adherence data at 6 &18
months post ART, compared using paired t-tests.
Results: Among 140 started on ART, 118 had pre ART SES data,
median f/u was 22 months, of these: 57% were women; median age
38 years; 67% married; 89 (78%) heterosexual sex as HIV risk; 40
(34%) had major OI and/or TB at presentation. Reported self-
occupation was: skilled laborers 35%; 10% unskilled laborers; 23%
housewives; 22% were professionals/ blue collar job;1 CSW, 1
student, 10 unemployed. The median pre-post ART CD4 cell counts
were: 187& 454 (pB0.01); median body weight pre-post ART was 54
& 57 kg (pB0.01); 97% were 100% adherent. The mean Pre-ART
total SES score was 37.06 (/ 10.2); and Post-ART SES score 40.62
(910.1 PB0.001) and these results were sustained over time,
remained significant when only monthly income included on
exclusion of fixed assets. Delta change in SES was directly correlated
















$758,618,000 $276,685,000 $1,035,302,000   
In1 $934,916,000 $368,002,000 $1,302,918,000 $267,616,000 1,097 1,823
In2 $1,058,479,000 $367,446,000 $1,425,926,000 $123,008,000 3,036 4,395
In3 $1,128,486,000 $394,732,000 $1,523,218,000 $97,292,000 485 680
*10-year aggregated totals, discounted, increments relative to next strategy.
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to increase in CD4 and weight, indirectly to being housewife/
unemployed and having a dead spouse.
Conclusion: Our data show a significant impact of ART on SES in a
sustained manner in a developing world setting, which has policy
level implications.
E41 - Pharmacoeconomics and cost
effectiveness
FRAE0102
The cost-effectiveness of maternal and infant
antiretroviral regimens to prevent vertical HIV
transmission in Malawi
P. Revill1, M. Sculpher1, S. Walker1, C.S. Chasela2, D. Kayira2,
M.C. Hosseinipour2,3, C. Merry4, M. Barry4, C.K. King5, D.J. Jamieson5,
D.M. Gibb6, C. van der Horst3 and M. Ryan4
1University of York, Centre for Health Economics, York, United
Kingdom. 2University of North Carolina Project, Lilongwe, Malawi.
3University of North Carolina at Chapel Hill, Division of Infectious
Diseases, Centre for AIDS Research, Chapel Hill, United States.
4Trinity College Dublin, Department of Pharmacology and
Therapeutics, School of Medicine, Dublin, Ireland. 5Centers for
Disease Control and Prevention (CDC), Atlanta, United States.
6Medical Research Council, Clinical Trials Unit, London, United
Kingdom
Presenting author email: paul.revill@york.ac.uk
Background: This study assessed the cost-effectiveness of maternal
triple-drug ARTor infant nevirapine to reduce HIV transmission during
breastfeeding from HIV-infected Malawian mothers, not meeting
treatment guidelines for their own health. Strategies were evaluated
at two entry points into the health system: (1) time of delivery,
for mothers who have not accessed ART antenatally, and (2)
antenatally.
Methods: Cost-effectiveness was estimated from the healthcare
perspective, using nationally representative unit costs, and was
evaluated in terms of HIV transmissions averted, life-years gained,
quality adjusted life-years (QALYs), and disability adjusted life-years
(DALYs). The risk of HIV transmission associated with the antenatal
and postnatal strategies were taken from the Kesho Bora and BAN
studies, respectively. Antenatal regimens were (1) AZT and (2) AZT,
3TC, lopinavir/ritonavir. The postnatal interventions were (1) mater-
nal ART (AZT, 3TC, lopinavir/ritonavir); (2) infant NVP; and (3) no
extended post-natal prophylaxis. Scenario analyses evaluated alter-
native drug combinations and prices, 2nd trimester initiation, and
varying paediatric ART coverage.
Results: For entry into the health system at delivery, infant
nevirapine throughout breastfeeding was cost effective. With
antenatal entry to the health system, antenatal AZT plus infant
nevirapine during breastfeeding was cost effective. The incremental
cost-effectiveness ratios for these strategies were $616.28 and
$1,031 per HIV transmission averted, $31.84 and $53.33 per life-
year saved, $34.25 and $57.20 per QALY and $32.47and $54.42 per
DALY averted, respectively. The recommended strategies did not
change in the alternative scenario analyses.
Conclusion: For pregnant, HIV-1 infected women presenting to the
health system at delivery and not requiring ART for their own health,
infant nevirapine throughout breastfeeding is a highly cost-effective
method for postpartum PMTCT. For those presenting antenatally,
antenatal AZT followed by infant nevirapine throughout breastfeed-
ing (World Health Organization Option A) is the most cost-effective
PMTCT strategy.
FRLBX06
The clinical and economic impact of a generic first-line
antiretroviral regimen in the U.S.
R.P. Walensky1, P.E. Sax2, Y.M. Nakamura3, M.C. Weinstein4, P.P. Pei3,
K.A. Freedberg1, A.D. Paltiel5 and B.R. Schackman6
1Massachusetts General Hospital, Harvard Medical School, Boston,
United States. 2Brigham and Women’s Hospital, Harvard Medical
School, Boston, United States. 3Massachusetts General Hospital,
Boston, United States. 4Harvard School of Public Health, Boston,
United States. 5Yale School of Medicine, New Haven,
United States. 6Weill Cornell Medical College,
New York, United States
Presenting author email: rwalensky@partners.org
Background: US guidelines recommend once-daily, one-pill efavir-
enz/emtricitabine/tenofovir as a preferred first-line ART regimen.
With the anticipated availability of generic efavirenz in the US,
the cost of a once-daily, three-pill alternative (generic efavirenz,
generic lamivudine, tenofovir) will decrease, but adherence and
virologic suppression may be lower. We project the clinical impact,
cost, and cost-effectiveness of the generic-based vs. brand-name
options.
Methods: Using an HIV simulation model (CEPAC-US), we examine 3
strategies: 1) No ART (for comparison); 2) three-pill generic-based
ART; and 3) one-pill brand-name ART. Inputs are from peer-reviewed
data: ART efficacies (24-week suppression: 78% generic-based vs.
85% brand-name); drug costs are 25% of average wholesale price

















QALY: Quality-adjusted life year; ICER: Incremental cost-effectiveness
ratio. *QALYs and costs discounted at 3% annually; undiscounted life
expectancy for one-pill brand-name 19.33 QALYs.
Figure. Incremental cost-effectiveness or brand-name compared
to generic based first-line ART regimen.
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$15,370/year for the regimen); the cohort is 84% male, mean CD4
317/ml. From the US health system perspective (2010 USD), we
report incremental cost-effectiveness ratios (ICERs, $/QALY) com-
pared against a $100,000/QALY threshold. We also project the
potential annual savings for those initiating ART (incident diagnoses,
2,500) and those eligible to switch to the generic-based regimen
(prevalent cases, 147,000)
Results: Compared to No ART, generic-based ART has an ICER of
$21,600/QALY. Compared to generic-based ART, brand-name ART
increases lifetime costs by $43,900, and per-person survival gains by
0.36 quality-adjusted life years (due to increased efficacy and
reduced resistance from emtricitabine compared to lamivudine),
for an ICER of $121,300/QALY (Table). ICERs are sensitive to
decreases in generic-based ART efficacy and to generic drug costs;
most plausible combinations lead to ICERs $100,000/QALY
(Figure). Estimated annual savings if all eligible US incident/prevalent
patients switched to the generic-based regimen are $1.01B.
Conclusion: Compared to a slightly-less effective generic-based
regimen, the cost-effectiveness of the guideline-recommended
brand-name regimen exceeds the $100,000/QALY threshold. Switch-
ing to generic-based regimens would yield substantial savings for
programs that fund HIV treatment.
E42 - Effects of public-private part-
nerships, and working with faith-based
groups and traditional healers on HIV
outcomes
TULBE01
Quantifying the role of private health providers in HIV
testing: analysis of data from 18 countries
D. Johnson, X. Cheng and S. Sulzbach
Abt Associates Inc., Bethesda, United States
Presenting author email: sara_sulzbach@abtassoc.com
Background: In many developing countries, reliance on private
providers for healthcare, even among the poor, is high. However,
less is known about health seeking behavior specific to HIV/AIDS
care. As countries increasingly view the private health sector as an
integral part of the overall health system, it is critical to understand
the current and potential role of private providers in addressing HIV/
AIDS needs.
Methods: We analyze 20 Demographic and Health Surveys from 18
countries conducted between 2005 and 2011 in which information
on source of HIV test is available.
Results: Use of private providers for HIV testing varies greatly
across countries (see Figure 1). Overall use of the private sector
for HIV testing is strongly correlated with use of the private
sector for other health services but not strongly correlated
with per capita GDP, uptake of HIV testing, or overall HIV prevalence.
At the household level, use of the private sector is highly correlated
with household wealth in nearly all countries (see Figure 2) but not
strongly associated with level of education, marital status or location
(urban vs. rural) in most countries.
Figure 2. Among Women Reporting Having Received an HIV Test from the Private Sector, Share from Each Wealth Quintile [Breakup of Users
of Private Sector for HIV Testing].
Figure 1. Among Those Who Received an HIV Test, Share Who
Received Test from Private Provider [Use of Private Sector for HIV
Testing].
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In addition to information on source of most recent HIV test, DHS
data also contains information on whether women who received
ANC were offered an HIV test allowing us to compare public and
private providers on this simple measure of performance. In all
countries but two (Malawi and Uganda) private providers were more
likely to offer an HIV test during ANC than their public and non-profit
counterparts.
Conclusion: The private sector plays a significant role in HIV testing
in many countries. More research is needed to understand how
private providers could be further leveraged to increase levels and
quality of HIV testing and counseling and strengthen national HIV
responses.
E47 - Human resources development
for prevention, treatment, care and
multi-sectoral responses
THPDE0104
Helping people deliver: how introducing pre-service training
in supply chain management has strengthened local
capacity, produced cost-savings and improved patients’
lives
E. Hasselberg1 and J. Chavez2
1Supply Chain Management System (SCMS), Boston, United States.
2Supply Chain Management System (SCMS), Lusaka, Zambia
Presenting author email: ehasselberg@pfscm.org
Background: Supply chains are essential to securing availability of
life-saving commodities for patients. Unfortunately, logistics training
is often absent from the professional education of staff operating the
supply chain. In-service training, while traditionally used to teach
supply chain skills, takes personnel away from their work, is
expensive to implement and often relies heavily on external technical
assistance. USAID is investing in pre-service training (PST) as a cost-
effective and sustainable alternative to build a competent health
workforce in supply chain management (SCM).
Methods: The Supply Chain Management System (SCMS), a project
under PEPFAR administered by USAID, works with local univer-
sities to incorporate SCM courses into pharmacy and nursing
programs and build the capacity of university staff to plan,
teach and manage those courses. Course content is based on local
context and existing supply chain systems and prepares health
workers for day-to-day supply chain tasks they will encounter
post-graduation.
Results: As a result of SCMS PST initiatives, the Namibian School of
Pharmacy now includes pharmaceutical management and procure-
ment courses in its curriculum. In Zimbabwe, with support from the
USAID j DELIVER PROJECT, three pharmacy programs offer SCM
courses, with nursing programs to follow suit. Two national
universities in Rwanda and Zambia require laboratory logistics
courses for laboratory science degree programs. Since the Zambia
course’s introduction, SCMS in-service training costs have been
reduced by 62%; 80% of the 272 students trained currently work in
MOH facilities.
Conclusion: SCMS PST activities build local capacity in health supply
chain and develop a sense of ownership for local training institutions
in creating a skilled SCM workforce. Future health workers graduate
with a fundamental understanding of SCM, enabling them to make
an immediate contribution to the health system. Savings from
reduced reliance on in-service training can be reinvested into
national HIV programs, allowing for expanded services and poten-
tially improved health outcomes.
E48 - Commun i t y coord ina t ing
mechanisms
WEPDE0205
Reducing harassment amongst sex workers: Aastha
experiences of community committees in addressing crises
in Mumbai, India
G. Nidhi1, V. Ranebennur2, D.S.S. Gaikwad3 and A. Bhende4
1FHI 360, India, Program-Community Mobilization and Advocacy,
Mumbai, India. 2FHI 360, India, Program, Mumbai, India. 3FHI 360,
India, Directorate, Mumbai, India. 4FHI 360, Aastha, Mumbai, India
Presenting author email: gnidhi@fhiindia.org
Background: Sex Workers (SWs) in Mumbai, India are highly
vulnerable and face numerous incidents of harassment from police,
stakeholders, clients, family members.
Since 2004, FHI 360 has implemented a BMGF supported HIV/STI
prevention project with over 80,000 male, female and transgender
SWs in Mumbai. A community led, crisis response system (CRS) was
devised to address the crises incidents.
Methods: In January 2007, SWs were collectivized by peer educators
(PEs) into site-level Task Force Committees (TFCs), members of
which are community leaders. The focus of the TFCs was to provide
instant support in times of harassment from key stakeholders
including police, criminal elements and regular partners. Core TFC
members were capacitated through training programs on legal
literacy, skill building on addressing incidents of stigma, discrimina-
tion and harassment and improving negotiation and communication
skills.
Results: From January 2007December 2011, over 84,000 crisis
incidents were supported. Analysis of program data, showed that the
Figure 1. Crisis incidents supported.
Figure 2. Average Crises Response Time.
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percent of crises support increased from 47% (January 2007) to 100%
(December 2011) [Graph 1]. The average response time to the crises
incidents reduced from 75 minutes (September 2007) to 21 minutes
(December 2011) [Graph 2]. Also the percent of police arrests, out of
the total crises occurred, reduced from 62% (January 2007) to 10%
(December 2011) [Graph 3].
Data from Behavioural Tracking Survey, a cross-sectional behavioural
study with 2,106 FSWs conducted in 2010 also showed that
90.7% FSWs who were aware of CRS had accessed crisis services
at least once in the last six months, as compared to those who
were not aware of the CRS (66.8%) (pB0.001 [OR]4.84:
3.836.12).
Conclusion: Site-level TFCs are integral to a CRS that responds
effectively and instantly to incidents of harassment faced by SWs.
Programmatically, this could lead to reducing barriers of access to
services.
E49 - Peer programmes and organizations
THPDE0305
Inmate peer educators are essential to prison-based HIV
testing and TB screening in Zambia
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Background: High HIV and TB rates, poor health services, over-
crowding and lack of human and financial resources are common in
prisons of sub-Saharan African countries, including Zambia. Severe
staff shortages and the need for inmate buy-in led to recruitment
and training of inmates to assist in the implementation of prison-
based HIV testing and TB screening. We describe the inmate peer
educator program implemented during a TB REACH-funded colla-
boration between the Zambia Prisons Service (ZPS) and the Centre
for Infectious Disease Research in Zambia.
Methods: Eligible peers were chosen by prison officers, and received
5 days of training to complete symptom assessments, refer inmates
for TB/HIV screening, collect sputum, assist with enrollment into
National HIV and TB treatment programs, and provide educational
outreach and counseling. Inmate drama members were also
mentored to convey health messages through acting, music, and
dance.
Results: We trained 74 peer educators and 57 drama members and
found that they were enthusiastic and committed to the screening
program. Between November 2010 and September 2011, peers led
6,436 inmates (average of 32 inmates screened per day), through HIV
testing and TB screening. Challenges included: requests for incen-
tives, concerns over TB exposure, and difficulty maintaining ade-
quate numbers of peers because of inmate release and transfer.
Solutions included: promotions within inmate hierarchies, provision
of N95 respirators, and additional training to maintain peer numbers
and establish peer-to-peer mentorship.
Conclusion: Scale-up of prison health services in sub-Saharan Africa
is an urgent priority. This inmate peer educator program was a low-
cost, effective intervention that was critical to the successful
implementation of this prison-based HIV and TB program. Ongoing
support and ownership by ZPS and prisoners is needed to ensure
long-term program sustainability.
E53 - Decentralization of services
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Outcomes of antiretroviral treatment programs in rural
Lesotho: health centers and hospitals compared
N.D. Labhardt1, M. Sello2, M. Mohlaba3, O. Keiser4, K. Pfeiffer5,
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Background: In order to improve access to antiretroviral therapy
(ART), Lesotho was one of the first countries in southern Africa to
adopt task-shifting from hospitals to nurse-led health centers (HC).
We compared outcomes in patients who initiated ART at HC with
those who started at hospitals in two catchment areas in rural
Lesotho.
Methods: Patients aged ]16 years who started ART in one of two
hospitals or one of their 12 affiliated HCs between 2008 and 2011
were included. Baseline characteristics were compared using Mann-
Whitney and Pearson’s chi-square tests. No follow-up was defined as
no recorded follow-up after starting ART, lost to follow-up (LTFU) as
not returning to the facility for]180 days after the last visit. Crude
retention in care was estimated using Kaplan-Meier methods.
Mortality, no follow-up and LTFU in patients who started ART in
hospitals and HCs were compared using logistic and cause-specific
Cox regression models. Odds ratios and hazard ratios, adjusted for
gender, age, CD4 count, WHO stage at start of ART and type of first-
line ART regimen are reported.
Results: A total of 3,733 patients, including 2,036 (54.5%) who
started ART at HC and 1?697 (45.5%) at hospital level, were analyzed.
Patients who started ART at hospitals had more advanced disease
than those in the HC-group (Table 1). Overall, 46 patients (2.3%) in
the HC and 58 (3.4%) in the hospital group had no follow-up visit.
Over 5,504 person-years, 414 patients died (11.1%) and 577 (15.5%)
were lost to follow-up. Crude, three-year retention was higher at HC
(67.8% (95% CI: 64.670.7) versus 61.9% (58.864.9)). However, in
Figure 3. Police Arrest and Total Crisis.
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adjusted analyses, mortality and LTFU were similar in both groups
(Table 2).
Conclusion: In rural Lesotho, patients who initiated ART in HCs had
less advanced HIV disease than those in hospitals. Retention in care
was similar in both settings.
WEAE0206
High rates of loss to follow-up during first year of pre-
antiretroviral therapy for HIV at primary health care level in
rural Uganda
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Background: Pre-antiretroviral therapy for HIV (pre-ART) is increas-
ingly recognized as an entry point to the continuum of care for HIV to
facilitate timely initiation of antiretroviral therapy (ART). In this study
we assess a public pre-ART program at primary health care level in
rural Uganda.
Methods: This retrospective analysis used a file and register audit at
all four governmental health centres (HC) providing ART and pre-ART
care in Iganga district, Uganda. All HIV patients registered from
February 2005 to August 2009 were included. We report rates of
retention and attrition for patients in pre-ART care and facility
performance indicators.
Results: Out of 2357 registered HIV-patients, 2024 (85.9%) were
still not initiated on ART by the time of our study. The overall
retention in care of these patients was 19.3% after 4.6 years since
introduction of the program with 1634 patients lost to follow up
(LTFU) and 390 retained in care. At one HC, the retention rate
was 3.6% (22 patients retained out of 603). The probability of
retention in care was 0.75 [CI 0.72-0.78] at the first month, 0.46
[CI 0.42-0.49] at 6 months, 0.36 [CI 0.32-0.39] at 12 months and 0.26
[CI 0.23-0.30] at 24 months after enrollment and significantly lower
than among patients who initiated ART. Of the patients alive and
attending the pre-ART program, 20.8% were eligible to ART according
to national guidelines but not yet initiated. Stock-outs of Cotrimox-
azole occurred at all HCs. At two HCs, more than one third of the
individual patient files of pre-ART patients were not available.
Conclusion: The pre-ART program at HC-level in the district under
investigation faces challenges in high rates of LTFU early after
enrollment of the patients. To assure timely initiation of ART, better
quality and new strategies to retain patients in pre-ART care
programs are needed.
THAE0103
PMTCT decentralization does not assure optimal service
delivery: revelations from successful individual-level
tracking of HIV-positive mothers and their infants
A. Edmonds1, D. Thompson1, V. Okitolonda2, L. Feinstein1,
B. Kawende2, F. Behets1,3 and PTME Team
1The University of North Carolina at Chapel Hill, Epidemiology,
Chapel Hill, United States. 2Kinshasa School of Public Health,
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North Carolina at Chapel Hill, Medicine, Chapel Hill, United States
Presenting author email: aedmonds@email.unc.edu
Table 1. Baseline characteristics of patients
ART start at Hospital ART start at Health Center p-value Total
Number of patients 1?697 2?036 3?733
Number of women (%) 1?081 (63.7) 1?307 (64.2) 0.75 2?388 (63.9)
Median age in years (IQR) 37 (3147) 39 (3249) B0.001 38 (3148)
Baseline median absolute CD4 count/ml (IQR) 163 (78270) 212 (127289) B0.001 194 (102281)
WHO stage III/IV (%) 850 (50.1) 654 (32.2) B0.001 1?504 (40.3)
Median weight in kg in (IQR) 55 (4863) 56 (5063) 0.08 55 (4963)
Baseline hemoglobin (g/dl) 11.6 (10.213) 12.3 (11.213.6) B0.001 11.9 (10.613.2)
EFV-based first-line regimen (%) 1?140 (67.6) 1?259 (62.1) B0.001 2?399 (64.6)
Table 2. ART outcomes by type of facility
No follow-up Mortality Loss to follow-up
Odds Ratio (95% CI) p-value Hazard Ratio (95% CI) p-value Hazard Ratio (95% CI) p-value
Unadjusted 0.03 0.01 0.08
Hospital 1 1 1
Health Center 0.65 (0.440.97) 0.77 (0.630.93) 0.86 (0.731.02)
Adjusted 0.21 0.54 0.21
Hospital 1 1 1
Health Center 0.75 (0.491.17) 1.07 (0.861.32) 0.89 (0.751.06)
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Background: As essential services for PMTCT are increasingly
decentralized to antenatal care (ANC) sites, the consequences of
shifting services from dedicated HIV care and treatment (C&T) clinics
remain incompletely explored. We compared service delivery at ANC
and C&T clinics in Kinshasa, DRC, a low HIV prevalence, resource-
deprived setting.
Methods: In 10/2010, an enhanced standard of care was introduced
at 44 ANC sites: personnel were retrained to implement the 2010
WHO PMTCT guidelines including Option A and co-located post-
delivery care, and were provided with new individual-level tracking
tools and supportive supervision. Women were encouraged to enroll
at either of two affiliated C&T sites for continued PMTCT and HIV
care but could opt to receive AZT-based prophylaxis at ANC sites
when it became available alongside CD4 testing in 2011. Antire-
troviral therapy was available only at C&T sites.
Results: Of 1,233 HIV-infected women tracked between 10/2010
and 12/2011, 926 (75.1%) were newly diagnosed; 306/926 (33.0%)
enrolled in C&T. Newly diagnosed women were more likely to receive
CD4 testing (RR2.2; 95% CI 1.9-2.6) and a WHO-recommended
regimen (RR1.6; 95% CI 1.4-1.8) if they enrolled in C&T than
if they remained at an ANC site. Infants were more likely to
receive a package of extended NVP, cotrimoxazole and DNA
PCR testing at C&T than at an ANC site (RR1.9; 95% CI 1.62.3).
At ANC sites, 116 women received AZT-based prophylaxis and
91 received CD4 testing; 95 infants received the postnatal
package.
Conclusion: Individual-level tracking of mothers and infants was
feasible in Kinshasa and revealed that PMTCT services were delivered
less effectively at sites historically focused on ANC rather than
HIV C&T. While decentralization increased care access, its potential
to further reduce vertical transmission cannot be fully realized
without sustained training and supervisory support to ensure
optimal quality of service delivery throughout the entire PMTCT
cascade.
THAE0104
Preventing mother-to-child HIV transmission through
community-based approach in Nepal
N. Shafique
UNICEF, HIV and AIDS Section, Lalitpur, Nepal
Presenting author email: nbshafique@unicef.org
Background: Since 1988, Nepal has evolved from a ‘‘low HIV
prevalence’’ to a ‘‘concentrated epidemic’’. In 2005, the Government
initiated PMTCT services in hospitals, but they were found to
be least accessible by most disadvantaged pregnant women
living in remote areas. In 2009, UNICEF and Government in
collaboration with CBOs introduced a community based PMTCT
service integrated with MNCH, in one of the highest HIV burden
districts of Nepal
Methods: The CB-PMTCT model uses the government’s existing
MNCH structures. Trained Volunteers provide HIV information to
pregnant women and refer them for ANC services. During ANC visits
pregnant women are encouraged to take HTC services. If positive,
the pregnant woman is referred for further treatment and support.
During the pregnancy she is provided with counselling on delivery
preparedness and treatment adherence. HIV-positive women are
encouraged for institutional delivery
Results: The CB-PMTCT intervention increased the ANC coverage
from 78.7% in 2009 to 82.2% in 2011. HTC uptake increased from
nationally 9% in 2008 to 40% in 2011 in the intervention areas.
In 2011, 82% positive pregnant women received ARV prophylaxis
compared to 50% in 2008, and infant ARV coverage reached 85%
from 57% in 2009. Institutional delivery increased from 7.5% to
16.1%.
Conclusion: Utilization of PMTCT by pregnant women dramatically
increased by taking services at the community level. The volunteers
and WLHIV created demand for PMTCT services and care practices.
The integration of PMTCT in MNCH services is an efficient, cost
effective and sustainable approach. Because of the proven efficacy
of the intervention Government is keen to scale up the model in
7 districts with Global Fund funding. In order to improve the
service utilization, HTC services should be decentralized up to the
community level. It is also imperative to address stigma and
discrimination and change social norms to ensure equitable access
to services by KAP.
E54 - Decentralization of services for ART,
community care and continuity of care
health services
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Scaling-up access to antiretroviral treatment: a comparison
of outcomes among HIV-positive children receiving
treatment at mobile and hospital-based HIV clinics in rural
Zambia
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Background: Travel time and distance are barriers to care for HIV-
infected children in resource-poor settings. Decentralization is one of
the strategies to scaling-up access to antiretroviral treatment (ART),
but few such programs have been evaluated. We compared out-
comes for children receiving care in mobile and hospital-based HIV
clinics in rural Zambia.
Methods: Outcomes were measured within an ongoing cohort study
of HIV-infected children seeking care at Macha Hospital, Zambia
since September 2007. Children in the outreach group received ART
from the Macha HIV clinic and transferred to one of three mobile
outreach clinics administered by Macha Hospital. Children in the
hospital group received ART at the Macha HIV clinic, and reported
Macha Hospital as their nearest healthcare facility.
Results: 46 children in the outreach group and 41 children in the
hospital group were included. The median time between enrolment
and transfer to the outreach clinic was 10.2 months (IQR:5.7,14.9).
After transfer to the outreach clinic, travel time was significantly
shorter and fewer caretakers used public transportation (before:
47.8%; after:2.8%; pB0.0001). Consequently, 44.4% of caretakers
reported lower transportation costs and 69.4% had fewer faced
obstacles with transportation. Caretakers reported receiving the
same quality of care. At ART initiation, median age, weight-for-age
z-scores (WAZ) and CD4% were similar for children in the hospital
and outreach groups. Children in both groups experienced similar
increases in WAZ and CD4%. Five children, all in the outreach group
(12.8% vs. 0.0%; p0.07), experienced virologic failure after their
transfer. The median percentage of visits with full adherence
(95%) was significantly lower in the outreach compared to the
hospital group (65% vs. 84%; p0.02).
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Conclusion: Despite similar clinical and immunologic outcomes,
children in the outreach group were less likely to achieve virologic
suppression, potentially due to lower adherence. Continued adher-
ence counseling is critical for the success of decentralized care.
E56 - Sca l ing -up methods and
experiences for HIV programmes
WEAE0401
Sustaining quality while scaling-up adolescent ART: findings
from Zimbabwe?s largest adolescent cohort
A. Shroufi1, M. Dixon2, H. Gunguwo2, M. Nyathi2, M. Ndlovu2,
J.F. Saint-Sauveur1, F. Taziwa1, W. Ndebele2 and C. Ferreyra3
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Background: As Anti Retroviral Treatment (ART) programmes
improve survival in early life the number of adolescents in need of
ART will continue to increase. Programmes will need to scale up
services which address the particular needs of adolescents. Here we
assess the experience of such scale up in a large urban adolescent
cohort.
Methods: Between 2004 and 2010 9,360 adults and 1,776 adoles-
cents commenced antiretroviral therapy (ART) at Mpilo OI ART
clinic, Bulawayo. A package of specific activities for adolescents was
implemented, to provide comprehensive care including active
defaulter tracing, a comprehensive, dedicated counselling pro-
gramme and psycho-social activities operating both inside and
outside the clinic, such as a youth club. Adolescents were engaged
in decisions regarding their care.
In this retrospective cohort analysis adolescents were defined as
those ] 10 and B19 years old at ART initiation date. Cox’s
proportional hazards model was used to calculate hazards and the
log rank test to assess significance.
Results: Between 2004 and 2010 a six-fold increase in adolescent
ART initiations occurred (Figure 1). 12 month adolescent loss to
follow increased in the first 3 years of the programme, peaking at
7%, subsequently falling to below 5% by the end of the study period.
There was no significant difference between adult and adolescent
hazard of death. (HR0.92, p0.3793) Loss to follow up was
significantly higher in adults than adolescents. (HR1.92,
pB0.0005) (Figure 2).
Conclusion: These results contrast other research, which generally
show adolescent outcomes to be worse than those in adults.
Outcomes in expanding programmes have also been shown to suffer
elsewhere.
As more HIV positive children survive into adolescence, ART
programmes must scale up comprehensive services for this group;
we show that good results are feasible with dedicated clinical and
psychosocial resources in resource poor settings.
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Nothing for us without us: community led approaches
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Background: Community based organizations (CBOs) and non-
governmental organizations (NGOs) have generally proven to be
effective instruments for sustainable implementation of HIV preven-
tion programs among female sex Workers (FSW). Affinity and
integrity with FSWs have enabled them to expand coverage and
medical service delivery by transferring responsibility to FSWs and
fostering demand driven approach.
To identify and understand factors that enhance performance of
programs with FSWs, Technical Support Unit (TSU) of the Karnataka
State AIDS Prevention Society (KSAPS) Government of Karnataka,
conducted case studies of two programs implemented by FSWs
collective (CBO) and an NGO. Both programs have achieved high
standards of service delivery.
Methods: Focused group discussions (FGD) were conducted
with the following: board members of CBO and NGO 2 FGDs (11
participants), outreach team 2 FGDs (18 participants), FSW peer
educators 2 FGDs (27 participants), Female Sex Workers 2 FGDs: (17
participants). FGDs were conducted with the KSAPS and TSU whoseFigure 1. ART Initiations in Mpilo Bulawayo: 20042010.
Figure 2. ART Loss to follow up Mpilo Bulawayo: 20042010.
Abstracts of the XIX International AIDS Conference
Journal of the International AIDS Society 2012, 15 (Suppl 3) Track E Implementation Science, Health Systems and Economics
264
mandate is to provide technical assistance to the prevention
programs.
Results: Factors that contributed significantly to improved perfor-
mance were that these projects are components of broader, holistic
agenda that puts women at its centre, addressing women’s needs,
including, but not limited to, HIV prevention.
Programs generate evidence-based plans from program data. Site-
based peer plans are used, which plan for individual FSW and tailor
services according to individual profiles, have improved TI perfor-
mance. This has helped Peer Educators to spend quality time in the
field, while also improving their productivity. Supportive hand
holding by Technical Support Unit has helped in diagnosing problems
and its resolution.
Conclusion: Embedding HIV prevention within broader programs
that respond to women’s needs, and in which FSWs play a deciding
role, increases likelihood of success of the programs. As NACP-III
nears its end and the nation prepares for NACP-IV, these findings
indicate promising direction for future.
E57 - Integration of HIV services rather
than stand-alone services, and services
which bond the community care with the
health facility services
WEPDE0206
HIV prevention through pharmacies network in Ukraine:
improving access to services for injecting drug users and
commercial sex workers
G. Naduta
ICF International HIV/AIDS Alliance in Ukraine, Policy and
Partnership, Kyiv, Ukraine
Presenting author email: naduta@aidsalliance.org.ua
Background: The prevalence of HIV infection in Ukraine is 1.33%
(adult). In Europe it is one of the highest rates. The highest
concentration of-among IDUs.
Pharmacy interventions started in Ukraine in 2007. The clients of
pharmacy interventions are mainly belong to IDUs, including female
IDUs, and commercial sex workers (CSWs).
Currently 143 pharmacies are implementing pharmacy-based pre-
vention projects in cooperation with 25 NGOs in 13 out of 27 regions
of Ukraine.
Methods: Organization of the project activities: an NGO and a
pharmacy sign a cooperation agreement.
NGO: transfers consumables to the pharmacy, trains pharmacy
workers, informs the target group about the project, pays for the
pharmacy services within the project and reports to the donor
agency funding the project (ICF ‘‘International HIV/AIDS Alliance in
Ukraine’’, funded by the Global Fund).
Pharmacy: provides free of charge services to the program clients,
provides the program client cards to the new clients (IDUs and
FSWs), and keeps record of the clients and distributed products.
The basic package at the pharmacies includes: syringe distribution/
exchange (35), alcohol swabs, condoms, information products,
delivery of the harm reduction program client cards to the new
clients. Counseling on safe behavior, referral of the clients to NGOs to
receive other services (testing for HIV, STIs, counseling by specialists)
are also provided.
Results: Achievements for 2011: General year coverage: 27 435
clients, who made more than 387 000 visits to the pharmacies.11
714 new clients (IDUs, CSWs) became the participants and
were issued à Participant card of the pharmacy programme.
Syringes exchange organized in 32 pharmacies (out of 143)-
permission for such exchange obtained from the local controlling
institutions.
Conclusion: Approximately 20.5 % of the over-all number of new
clients (57 143) was involved into the HIV prevention programs of
Alliance in Ukraine through the pharmacies in 2011.
E58 - Role of community organizations in
linking people to HIV services and
strengthening the health system
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improved virological suppression in adults receiving
antiretroviral treatment: five-year outcomes from a
multicentre cohort study in South Africa
G. Fatti1, A. Grimwood1 and J. Shea2
1Kheth’Impilo, Cape Town, South Africa. 2University of Cape Town,
Child Health Unit, School of Child & Adolescent Health, Cape Town,
South Africa
Presenting author email: ashraf.grimwood@khethimpilo.org
Background: Sub-Saharan African antiretroviral treatment (ART)
programmes have a severe professional staff shortage resulting in
inadequate support for patients which contributes to increasing
virologic failure. However, community-based adherence-support
(CBAS) workers now form a significant work-force. This study
evaluated the effect of CBAS on virological outcomes at 57 non-
governmental organization-supported public ART facilities in four
South African provinces.
Methods: CBAS workers provide education and psychosocial support
for ART patients through home visits to assess and address
adherence challenges. A multicentre cohort study was performed,
including adults starting ART between January 2004September
2010 at clinics where patients were eligible to receive CBAS.
Prospectively collected routine electronic data were analysed. Out-
come measures were virological suppression (VS) (viral load B 400
copies/ml) at six-monthly intervals until 5 years of ART. Multivariable
generalised estimating equations were used to compare VS between
patients who received and not receiving CBAS, using an intention-to-
treat approach. Extreme-case sensitivity analyses were performed to
estimate bias due to missing viral load results.
Results: 66,953 patients were included: 19,668 (29.4%) received
CBAS and 47,285 (70.6%) did not. At baseline, median age was 34.8
years; 45,844 (68.5%) were female; median CD4 cell count was 125
cells/ml (IQR: 65175). After six months of ART, VS was 76.6%
(95% CI: 75.8%-77.5%) and 72.0% (CI: 71.3%-72.5%) in CBAS patients
and non-CBAS patients, respectively (PB 0.0001). In multivariable
analyses after one and five years of ART, CBAS was associated with
improved VS, adjusted odds ratio (aOR) 1.33 (CI: 1.241.43) and aOR
2.66 (CI: 1.614.40), respectively. Improved virological suppression
in CBAS patients remained evident in sensitivity analyses considering
missing test results as either suppressed (aOR 1.44 [CI: 1.371.52])
or unsuppressed (aOR 1.15 [CI: 1.111.19]).
Conclusion: CBAS was associated with improved virological suppres-
sion, the magnitude of which increased for longer therapy duration.
Expanded implementation of this intervention should be considered
in resource-poor settings.
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Background: In the DRC, traditionally stigmatized groups such as
MSM are also those most at risk of HIV infection. In the first activity
of its kind in Kinshasa, Projet Integré de VIH/SIDA au Congo (ProVIC),
a USAID/PEPFAR-funded HIV/AIDS project, partnered with local
nongovernmental organization Progrès Santé Sans Prix (PSSP) to
assess the receptiveness to and feasibility of providing voluntary
nighttime mobile HIV counseling and testing (HCT), or ‘‘moonlight’’
testing, to MSM using rapid finger-prick technology. Providing quality
services to MSM and addressing their specific needs, including
combating stigma, are important to reversing the HIV/AIDS epidemic
in the DRC.
Methods: MSM were identified through risk mapping conducted
at 15 sites in Kinshasa in 2010. Teams worked with groups
of MSM peer educators from both the community and PSSP to
provide HCT services using the rapid finger-prick method. Four
mobile HCT teams, each including two laboratory technicians
and a supervisor, conducted two moonlight HCT clinics per week.
Attendance at the mobile HCT was carefully monitored, and
observations on the strategy’s successes were solicited from program
staff.
Results: MSM attendance was initially low, with only 20 MSM
accessing HCT services per night; over the course of the pilot,
however, this number grew to an average of 80 clients per night. A
seroprevalence of 30 percent was found among MSM ages 20 to 30.
Involving MSM peer counselors in this intervention played an
important role in the feasibility and effectiveness of this pilot.
Conclusion: Rapid moonlight HIV testing for MSM led to increased
service utilization because services were more easily accessible;
clients were pleased to receive prompt, quality services without the
perception of negative judgment. Staff reported that involving MSM
peer counselors in this intervention plays an important role in these
outcomes. Nighttime testing for MSM under ProVIC has since been
expanded to two additional provinces in 2012.
E59 - Models for HIV service delivery in
conflict and post-conflict settings
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Ensuring continuity of antiretroviral therapy among
displaced populations during Ivorian post-election violence,
2011
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Figure 1. Proportions of patients achieving virological suppression in (a) intention-to-treat (ITT) analyses censoring missing values,
(b) ITT analyses regarding missing values as suppressed, (c) ITT analyses regarding missing values as unsuppressed and (d) on-treatment
analyses.
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Background: Post-electoral unrest in Ivory Coast led to major
population displacement. Looting, lack of personnel, shortage of
drugs, difficult physical accessibility and insecurity challenged access
to HIV services. Given the individual and public health impact of
antiretroviral therapy (ART) interruption, addressing continuity of
treatment was defined as a priority since up to 14,500 Ivorians under
treatment could be affected.
Methods: As such, UNHCR ensured that all partners integrate HIV
and AIDS related Identification, Communication and Case Manage-
ment in the overall relief response. Out reach and registration of
refugees and internally displaced persons were used as opportunities
to link up those in need of ART. Messages delivered during
gatherings encouraged PLWH to contact focal points for care and
treatment.
HIV Joint assessment missions highlighted lack of ART-related inputs
conflict affected areas.
Results: In Ghana and Liberia, among 258 refugees living with HIV
registered, 142 were receiving ART. 60% of PLWH receiving ART in
western Ivory Coast and 83% in Abidjan had interrupted their
treatment for more than 3 weeks at time of identification. Language
barriers (refugees), fear for stigmatisation and lack of ART services in
refugees and IDP hosting areas were main reasons for treatment
interruption.
People in need of ART were referred to closest treatment centres.
Cross-border arrangements were made between Liberia and Ivory
Coast to overcome a difference in second line therapy. UNHCR
procured portable CD4 machines in conflict-affected areas to
improve treatment quality.
Conclusion: Early identification of cases and communication through
different strategies was essential to limit treatment disruption. Cross-
border coordination and contingency planning for drug procurement
and distribution enables continuity of treatment. The importance of
continuity of HIV-related business continuity including treatment
need to be further emphasised to patients, as well as planners and
relief assistance managers.
Media should be cautious when talking about HIV status of a
displaced population.
THPDE0203
The challenge of maintaining continuum of care and
support to PLHIV in health facilities located in military
conflict zones in Ivory Coast
B. Doumbouya1, M. Zaho2, S. Adouko1, E. Komena3, B. Mensah-
Maı̈ka4 and S. Touré5
1ACONDA VS CI, Public Health, Abidjan, Cote D’Ivoire. 2ACONDA VS
CI, PWP, Abidjan, Cote D’Ivoire. 3ACONDA VS CI, Care and Support,
Abidjan, Cote D’Ivoire. 4ACONDA VS CI, Prevention, Abidjan, Cote
D’Ivoire. 5ACONDA VS CI, Poject Executive Direction, Abidjan, Cote
D’Ivoire
Background: Post-election crisis in 2010 in Ivory Coast caused
militaries conflicts in several cities, disturbing health centres
activities. NGO Aconda tried to support provision of care to PLWHA.
To describe strategies implemented by Aconda to ensure continuum
of care and support to PLWHA in health centers located in conflict
zones.
Methods: It is a prospective study which describes activities of
Aconda in health centres located at conflict area during war in Ivory
Coast. Data has been collected from monthly reports.
Strategies were based on reduction of HIV activities package to
an absolute minimum: supplying ARV to health centres; providing
ART to patients in follow; continuing PMTCT and providing
ARV prophylaxis to pregnant women. Communities based Organiza-
tions made active research of patients lost to follow and referred
them to health facilities for care. Pharmacists gave systematically at
least 3 monthly ARV provision to patients coming to visits.
Counselling and testing Activities, biology and ART initiation were
stopped.
Results: From January to June 2011, 05 health regions: Abidjan,
Duékoué, Guiglo, Bloléquin and Toulépleu were located conflict
zones. We noted 45/68 centres were functional: 40 in Abidjan, 3 in
Guiglo and 2 in Duékoué. We note that 11 centres have been looted;
7 completely and 4 partially. Because of non accessibility for drug’s
vehicle, 32 sites had failures in delivering ART. In 28 sites, less than
50% of medical staff was present. In 12 centres where caregivers
were absent, the provision of ART to patients has been ensured by
counsellors and data managers. In the 3 months, 17,471 PLWHA
(8.7% of children) received ART and 475 pregnant women, the ART
prophylaxis.
Conclusion: Militaries conflicts cause a dislocation of health
systems. Aconda managed to maintain care and support to PLWHA
in health centres in war area, by reducing to absolute minimum
services.
E60 - Micro-finance programmes
FRAE0105
Small scale income generating initiatives mitigate the socio-
economic vulnerability of HIV households in Bangladesh
N. Purification
Notun Jibon Shomaj Kollan Shongstha (NJSKS), DhakaBangladesh
Presenting author email: npurification@gmail.com
Background: HIV/AIDS has a devastating impact on the livelihood
of peoples living with HIV/AIDS (PLHA) in a developing country like
Bangladesh. Stigma and discrimination in the local conservative
society makes their socio-economic condition more miserable.
Methods: Notun Jibon Shomaj Kollan Shongstha, a PLHA self help
organization has started a peer-led programme, known as Income
Generating Initiatives for the PLHA in Bangladesh (IGIPB) since
March, 2010 to address the socioeconomic vulnerability of PLHA in
Bangladesh.
Results: To date, the programme has covered total 46 PLHA
families having average 4 members per family living at rural areas.
A total of 143 PLHA has been supported, out of which, 43% were
male (n61), 33% (n47) were female and the rest were
children. After affected by HIV, the house hold income dropped,
on average, by 33%, whereas household expenditure increased by
110%, which was mainly for medical purposes. Through the
programme, the following services were provided: vocational
training to all covered adult male and female (76%, n108); job
assistance (n17), 42% (n7) of them were female; microcredit
loans to start small scale business (n7, all were widowed female;
health loans (n22), 68% (n12) of them were female and 13%
were children (n3). Lump sum educational assistance grant (45
US Dollar per year per children) was provided to 35 HIV affected
children (24% of the total covered PLHA). Moreover, job place
advocacy and sensitization on HIV/AIDS were also done in different
organizations (n12), Compared to the baseline, the average
monthly income in each house hold increased 5.7 times higher
after 1 year of coverage (mean9SD in US Dollar, 35911 vs
201921, pB0.005).
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Conclusion: The success of this small scale programme demonstrates
the importance of economic coverage for restoration of PLHA
livelihood. Long term, large scale comprehensive programme is
therefore needed further.
E63 - Economic evaluation of prevention,
t reatment , care and mit igat ion
programmes, adherence schemes,
sustainability of programmes and
financial strengthening initiatives
MOAE0201
Cost and efficiency analysis of the Avahan HIV prevention
programme for high risk groups in India
S. Chandrashekar1, A. Vassal2, G. Shetty3, M. Alary4 and P. Vickerman2
1Dept of Epidemiology, St. John’s Research Institute, Bangalore, India.
2London School of Hygiene and Tropical MedicineGlobal Health and
Development, London, United Kingdom. 3Karnataka Helath
Promotion Trust, Bangalore, India. 4Centre Hospitalier affilie
Universitaire de QuebecPopulation Health Research, Quebec, Canada
Presenting author email: sudhashreec@yahoo.co.in
Background: The India AIDS Initiative (Avahan) is involved in
scale up of HIV prevention interventions among high-risk groups
(HRGs). The few existing studies limit their cost analysis to the
implementing non-governmental organisations (NGOs). This is the
first study to analyse the costs of HIV prevention at scale, over four
years, including systems costs. These systems costs are particularly
important for those replicating scale-up of HIV prevention in
different settings. We present here the final results of a four year
costing effort.
Methods: Financial and economic costs were collected from 64
districts, 137 NGOs and supporting costs at the state and costs of
programme management by the Bill and Melinda Gates Foundation
over four years, presented in US$ 2008 (3% discount rate). The
intervention package included outreach, STI services, condoms,
capacity building, community mobilisation, advocacy and enabling
environment.
Results: Unit costs per person reached, per contact, per estimated
population ranged US$ 232 (44840), US$ 68 (13242) and US$ 175
(95443) respectively. Key factors driving cost variation include scale.
Although costs fell with scale, they also increased over time with
inclusion of new districts and activities as the programme developed
(including high risk men who have sex with men, advocacy, and
community mobilisation). The total economic costs (20042008)
were US$ 97,966,216 of which approximately 35% was spent at
NGO level, 30% at the State level and 35% at the national level
which were mainly incurred for capacity building and programme
management.
Conclusion: The rapid scaling up HIV prevention requires significant
investment in expertise enhancement and programme administra-
tion. These are not captured in routine cost analysis, which may
misinform resource planning. At scale the unit cost of services
provision falls, however actual cost reduction may take longer as
programmes evolve, and activities are added. Policy makers should
take into account these additional costs while planning public health
interventions.
MOAE0204
Increasing investment in syringe exchange is cost-saving HIV
prevention: modeling hypothetical syringe coverage levels
in the United States
T.Q. Nguyen1, B.W. Weir1, S.D. Pinkerton2, D.C. Des Jarlais3 and
D. Holtgrave1
Table 1. Parameters in Modeling
n number of injecting drug users
N total number of drug injections per year
SSEP total number of syringes supplied by SEPs-base case
DS hypothetical increase in number of SEP syrings
SSEP-H total number of syrings supplied by SEPs-hypothetical case SSEP-HDS
SCSEP SEP syringe coverage-base case SSEP/N
SSEP-H SEP syringe coverage-hypothetical case SSEP-H/N
Snon-SEP number of syringes a user gets from non-SEP sources per year
Snon-SEP Total nuber of syrings from other sources-base case
r replacemant rate (rate at which increased SEP syrings supply lower use of
non-SEP syrings)
Snon-SEP*n
Snon-SEP-H Total number of syrings from other sources hypothetical case Snon-SEP*rDS
B Number of injection with from other sources hypothetical case
CH Proportion of syrings contaminated with HIV-hypothetical case 5c(BSSEPSnonSEP)/(BSSEP-HSnonSEP-H)
I Number of new HIV infections due to IDU per year-base case
IH Number of new HIV infection due to IDU per year-hypothetical case =I(CH/C)
Iavert Number of infections averted as a result of increased SEP I  IH
ju Cost of syringe exchange programming, per syringe
F Additional founding requried DS*U
t Life time treatment cost per infected person
Tsaved Savings in life time treatment cost Iaverted*t
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Presenting author email: tqnguyen@jhsph.edu
Background: Syringe exchange for injecting drug users (IDU) is
controversial and has limited funding in the US. To inform policy,
we examine whether increasing investment in syringe exchange
programs (SEPs) would be cost-effective for HIV prevention.
Methods: We model HIV incidence in hypothetical cases with higher
SEP syringe coverage (i.e., percent injections with a new syringe from
SEP) than current levelbase case, and estimate additional funding
required, number of injections averted, and HIV treatment costs
saved.
The ratio of HIV incidence (hypothetical to base case) is established
based on the transmission equation and simplified to the ratio of
proportions of HIV-contaminated syringes (hypothetical to base case),
which is a function of number of injections with a receptively shared
(‘‘borrowed’’) syringe and numbers of syringes from SEPs and other
sources. A maximal bound for hypothetical case incidence is
calculated.
SEP syringe coverage and costs data are from the Beth Israel/NASEN
survey. HIV incidence and lifetime treatment costs are from the CDC.
We assume 1/2 of IDU-category and 1/4 of MSM/IDU-category
infections are due to injection risk.
We conduct sensitivity analyses on ‘‘borrowing’’ probability, number
of non-SEP syringes, extent to which SEP syringes replace non-SEP
syringes, and proportions of IDU-category and MSM/IDU-category
infections that are due to injection risk.
Results: Increasing SEP syringe coverage (now 2.9%) to 5%
would avert 169 infections, requiring 19 million USD additional
investment but saving 66 million USD in treatment costs. A larger
increase to 10% would avert 497 infections, requiring 64 million USD
investment but saving 193 million USD in treatment costs. Results
should be updated when new data on parameter values become
available.
Conclusion: SEPs are effective and cost-saving, and thus should be
priority in the US. The ban on federal funding for SEPs should be
lifted, and federal funding allocated to expanding SEPs.
FRAE0101
What does it cost to raise an orphan? A comparison
of OVC costs in Ethiopia and Botswana
D. Telake1, C. Formson2 and S. Forsythe3
1Independent Consultant, London, Canada. 2Independent
Consultant, Gaborone, Botswana. 3Futures Institute, Fountain Hills,
United States
Presenting author email: sforsythe@futuresinstitute.org
Background: Estimating costs associated with OVC services is
crucial in resource allocation, budgeting and sustainability planning.
The estimated OVC population is 5.4 million in Ethiopia but only
130,000 in Botswana. In Ethiopia, it is estimated that only about
5% of orphans are receiving support from the government and
NGOs, whereas in Botswana, approximately 49% are receiving
support.
Methods: A costing exercise was conducted for 20 OVC programs in
Ethiopia and 19 in Botswana. The data collection process involved
conducting interviews with program managers and finance officers.
This study followed an economic approach, where the value of all
resources deemed necessary to deliver services to OVC were taken
into account.
Results:Most of the organizations in both countries offered between
4 and 8 services to OVC. The most common services offered to OVC
were education, psychosocial support and food/nutrition. The cost of
reaching an OVC differed significantly across countries, with a unit
cost of $80 in Ethiopia and $946 in Botswana. Even for specificFigure 1.
Figure 2. Additional investment required & savings in HIV
treatment costs (million 2011 USD) for each SEP syringe coverage
level.
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services, the cost differed significantly both within and across
countries.
Conclusion: This analysis provides important comparative informa-
tion about the range of costs by service area and the overall cost
per child reached. The analysis shows that unit costs decline signi-
ficantly as programs are scaled-up (diminishing marginal returns),
but then increase as OVC programs grow bigger (diseconomies
of scale). Differences in unit costs appear to be largely attributable
to the type and intensity of services provided, as well as the
overall difference in the cost of living between the two countries.
The analysis could not, however, make any conclusions about the
effectiveness of the interventions provided. It is recommended
that future OVC research focus on measuring both costs and
effectiveness.
FRAE0103
Economic evaluation of the national program to prevent
mother-to-child transmission of HIV in Ghana
A. El-Adas1, R. Amenyah2, A. Koleros3, N. Akwei Addo4, F. Asante5,
P. Wondergem6, K. Atuahene7 and K. Asante4
1Ghana AIDS Commission, Accra, Ghana. 2Ghana AIDS Commission,
Technical Services Directorate, Accra, Ghana. 3Futures Group/Health
Policy Project, London, United Kingdom. 4National AIDS and STD
Control Program, Accra, Ghana. 5University of Ghana, Institute of
Statistical, Social, and Economic Research, Accra, Ghana. 6USAID
Ghana, Accra, Ghana. 7Ghana AIDS Commission, Research,
Monitoring and Evaluation Division, Accra, Ghana
Presenting author email: aeladas@ghanaids.gov.gh
Background: Based on 2009 WHO clinical guidelines for the
prevention of mother to child transmission of HIV (PMTCT), the
Government of Ghana updated its National PMTCT Guidelines in
2010, indicating new antiretroviral (ARV) drug regimens for treat-
ment and prophylaxis, and introducing new services. Few interna-
tional studies have examined costs of PMTCT services under new
WHO guidelines and until now, no studies in Ghana had examined
the cost of delivering these services.
Methods: We analyzed the cost of PMTCT services in the National
PMTCT Guidelines: HIV testing and counseling (HTC), antiretroviral
prophylaxis and/or therapy for seropositive pregnant women
and postpartum care for seropositive mothers and their HIV-exposed
infants. We used a normative approach with elements of top-
down and bottom-up costing, first developing a representative
care schedule according to national guidelines, and refining it based
on expert interviews. Data were collected at the central level and
from a purposive sample of 14 facilities reflecting characteristics
Figure 2. Distribution of direct and indirect costs, by mother/child pairs.
Figure 1. PMTCT Unit cost for Mother/child pairs, in US$.
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thought to influence unit cost, including facility level and facility
ownership.
Results: We found an average cost of US$56 for providing
HTC services, US$739 for seropositive pregnant women on ARV
prophylaxis, and US$1,054 for sero-positive pregnant women on ARV
treatment. The cost for providing PMTCT services to an HIV-exposed
infant ranged from US$29 to US$69 (Figure 1).
Direct costs accounted for the majority of total cost, comprised
primarily of costs for antiretroviral drugs, laboratory testing, and
staff time; suggesting that the unit cost of delivering PMTCT
services will not vary significantly in terms of changes in client load
(Figure 2).
Conclusion: We found higher staff costs for delivering the same
services at higher-level facilities, where more specialized staff deliver
services, suggesting task shifting could achieve cost efficiencies.
These data can be used to better inform resource allocation
decisions as PMTCT programs are scaled up in Ghana and other
countries.
E64 - Sustainability of ART programmes
and adherence in developing countries
MOAE0205
Transition from stavudine to tenofovir and zidovudine for
first-line treatment of HIV/AIDS in low- and middle-income
countries
E. Dancel and P. Ashigbie
Department of Family Medicine, Boston University School of
Medicine, Boston, United States
Presenting author email: ellendancel@gmail.com
Background: In 2009, the WHO recommended the transition from
stavudine (d4t) containing regimens due to side effects in favor of
regimens containing zidovudine (ZDV) and tenofovir (TDF). We
describe the transitions from stavudine to preferred regimens and
the current purchasing trends.
Methods: We analyzed 17,819 adult antiretroviral purchases be-
tween 2009 and 2011, as reported to the World Health Organization
Global Price Reporting Mechanism, the Global Fund Price Quality
Report and by UNITAID.
Results: Stavudine’s total market value declined from 99.85 million
USD in 2009 to 29.7 million USD in 2011. Purchases of 3-in-1 fixed
dose combinations (FDC) containing d4t represented 1.2 million
people who could be treated in a year (person-years) in 2009,
increasing to 1.3 million person-years, before dropping to 472,000
person-years in 2011. Purchases of TDF 3-in-1 FDCs increased from
41,000 to 145,000 person-years from 2009 to 2011. Zidovudine 3-in-
1 FDC purchases increased from 1.18 to 1.74 million person-years
between 2009 and 2010, but then dropped in 2011. Of the 74
countries purchasing stavudine in 2009, 24% did not purchase
stavudine in 2010 or 2011, while an additional 24% did not pur-
chase stavudine in 2011. In all, 52% of countries continue to
purchase stavudine products.
The median annual price of the 3-in-1 FDC containing d4t dropped
from 77 to 62 USD per year from 2009 to 2011. ZDV median prices
were 137 and 113 USD in 2009 and 2011, respectively. TDF 3-in-1
with emtricitabine exhibited the smallest change, from 250 USD/year
in 2009 to 242 USD in 2011. The 3-in-1 with TDF and lamivudine held
the lowest median price, at 174 USD in 2011.
Conclusion: Transition from stavudine has been slow, though
some countries have exhibited rapid transition. Price remains a
critical concern in transition from stavudine to ZDV or TDF regimens.
E65 - Economic strengthening initiatives
( inc luding micro- f inance, health
insurance, etc.)
WEAE0402
Self-esteem, self-efficacy and hope among vulnerable
adolescents affected by HIV participating in community-
based savings and lending groups in rural Nyanga district,
Zimbabwe
S. Senefeld1, C. Miller1, D. Mgugu2, G. Mavise2 and W.-A. Rowe1
1Catholic Relief Services (CRS), Baltimore, United States. 2Catholic
Relief Services Zimbabwe, Harare, Zimbabwe
Presenting author email: carrie.miller@crs.org
Background: Approximately 25% of Zimbabwe’s children are esti-
mated to be orphaned, with the majority orphaned due to AIDS-
related illnesses. HIV-affected households often face severe financial
constraints making them unable to meet their basic needs. Financial
stress can negatively impact overall mental health, life satisfaction,
and wellbeing in numerous ways. Perceived control over one’s
economic situation and sense of self can mediate financial distress.
Methods: Over a one year period, 2000 adolescents participated in
community-based savings and lending groups (SLG), and 50% also
received life skills education (LSE). A quantitative survey was
administered to a randomly selected sub-sample of the project
population matched with a sample of adolescents from a non-
intervention control ward. Surveys were administered in Shona and
back translated into English. Data were entered into SPSS and
analyzed using univariate and bivariate measures.
Results: 160 adolescents participated in the survey. Average age was
15-years-old with an average household size of seven members.
Adolescent SLG group members (n139) reported statistically
significant higher scores on self-efficacy (pB.001), self-esteem
(pB.01), and hope (pB.01) than adolescents from the control
group (n21). There were no statistically significant differences
between adolescents who received SLG only compared to those who
received SLG plus LSE, although most of the random sample received
both interventions. While 75% of adolescents reported that care-
givers decided how general household income was spent, 45% of
adolescents reported caregivers decided how their SLG funds would
be spent; 33%made independent decisions regarding their funds.
Hope scale scores positively correlated with increased decision
making power over funds.
Conclusion: Adolescents affected by HIV face many challenges
including poverty and unknown futures. Economic empowerment
may provide an option for responding to both immediate financial
concerns and also building mental health resilience and outcomes for
the future.
E66 - Consequences of test-and-treat
programmes on investments in human
capital and on household finances/
wealth
THAE0102
Improved employment and children’s education outcomes
in households of HIV-positive adults with high CD4 counts:
evidence from a community-wide health campaign in
Uganda
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Background: Despite growing evidence that socio-economic out-
comes among HIV-infected adults show improvement after antire-
troviral therapy (ART) initiation, little is known about the variation in
these outcomes among a population that also includes individuals
with high CD4 counts and those not enrolled in care. We examined
associations between CD4 count and socio-economic outcomes
among adults participating in a community-wide health campaign
in a rural Ugandan parish.
Methods: A one-week community health campaign offering diag-
nostic and treatment services for HIV and other infectious and non-
communicable diseases was conducted in May 2011. Data on
campaign participants? employment were collected, and a detailed
household socio-economic survey was conducted among a random
subset of participants. Multivariable regression was used to assess
relationships between CD4 count and employment and educational
outcomes.
Results: 2,323 adults (74% of the community) participated in the
campaign. 179 adults (7.8%) tested HIV-positive and 46% were newly
diagnosed. HIV-positive adult participants with CD4 550 and 350
550 worked 4.8 and 5.3 more days during the past month than those
with CD4B200 (pB0.05). No differences in work patterns were
found between participants with CD4 200-350 andB200. The
association was similar among those on ART and not on ART.
Children’s school enrollment was also associated with adults’ CD4
counts. Children in households of adults with CD4 350 had 20%
higher school enrollment rates than children in households of adults
with CD4B200 (pB 0.05). Finally, socio-economic outcomes of HIV-
participants with high CD4 counts resembled those of HIV-negative
participants.
Conclusion: Outcomes of HIV-positive adults with high CD4 counts
are not only better than those of adults with low CD4 counts, they
also resemble those of HIV-negative adults. Early initiation of ART
could generate economic benefits by preventing a decline in
employment and education outcomes and maintaining them at
levels seen among HIV-negative peers.
TULBE05
Dramatic increases in population life expectancy and the
economic value of ART in rural South Africa
J. Bor1,2, A.J. Herbst2, M.-L. Newell2,3 and T. Bärnighausen1,2
1Harvard School of Public Health, Global Health and Population,
Boston, United States. 2Africa Centre for Health and Population
Studies, University of KwaZulu-Natal, Mtubatuba, South Africa.
3Centre for Paediatric Epidemiology and Biostatistics, University
College of London Institute of Child Health, London, United Kingdom
Presenting author email: jbor@hsph.harvard.edu
Background: Large increases in adult life expectancy are anticipated
in HIV endemic regions, due to antiretroviral treatment (ART). Such
changes may have important implications for economic decision-
making on the part of individuals and governments.
Methods: We estimate adult life expectancy (15e15) annually for
20002011 using data from a large population cohort in rural South
Africa (n149,640), a population where 28% of adults were infected
with HIV in 2011. We assess the distribution of life spans in 2003,
prior to the public sector roll out of ART in South Africa, and in 2011.
We use observed changes in adult life expectancy to compute a cost-
benefit ratio for government provision of ART in this setting.
Results: After declining in the early 2000s, adult life expectancy in
the population cohort increased from 52 years in 2003 to 61 years in
2011 (Figure 1); gains were larger for women (9.5 years) than for
men (6.6 years). Changes in the distribution of lifespans reveal a
substantial shift towards older ages (Figure 2). Applying standard
estimates of the value of a statistical life-year (1-3 times per capita
GDP), ART roll-out in this community has led to lifetime gains of
$26,000 to $77,000 per capita. This is 2-6 times larger than the per
capita cost of providing lifelong ART to every person who contracts
HIV in this community, which we estimate at $13,400, based on 2012
cost figures from the President?s Emergency Plan for AIDS Relief.
Conclusion: ART roll-out has resulted in large increases in adult life
expectancy in rural South Africa. The economic value of these health
gains far outweighs the costs of treatment. Future research is
needed to understand how people perceive these changes in
longevity, and how these changes affect attitudes, such as fatalism,
Figure 1. Adult life expectancy, 20002011.
Figure 2. Distribution of Lifespans, 2003 and 2011.
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and behaviors, such as healthcare-seeking, risk-taking, and educa-
tional choices.
MOPDE0206
The impact of antiretroviral therapy on the social, economic
and working conditions of patients with HIV in Malawi
S. Orlando1, E.S. Alumando2, M.C. Marazzi3, P. Germano4,
G. Guidotti5, E. Gennaro6, F. Ciccacci7 and L. Palombi8
1Community of Sant’Egidio, DREAM Program, Rome, Italy. 2University
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Spallanzani’ I.R.C.C.S., Rome, Italy. 5University of Pisa, Pisa, Italy.
6Università Gabriele D’Annunzio Chieti Pescara, Chieti, Italy.
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Background: Antiretroviral therapy (ART) for treatment of HIV/AIDS
patients in less developed countries (LDCs) produces an impact on
individual health and indirectly impacts socio-economic status. We
investigated the impact of an ART program on work productivity and
household income as these are key parameters for cost-benefit
analyses of HIV public programs and policies.
Methods: Health status of HIV-infected patients on ART was
determined at baseline and subsequent visits through assessment
of Body Mass Index (BMI), hemoglobin, viral load and CD4 cell
subsets. Socio-economic status was assessed exploring productivity
(hours worked), income, and other economic variables through
patient interviews. Using a prospective design we followed a cohort
of patients from the DREAM program Malawi with the following
inclusion criteria: HIV positivity, age]15, ART initiation within 2
months of enrollment. All subjects had at least 8 months of follow-up
post-ART initiation. Health, income and productivity parameters
were evaluated through paired t-test.
Results: 165 subjects were followed from 1/2008 to 3/2009. The
overall health status of subjects improved significantly based on
clinical and virologic parameters (Table). A positive overall impact on
productivity and income was noted with hours worked in the last
week increasing by 25%, hours worked in the last month increasing
by 31%, income generated in the last week increasing by 85%,
income in the last month increased by 80% (Table). For patients
who were unemployed at baseline (n37) mean income was too
low (B4$ per month) to be relevant for the analysis. With the
exclusion of unemployed patients at baseline, the increase in last
week/last month hours worked was 35% and 43% respectively,
and last week/last month income 93% and 89% respectively
(400$ per year).
Conclusion: ART therapy has a strong impact on patients productivity
and income, and provides an economic incentive towards sustain-
ability of ART delivery programs in LDC.
WEPDE0201
Does condom use affect the earnings of commercial sex
workers? New evidence from a survey of female sex
workers in India
S. Mondal and I. Gupta
Institute of Economic Growth, Delhi, India
Presenting author email: kumar.swadhin@gmail.com
Background: Unsafe sex is the major cause of transmission of HIV in
developing countries like India. Condom use is, therefore, seen as the
most effective instrument against the transmission of HIV. However,
use of condoms in commercial sex is still nowhere universal. Part of
the reason could lie in the evidence that sex workers lose income
when they enforce the use of condoms among their clients.
This paper re-examines how condom use affect the price for
commercial sex.
Methods: A survey of 5498 female sex workers from four high HIV
prevalence states of India was analyzed using a simultaneous
equations model using three-stage least squares method, to identify
the causality between condom use and price for commercial sex.
Results: The data indicated that 77 percent of the sex workers are
consistent condom user. The analysis shows that there both price of
sex and condom use influences each other. Also, results indicate that
all types of sex workers (Road, Brothel, Hotel and Bar) except
brothel-based workers received 35 percent higher earnings when
they have protected sex than unprotected sex. Brothel based sex
workers earned 24 percent less when they enforced the use of
condom. The other exogenous factors that affect the price are
negotiating power, level of education, type of sex workers (other
sources of income, number of client visit per day, contract under
pimp etc.). Hotel and bar based sex worker getting comparatively
higher price.
Conclusion: The market for sex work has changed in favour of sex
workers and condom use generally no longer has a negative
premium for most of the sex workers. It is, therefore, possible to
step up the intensity of behavioral intervention for enhancing
Mean Value (status class)
Mean increase in status




Variables Baseline (t0) Follow-up (t1) Min Max P
Malnutrition (BMI) 21.38 (0.82) 21.79 (0.92) 0.10 (12%) 0.03 0.18 0.009
Hemoglobin 11.61 (1.76) 12.99 (1.96) 0.20 (11%) 0.10 0.29 B0.001
CD4 cell count (cells/mm3) 276 (0.76) 379 (1.23) 0.47 (62%) 0.35 0.59 B0.001
HIV-1 RNA Log10 3.93 (0.48) 0.71 (1.85) 1.37 (285%) 1.20 1.53 B0.001
Hours worked last 7 days 24 30 6 (25%) 1 11 B0.05
Hours worked last 30 days 96 126 30 (31%) 13 48 B0.01
Income over last 7 days (USD) 10.93 20.25 9.31 (85%) 1.45 17.17 B0.05
Income over last 30 days (USD) 43.97 79.29 35.32 (80%) 11.88 58.76 B0.01
Change in health and economic parameters.
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condom use among the sex workers without worrying about its
impact on their earnings.
E68 - Investment frameworks and models
in a period and in settings of decreasing
financial resources.
MOAE0203
Company-level ART provision to employees is cost saving: a
modelled cost-benefit analysis of the impact of HIV and
antiretroviral treatment in a mining workforce in South
Africa
G. Meyer-Rath1,2,3, J. Pienaar4, B. Brink5, A. van Zyl6, D. Muirhead6,
A. Grant7, G. Churchyard6, C. Watts2 and P. Vickerman8
1Boston University Center for Global Health and Development,
Boston, United States. 2London School of Hygiene and Tropical
Medicine, Department of Health Services Research and Policy,
London, United Kingdom. 3University of the Witwatersrand, Health
Economics and Epidemiology Research Office (HE2RO),
Johannesburg, South Africa. 4Highveld Hospital, Thermal Coal,
Emhalahleni, South Africa. 5Anglo American, Johannesburg, South
Africa. 6The Aurum Institute, Johannesburg, South Africa.
7Department of Clinical Research, London School of Hygiene and
Tropical Medicine, London, United Kingdom. 8London School of
Hygiene and Tropical Medicine, Department of Global Health and
Development, London, United Kingdom
Presenting author email: peter.vickerman@lshtm.ac.uk
Background: HIV impacts heavily on rates of absenteeism, labour
force turnover and, ultimately, cost of operations of companies in
sub-Saharan Africa. Employers increasingly supply HIV testing and
antiretroviral treatment (ART) programmes at the workplace. The full
economic impact of ART provision on a mining workforce has not yet
been analysed.
Methods: We developed a dynamic health-state transition model to
analyse the economic impact of HIV and the cost benefit of
ART provision in a mining company in South Africa between 2003
and 2022. The model was fitted to the workplace using information
on the size, composition, turnover, HIV prevalence and CD4 counts
of the workforce from company records. Bottom-up analyses of
economic costs at the company supplied data on inpatient and
outpatient resource utilisation and the costs of absenteeism and
replacing a sick worker. Costs are analysed from the company
perspective and presented undiscounted and discounted at 5%.
Results: As a result of lower mortality and morbidity in the
employees covered by ART, survival in employment of HIV-positive
employees grows by 7% as ART coverage increases from 21% to 80%
of eligible HIV-positive employees by 2022. The associated reduction
in absenteeism and benefit payments more than offsets the
additional cost of the ART programme, leading to a 9% decrease in
the total and annual cost of HIV to the company and a 15% decrease
in the mean cost per HIV-positive employee by 2012 (Table 1). 48%
and 37% of cost savings are due to reductions in benefits and
absenteeism, respectively (Table 2). Savings to the company average
USD 1.1 million per year. Total HIV-related costs equal 1.5 to 3.5% of
payroll.
Conclusion: ART provision at the workplace level is cost-saving for
the company. Our results point to private-sector ART provision as a
viable alternative to overburdened public sector ART programmes.
E70 - Cross-national comparisons
WEAE0403
The state of the national response to prevent HIV among
young people: a review of national reporting in 20 high-
prevalence countries
I. Birdthistle1, S. Dringus1, L. Knight2, E. Yankah2, P. Idele3, C. Suzuki3,
L. Nguyen3 and S. Kasedde4
1London School of Hygiene & Tropical Medicine, Epidemiology &
Population Health, London, United Kingdom. 2Consultant, London,
United Kingdom. 3UNICEF, New York, United States. 4UNICEF, New
York, United Kingdom
Presenting author email: isolde.birdthistle@lshtm.ac.uk
Background: Given recent international commitments to the pre-
vention of HIV among young people, we sought to assess the
national response to prevent new infections among 10-24 year olds
in countries with high HIV prevalence.
Table 2. Mean annual cost per item 20032022
Annual cost per item
in 2006 USD (% of
annual cost)
Difference to No ART
(% of total savings)Cost item No ART With ART




1.4 (12%) 1.3 (12%) 0.1 (6%)
- of which inpatient
care
0.4 (9%) 0.3 (9%) 0.1 (0.2%)
- of which outpatient
care
1.1 (3%) 0.9 (3%) 0.2 (6%)
Absenteeism 5.2 (42%) 4.6 (41%) 0.6 (37%)
Benefits 5.0 (40%) 4.2 (37%) 0.8 (48%)
Training and
recruitment
0.7 (6%) 0.6 (5%) 0.1 (9%)









Total cost (millions) 363 331 9%
Mean annual cost (millions) 18 17 9%




Total cost (millions) 282 257 9%
Total annual cost (millions) 14 13 9%
Mean annual cost per HIV-positive
employee
11,792 10,003 15%
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Methods: For 20 countries with generalized HIV epidemics, current
national strategic plans and progress reports were reviewed to assess
the national response in terms of: planning, measured by the
inclusion of youth-specific strategies within national AIDS plans; and
implementation, or the extent to which prevention activities reach
the intended audience.
Results: All 20 countries include youth-specific strategies in their
current national AIDS plan, and school-based HIV prevention was the
youth prevention strategy most often included. Governments of all
20 countries report that school-based HIV education is reaching the
majority of people in need, and included in primary, secondary, and
teacher training curricula. The proportion of schools providing life-
skills based HIV education varies from 2% to 100%. Programmes for
out-of-school youth, behaviour change communication, and condom
promotion were commonly included in national strategies, however,
their content, quality and coverage were generally not reported. In
UNGASS country progress reports, few countries disaggregate by age
and sex the UNGASS indicators relevant to young people, or report
comparable statistics over time.
Conclusion: In 20 high-prevalence countries, HIV prevention among
young people is considered a priority in national plans, and the most
widely implemented intervention for youth is school-based preven-
tion. Monitoring youth-focused programmes should be improved to
assess coverage, quality and delivery through comparable data over
time. At a minimum, reporting UNGASS indicators by age and sex will
improve the usefulness of national progress reports in tracking
prevention efforts for youth. As a priority, systems are needed to
report planning and programmes to promote condoms and HIV
testing among young people, given the scarcity of data at the
national level.
E72 - Sustainability of financing and
programmes
MOAE0302
Sustainability of HIV programs: lessons learned from
sustainability analyses in four countries
I. Katz1, W. Wong1, D. Glandon1, B. Kargbo2, R. Ombam3, S. Singh4
and J. Osika1
1Abt Associates, Health Systems 20/20, Bethesda, United States.
2National AIDS Secretariat, Freetown, Sierra Leone. 3National AIDS
Control Council, Nairobi, Kenya. 4National AIDS Programme
Secretariat, Georgetown, Guyana
Presenting author email: katz@cantab.net
Background: The political will to achieve universal access of HIV
services by 2015 versus the decline in HIV donor funding requires HIV
programs to rethink the current model of scaling up towards
universal access, particularly when it relies heavily on donor funding.
Methods: The study reviews the results of the HIV/AIDS Program
Sustainability Analysis Tool (HAPSAT) studies in four countries:
Guyana, Kenya, Sierra Leone, and South Sudan. It focuses on
sustainability challenges in the areas of financing, programming
and human resources, and selected proposed solutions to these
challenges.
Results: The sustainability issues encountered in the four countries
were largely associated with these countries’ heavy dependence on
donor funding. In the initial years of the respective HIV/AIDS
programs, this led to the expansion of HIV services beyond the
levels that can be sustained without donor support. This expansion,
for example, included stand-alone HIV clinics catering to a small
number of patients. Solutions to the sustainability challenges can be



















Kenya Low 6.3% among
1549 year
olds
61% Need to sustain









50% Need to sustain









8.3% Global Fund grant
(a key source of






Prioritization 1) Tailored IEC/BCC for MARPs and mass media
for general populations (Sierra Leone, South
Sudan); 2) Prioritization of use of various mass
media based on unit cost per message exposure
(South Sudan); 3) Target setting based on past
performance to factor proxy for capacity (Sierra
Leone, South Sudan)
Efficiency 1) Limiting the number of financing agents
(South Sudan); 2) Identification of existing
datasets that can be assembled into a central
strategic database to facilitate coordination of
donors (Guyana); 3) Integration of HIV-related




1) Providing a plan to close a US$1.67 billion
gap, through a combination of air freight levy,
increasing the insurance premium, increasing
government budget allocation, and
decentralizing ART service delivery (Kenya); 2)
Illustrating to donors the added value of their
funding by unit cost analysis (South Sudan)
Examples of Sustainability Recommendations
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different interventions, and between target populations to be
reached by a given intervention. Prioritization is more challenging
where no cost-effective information exists, e.g., when dealing with
non-clinical interventions. In such cases, the relevance of the
intervention to the specific country context and the capacity to
scale-up and sustain were assessed; 2) Efficiency, which includes,
among others, partial or full integration of HIV services with the
wider health and social services; and 3) Resource mobilization, from
traditional sources such as governments, as well as innovative
resources such as a levy tax on airlines.
Conclusion: With the decline in donor HIV funding, national HIV
Programs will have to reassess the components of their respective
programs in the context of sustainability. Countries will benefit from
integrating sustainability plans into their strategies, operational plans
and funding proposals.
WEAE0105
Affordability of HIV/AIDS treatment in developing countries:
an analysis of ARV drug price determinants
L. Sagaon Teyssier1,2,3, Y. Arrighi1,3,4, B. Dongmo Nguimfack5 and
J.-P. Moatti1,2,3
1INSERM, U912 (SESSTIM), Marseille, France. 2Aix Marseille Univ,
IRD, UMR-S912, Marseille, France. 3ORS PACA, Observatoire Régional
de la Santé Provence Alpes Côte d’Azur, Marseille, France. 4GREQAM,
Groupement de Recherche en Economie Quantitative d’Aix-Marseille,
Marseille, France. 5WHO, World Health OrganizationGeneva,
Switzerland
Presenting author email: jean-paul.moatti@inserm.fr
Background: Although prices for first-line drugs fell during the last
years, affordability remains a critical issue in developing countries.
Failure to first-line drug treatment increases the number of people
living with HIV/AIDS (PLWHA) that require second-line treatment.
The aim of this study is to analyze the global antiretroviral prices
between 2003 and 2011 and associated factors, particularly
differences between innovator/generic drugs, and the innovator
prices evolution as the patents get closer to expiration.
Methods: Retrospective transactional data for antiretroviral procure-
ments between 2003 and 2011 from the Global Price Reporting
Mechanism (GPRM/WHO) was used. For every transaction, price,
quantity, supplier and drug characteristics were recorded. Descrip-
tive analyses were based on daily dose prices and quantities (PDD,
QDD). Logarithm of PDD was regressed on transaction year,
log(QDD), therapeutic class, years before patent expiration, formula-
tion, and innovator/generic indicator.
Results: Mean PDD decreased from US$1.1 in 2003 to US$0.48 in
2011. In this period, mean PDD of generic drugs fell about 40.8%,
while mean PDD of innovator drugs increased about 22%. Innovator
firms sold 7% of purchased quantity (20% of total expenditure in
antiretrovirals). Econometric analysis demonstrates price sensitivity
to therapeutic classes, formulation, and quantities. Innovator
prices are 35% (pB 0.001) higher than generics. In addition, the
estimation suggests that innovator prices increase when initial
patents arrive to expiration: 6.3% (pB 0.001) per year. Although
first-line prices are in average 131% (pB 0.001) lower than second-
line, innovator prices for first-line drugs are 33% (pB 0.001) higher
than generic drugs.
Conclusion: Procurement policies should pay attention not only
to higher prices practiced by innovator firms for drugs recommended
in first-line regimens, but also to drugs with patents arriving
to expiration whose prices are higher than drugs with patents
expiring later. Where patent protection is concerned, high prices may
impair the delivery of higher quality treatment in developing
countries.
TULBE06
Scenario-based cost projections for PEPFAR resource
requirements for the ART program in Ethiopia from
FY2011-FY2015
S.A. Ali1, N. Menzies2, T. Kenyon1, Z. Melaku3, T. Gadisa3, B. Graham4,
G. Feleke4, S. Zewdu5, M. Makonnen6, D. Mattanovich7 and Y. Mamo7
1United States Centers for Disease Control & Prevention (CDC)-
Ethiopia, Addis Ababa, Ethiopia. 2ICF Macro, Atlanta, United States.
3Columbia University International Center for AIDS Care and
Treatment Program (CU ICAP)-Ethiopia, Addis Ababa, Ethiopia.
4University of Washington International Training and Education
Center for Health (I TECH)-Ethiopia, Addis Ababa, Ethiopia. 5Johns
Hopkins University Technical Support for The Ethiopian HIV/AIDS ART
Initiative (JHU TSEHAI), Addis Ababa, Ethiopia. 6Catholic Relief
Services/AIDSRelief Ethiopia, Addis Ababa, Ethiopia. 7University
of California-San Diego (UCSD)-Ethiopia, Addis Ababa, Ethiopia
Presenting author email: ahmeds@et.cdc.gov
Background: Providing HIV treatment consumes substantial
program resources. Forecasting future resource requirements can
help ensure uninterrupted service delivery as treatment programs
grow. We undertook cost analyses and projections for PEPFAR
resources required to continue supporting the national ART
program in Ethiopia under various scenarios from FY2011 through
FY2015.
Figure 2. Trends in projected costs (in millions USD).
Figure 1. Base Case projections FY 20112015.
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Methods: We collected data on actual expenditures devoted to
supporting treatment programs in FY 2010, and used these data to
calculate unit costs for various services. Data about patient and
program characteristics were collected from performance reports,
indicator targets, results of cohort analyses, and known program
mark-ups and prices. We used the PEPFAR ART Costing Model 2010
to calculate resource requirments under scenarios describing
different rates of new patient enrollment.
The base case scenario assumed continued program growth at its
current pace, adding 4,000 new ART patient slots every month from
an initial patient volume of 207,458 ART patients. We assumed that
Pre-ART patient volume continues to grow proportional to ART
patient volume. This base case scenario was compared to 1) a slower
(50% reduction) in patient uptake from base case scenario, 2) linear
scale-up to universal access targets, 3) rapid scale-up to universal
access targets.
Results: Faster rate of scale-up requires markedly increased
resources for expanding capacity to accommodate a large number
of patients at the initial phase, but in subsequent years, annual
costs drop sharply and drop below the slower rate of scale-up for
universal access. However, the total 5 year cost was higher than
in all other scenarios. ARV costs represent a small fraction of total
PEPFAR costs, as these costs are largely covered by the national
government through Global Fund and other donors.
Conclusion: Programs need to weigh the higher costs of rapid scale-
up, and the improved health outcomes and economic gains of
universal access in making planning decisions.
E73 - Measuring eff ic iency and
effectiveness of national AIDS programmes
MOAE0303
Spending on ART by provinces in South Africa: trends, cost
drivers, (in)efficiencies and sustainability
N. Simelela1, S. Senabe2, C. Sozi3, H. Damisoni3 and T. Guthrie4
1President’s Office, South Africa, Pretoria, South Africa. 2Department
of Public Service and Administration, Pretoria, South
Africa. 3UNAIDS, Pretoria, South Africa. 4Centre for Economic
Governance and AIDS in Africa (CEGAA), Cape Town,
South Africa
Background: In 2003, the South African government committed to
providing ART free to HIV-positive patients attending public health
care facilities. National Treasury increased the budget allocations to
cope with the rapid rate of ART roll-out, and has committed to
increasing its allocations by 22% on average over the Medium Term
Expenditure Framework (MTEF) period (2010/11 to 2012/13).
Initially, provinces struggled with lack of capacity, stock-outs and
even underspending. In recent years, some of these challenges have
been reduced as procurement and supply systems have been
improved and human resource capacity has been expanded.
However, examining the different provincial ART expenditure in
relation to respective numbers of ART patients and HIV prevalence
shows interesting variations, highlighting possible areas for improved
efficiency in some provinces.
Methods: The total public spending that was labelled as‘‘ART’’ by the
South African provinces was identified for the years 2007/08, 2008/
09 and 2009/10, and broken down into cost components. This was
limited by the level of disaggregation available in the public
expenditure records. Simple unit costs were calculated using the
total provincial ART spending per annum, divided by the number of
public ART patients in that province in each year.
Results: The rough estimates of unit costs over the three years show
increasing efficiencies in delivery, with variations in the key cost
drivers per province. Comparing the provincial spending with
estimated numbers of patients in need of treatment indicates that
allocations and spending appear to be along lines of capacity to
deliver, rather than of need. As spending on ART in SA dramatically
increased, spending on prevention interventions decreased nomin-
ally and proportionally, raising concerns of sustainability. The
attached figures present some key findings.
Conclusion: The study concludes with recommendations for
improved efficiency of ART spending and delivery, and sug-
Figure 1. South African Provincial DOH Spending on ART and Numbers of ART Patients (ZAR Mill, ‘000s patients, 2009/10).
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gestions for more equitable allocations across provinces in South
Africa.
E74 - Ethics of operations research, HIV
programme implementat ion and
economic evaluation
WEAE0303
Mobile phone adherence support for antiretroviral therapy:
what would it cost the National AIDS Control Program in
India?
R. Rodrigues1,2, A. Shet2,3, N. Swaroop4, S. Shastri5, L. Bogg6 and
A. De Costa2
1St John’s National Academy of Health Sciences, Community Health,
Bangalore, India. 2Karolinska Institutet, Global Health, Stockholm,
Sweden. 3St. John’s National Academy of Health Sciences, Pediatrics,
Bangalore, India. 4St John’s National Academy of Health
SciencesHIVIND Project, Bangalore, India. 5Karnataka State AIDS
Prevention Society, Bangalore, India. 6School of Sustainable
Development of Society and Technology, Stockholm, Sweden
Presenting author email: rashmijr@gmail.com
Background: Mobile phone reminders for adherence support in HIV
have gained popularity in recent years. While many studies have
proven the effectiveness of such reminders, few have assessed the
costs on a large scale. This study aims to assess their costs of such
Figure 2. South African Proportional ART Spending per Production Factor, By Province (2009/10).
Figure 3. South African Provincial DOH Public ART cost per patient per annum (ZAR) and HIV Prevalence (%, 2009/10).
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Table 1. Healthcare program costs for mobile phone adherence support for patients attending an HIV clinic in South India
At healthcare provider level
One-time costs* Costs (USD) Annualised cost (USD)
Development of the intervention 402.66/5yrs 80.53
Development of the web interface 201.33/5yrs 40.27
Equipment costs (llaptop and 1 mobile phone) 664.38/5yrs 132.88
Fixed costs* Cost (USD) Annualised cost (USD)
Service maintenance 603.99/year 603.99
Equipment maintenance 28.19/3years 9.40
Program manager
(10% of annual time, 503.32USD/mth salary) 603.99
Overheads 201.33/year 114.40
Data manager (15min/week, 140.93USD/mth salary) 10.63
Tota cost 1596.07
Variable Costs* Costs (USD) Annual Cost/patient (USD)
IVR cost 0.03Q/IVR 1.57
SMS cost 0.004/SMS 0.21
Counselor
(20min/patientyyear, 24.16USD/mth salary) 0.11
Total variable cost 1.89
Total costs Annual Cost (USD)
Total cost 
One-time cost  Fixed costs  n(vanable costs) 4627.60
Total cost/patient (number of patients 1600)@ 2.89
*One time costs: one time investments made either by healthcare providers.#Fixed costs: Costs that do not change with the units of
consumption. $Variable costs: Costs that change with the units of consumption. @Number of patients receiving ART at St. Johns Medical College
Hospital. Bangalore. India. 1USD 49.67INR as of 15th February 2012
Cost of mobile phone reminders
Figure 1. Total and variable costs for scale up of mobile phone adherence reminders (IVR+SMS) for Antiretroviral Therepy in the Indian
context [Total and Variable costs for scale up].
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reminders to support adherence in patients on antiretroviral therapy
(ART) within the context of the National AIDS control Program of India.
The mobile phone reminder in this study consists of a combination of
an interactive voice response (IVR) and picture message (SMS); both
forms of adherence reminders are received by patients once a week.
This intervention was developed for the HIVIND trial in India.
Methods: The study was done from a program perspective at
St. John’s Medical College Hospital, Bangalore, India. Total costs of
establishing and maintaining the mobile phone reminders were
studied. Sequential procedure for costing was used. This involved
identifying, measuring and pricing resource use in natural units
(eg: minutes). Sensitivity analysis for scale up involved: (1)
varying the number of patients and (2) varying the constituents
of intervention ie; (i) IVR and SMS (ii) SMS alone (iii) IVR alone.
Results: Total cost for mobile phone adherence reminders is
2.89USD/patient/year for 1600 patients on ART at the study site
(Table 1). Estimated cost to the national program is 0.68USD /
patient/year for scale up from 0.42million currently on ART to
0.8million patients expected to receive ART by 2017 (Figure 1). Cost
estimates for individual components ie; IVR alone and SMS alone for
0.8million patients are 0.64USD/patient/year and 0.16USD/patient/
year respectively (Table 2).
Conclusion: From our study, the Indian program would incur an
overall cost of 0.086% of its current 5year budget to provide such
adherence support. The costing results of this study are relevant for
policy makers when considering interventions to enhance adherence
support within the national program.
E75 - Use of operations research to
support the response to HIV prevention
and treatment
MOPDE0202
Factors associated with non-utilisation of antenatal care
services by women delivering with an unknown HIV status
at four poly-clinics in Chitungwiza, Zimbabwe
V. Makani1, S. Rusakaniko1, A. Angela2, B. Makunike -Chikwinya3,
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Presenting author email: vimbai@zappuz.co.zw
Background: Increasing numbers of women are presenting in labour
without prior antental care (ANC) with unknown HIV status in the
town of Chitungwiza, Zimbabwe (from 918 in 2009 to 4768 2010)
depite efforts to raise community awareness and national maternal
and child health campaigns. A study was conducted to identify
factors associated with utilisation and non-utilisation of ANC services
among women delivering in four Chitungwiza clinics.
Methods: A one to one unmatched case control study was conducted
at four PMTCTsites from February–April 2011. A case was any woman
who presented in labour without prior ANC or had attended only one
ANC visit. A control was any woman who presented in labour having
attended two or more ANC visits. Systematic sampling was done using
delivery registers as sampling frames. First case was randomly
selected then every second woman until the required sample size
was reached. An administered questionnaire was used to collect data.
EpiInfo v3.5.3 was used for analysis.
Results: There were 232 cases and 232 controls with a median age
of 25 in both groups. Unaffordable of ANC fees (OR3.8; 95% CI:
1.3910.46), seeking Tradtional Birth Attendant (TBA) servises
(OR3.2; 95% CI: 1.168.85), and religious beliefs (OR1.7; 95%
CI: 1.092.68) increased the likelihood of not booking for ANC.
Independent determinats of non-utilisation of ANC included belong-
ing to the apostolic faith (AOR3.1[1.059.18],seeking TBA services
with previous pregnancy (AOR3.2 [1.168.86], unaffordable user
fees (AOR3.0 [1.157.69]). Having received information on ANC
with previous pregnancy (AOR0.16 [0.100.26], death of a child
(AOR0.41 [0.190.93] and being HIV-positive (AOR0.39 [0.23
0.64)] were independent determinants of ANC utilisation.
Table 2. Sensitivity analysis of costs for mobile phone adherence support for antiretroviral therapy based on the number of
patients and type of mobile support
Patient Numbers 100000 426000$ 800000#
Mobile support IVR SMS IVR SMS IVR SMS
Onetimefixed costs (USD) 1596.07 1596.07 1596.07 1596.07 1596.07 1596.07
Annual variable cost/patient* (USD)
IVR cost/30 sec call 0.52 NA 0.52 NA 0.52 NA
Cost/SMS NA 0.04 NA 0.04 NA 0.04
Counselor cost 0.11 0.11 0.11 0.11 0.11 0.11




n (variable costs) 65437.42 17279.58 273560.23 68407.83 512326.89 127064.16
Total Cost/patient* 0.65 0.17 0.64 0.16 0.64 0.16
*IVR cost/30 sec call=0.01USD, and cost/SMS=0.0008USD if number of patients ]100000 patients.
$Number of patients on ART under the National AIDS Control Program in 2011 (NACP). #Number of patients expected to receive ART under the
NACP Phase IV (20122017) (Reference: Working group on AIDS control for the 12th five year plan, Planning commission, GOI). @Total costs
approach variable costs as number of patients increase. 1USD=49.67INR as of 15th February 2012.
Sensitivity analysis of costs.
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Conclusion: Revision and enforcement of national polices on ANC
user fees is necesary to improve ANC utilisation, access to HIV testing
and counselling, treatment care and support during pregnancy and
ensure that ANCservices are accessible to pregnant women at an
affordable fee.
E77 - Operations research making a
difference in programme performance
WEAE0203
Risk factors and true outcomes of children lost to follow-up
from antiretroviral therapy in Lilongwe, Malawi
C. Ardura Garcia1, H. Tweya2, C. Feldacker2, S. Phiri2 and R. Weigel3,4
1Liverpool School of Topical Medicine, Liverpool, United Kingdom.
2Lighthouse Trust Clinic, Kamuzu Central Hospital, Lilongwe, Malawi.
3Liverpool School of Topical Medicine, Disease Control Strategy
Group, Liverpool, United Kingdom. 4Lighthouse Trust, Kamuzu
Central Hospital, Lilongwe, Malawi
Background: Loss to follow-up (LTFU) negatively affects antiretroviral
therapy (ART) programmes by leading to viral resistance as well as
immunological and clinical failure among patients and by biasing
mortality estimates. Among children, risk factors for LTFU and true
outcomes of these patients are not well known. The objectives of the
study were to analyze LTFU risk factors of children on ART and to
determine their true outcomes through active tracing.
Methods: Descriptive retrospective cohort study of 1182 children
that were on ART at an urban HIV clinic in Malawi between April
2006 and December 2010. Since 2006, the clinic implements an
innovative programme, Back-to-Care (B2C), to increase ART patient
retention through phone and field tracking. Baseline characteristics
routinely collected at ART initiation were gathered together with the
information obtained from the B2C field tracing team to determine
ART initiation factors that influenced subsequent LTFU.
Results: Of 985 children (1999 children-years) on ART included in the
analysis, 251 (25%) were LTFU, a LTFU rate of 12.6/100 children-
years. No available CD4 count at initiation [Adjusted Hazard Ratio
(AHR): 2.01, 95% CI: 1.313.07]; nutritional wasting (AHR: 1.6, 95%
CI: 1.172.18) and age under 2 years (AHR: 1.55, 95% CI: 1.022.37)
all independently increased the risk of LTFU. Of 201 LTFU children
traced, 158 (79%) were found: 11% died, 26% transferred out (TO) to
another treatment centre and 63% were alive. LTFU rate was
reduced by 62% after tracing. Mortality estimates were corrected,
increasing from 2.6% to 4.8%.
Conclusion: Increased patient retention efforts, coupled with more
active tracing of LTFU children on ART, could reduce LTFU, increase
patient adherence, and improve mortality rate estimates.
E80 - Strategies for phasing-in viral load
in resource-limited settings
TUPDE0206
Use of viral load testing in resource-limited settings to
confirm treatment failure in children: experience from
Nyanza Province, western Kenya
H. Muttai1, L. Wanjiku2, A. Gichangi2, F. Miruka1, T. Ayuaya3, D. Soti4,
C. Zeh1 and M. Ackers5
1Centres for Disease Control and Prevention (CDC), Division of Global
HIV/AIDS, Kisumu, Kenya. 2Centres for Disease Control and
Prevention (CDC), Division of Global HIV/AIDS, Nairobi, Kenya.
3KEMRI/CDC Research and Public Health Collaboration, HISS, Kisumu,
Kenya. 4Ministry of Health, Kisumu, Kenya. 5Centres for Disease
Control and Prevention (CDC), Atlanta, United States
Presenting author email: hmuttai@ke.cdc.gov
Background: In Kenya, about 47,000 (9%) of the 520,000 people on
antiretroviral therapy (ART) are children. Use of virologic measure-
ment to monitor response to ART is not routinely provided due to
cost and accessibility; however, viral load (VL) testing is being offered
in limited settings to confirm treatment failure.
Methods: We analysed demographic and clinical data from pediatric
patients (B15 years) meeting national criteria for treatment failure
who submitted samples for VL testing from 68 clinical sites in Nyanza
Province. Immunologic criteria included CD4 count or percent non-
response (riseB50 cells/mm3 or persistent CD4B100 cells/mm3) or
CD4 fall 50% of peak, to baseline, or below threshold value for
age. Clinical criteria included new/recurrent WHO stage 3/4 condi-
tions, poor growth, or recurrent infections.We evaluated the positive
predictive value (PPV) of using immunologic and clinical criteria to
diagnose virologic failure (VL1,000 copies/ml, after6 months of
ART).
Results: Between Sept 2008-June 2011 336 pediatric samples were
tested; patient median age 10 years (range 114) and 143 (43%)
were female. 94% were on a first-line nevirapine/efavirenez-based
regimen, median duration on ART was 2.6 years, 213 (63%) patients
met 1 immunologic criteria, 51 (15%) 1 clinical criteria, and 71
(22%) met both. Despite 99% of clinicians reporting satisfactory
patient ART adherence, 287 (85%) samples indicated virologic failure.
The PPV of immunologic criteria was 87% (95% Confidence Intervals
[CI] 84%90%) compared to 62% PPV (95% CI 50%73%) for clinical
criteria. The PPV of both criteria present was 96% (95% CI 88%98%).
Conclusion: Virologic failure was confirmed in 85% of pediatric ART
patients with suspected treatment failure. Immunologic criteria in
combination with clinical criteria were more useful in correctly
identifying patients requiring regimen changes and reduced the
number of false positives compared to using clinical criteria or
immunologic alone.




Routine viral load testing among pregnant HIV-positive
women on antiretroviral therapy: implications for
prevention, Nyanza province, Kenya, 2011
L. Nganga1, H. Muttai1, G. Anthony1, F. Miruka1, D. Soti2, J. Okonji3
and M. Ackers4
1Centers for Disease Control and Prevention, Nairobi, Kenya. 2Kenya
Ministry of Public Health and Sanitation, Nairobi, Kenya. 3Kenya
Medical Research Institute, Nairobi, Kenya. 4Centers for Disease
Control and Prevention, Atlanta, United States
Presenting author email: lnganga@ke.cdc.gov
Background: Highly active antiretroviral therapy (HAART) among HIV-
infected women during pregnancy and breastfeeding reduces the risk
of HIV transmission. Maternal HIV viral load (VL) is an important
predictor of transmission risk, and VL monitoring during pregnancy
could be useful to optimize clinical management. However, routine
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VL monitoring is not widely available in Kenya. We assessed routine
VL monitoring for pregnant HIV-infected women on HAART to
determine the proportion of women who were not reaching
treatment and prophylaxis goals
Methods: We initiated a pilot in September 2008 in Nyanza at 66
clinical sites offering VL testing for patients identified as meeting
clinical and immunologic criteria for treatment failure or who were
pregnant. Frequencies, proportions, and interquartile ranges (IQR)
for demographic and clinical data were calculated. Bivariate analysis
examined potential correlates of detectable VL (400 copies)
Results: Between 2008 and June 2011, pregnant women, without
evidence of clinical or immunological failure, constituted 683 (8%) of
8073 patient samples submitted for VL testing. Median age was 29
years (IQR 2633) and median baseline CD4 count was 190cells/
mm3 (IQR 102279). The median duration of HAART was 2 years (IQR
13) and 99% were on a first-line regimen (zidovudine/stavudi-
nelamivudinenevirapine/efavirenz). 161 (24%) of samples
yielded a detectable VL. Women with a baseline CD4B200 were
more likely to have a detectable VL (OR1.79, 95% CI 1.242.57)
compared to those with a CD4200. Age and duration of HAART
were not associated with a detectable VL
Conclusion: One in four pregnant women on HAART, without current
indications of treatment failure, had a detectable VL. Pregnant
women, especially those with low baseline CD4 counts, should
receive enhanced ART adherence counseling and close clinical
monitoring. Routine use of VL testing during pregnancy can identify
women requiring additional intervention to maximize care and
prevention outcomes.
Disclaimer: The content and views in this abstract are solely the
responsibility of the authors and do not necessarily represent the
official views of the affiliated organizations, United States Govern-
ment, or Government of Kenya.
E82 - Operations research in the use of
laboratory monitoring, other than viral
load
TUPDE0202
Assessment of laboratory test utilization for HIV/AIDS care
in ART clinics of Malawi
S. Palchaudhuri1, H. Tweya2 and M. Hosseinipour1
1UNC Project-Malawi, Lilongwe, Malawi. 2Lighthouse Trust Clinic,
Lilongwe, Malawi
Presenting author email: sonalipc@umich.edu
Background: Transition to CD4 monitoring for pre-ART assessment
and viral load (VL) monitoring for ART response assessment is
planned in Malawi. We assessed how often clinicians ordered these
tests as compared to current guidelines, and whether the samples
were successfully and promptly processed.
Methods: We conducted a retrospective review from electronic
medical records of all patients seen from August 2010 through July
2011, in two urban HIV-care clinics that utilize 6-monthly CD4
monitoring regardless of ART status. We calculated the percentage of
patients on whom clinicians ordered CD4 or VL analysis for routine
care, using blood-draw as a proxy for ordering. For all CD4 and VL
samples sent to the adjacent Ministry of Health central laboratory,
we determined rates of successful lab-processing, and mean time to
returned results.
Results: Of 22,488 patients seen, 8147 (35%) had at least one
blood draw for CD4 count. Of all CD4 samples sent, 8061/8754 (92%)
samples were returned as successfully processed. Of those, mean
time to processing was 1.6 days (s.d 1.5) but mean time to
results being available to clinician was 9.7 days (s.d. 3.5). Regarding
VL, 189 patients (1% of the 18,330 on ART) had a blood draw and
only 118/213 (55%) samples were returned as successfully pro-
cessed. Mean processing time was 39.9 days (s.d. 24.6); mean time
to results being available to clinician was 43.9 days (s.d. 28.8). During
the one-year evaluated, there were multiple lapses in processing
VL samples for up to 2 months; no samples were processed after
May 2011.
Conclusion: Clinicians grossly underutilize CD4 and VL as diagnostic
and monitoring tools. Laboratory processing failures and turnaround
times are unacceptably high, especially for viral load analysis.
Alternative processing techniques or results reporting strategies,
such as point-of-care devices or SMS result reporting, may offer
considerable improvement before successfully adopting these tests
as standard-of-care.
TUPDE0204
Evaluating the effect of the use of point-of-care CD4
machines on access to antiretroviral therapy (ART) eligibility
screening and ART initiation for HIV-positive pregnant
women in Zimbabwe: towards elimination of new
paediatric HIV infection by 2015
A. Muchedzi, A. Chadambuka, B. Chikwinya and A. Mahomva
Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), Harare,
Zimbabwe
Presenting author email: amuchedzi@pedaids.org
Background: Treatment-eligible HIV-positive pregnant women have
the highest risk (75%) of transmitting HIV to their infants, but only
a small proportion of women are being initiated on antiretroviral
therapy (ART) during pregnancy in Zimbabwe, partially due to limited
access to CD4 testing to determine treatment eligibility. We assessed
whether introducing point-of-care (POC) CD4 machines at 43 high-
volume, Elizabeth Glaser Pediatric AIDS Foundation supported,
PMTCT sites in Zimbabwe increased the proportion of HIV-positive
pregnant women assessed for ART eligibility and subsequently
initiated on ART.
Methods: A quasi-experimental before and after study design was
conducted, with 43 high-volume PMTCT sites selected based on
number of HIV-positive pregnant women seen. POC CD4 machines
were deployed to all 43 sites in June 2011 following health worker
trainings on usage of machines and tools (registers, summary
sheets). Data were collected before (AprilJune 2011) and after
(JulySeptember 2011) deployment of POC CD4 machines (inter-
vention). Data were analyzed using SPSS v15.0. Differences between
proportions were tested using Wilcoxon signed rank test.
Results: Before introduction of the POC machines, 617 (51%) of
1,210 HIV-positive pregnant women received a CD4 test at the 43
sites. After the machines were introduced, 890 (81%) of 1,100
women received a CD4 test. There was a significance difference
between the proportion of women tested for CD4 count before and
after the intervention (P0.023) and between the proportion
initiated on ART before and after the introduction of the CD4
machines (9% [104] before versus 25% [276] after; (P0.001).
Conclusion: Deployment of POC CD4 machines was associated
with increased CD4 testing and ART initiation for HIV-positive
pregnant women at the 43 intervention sites. Based on these early
results, expansion of POC CD4 machines to all high volume PMTCT
sites in Zimbabwe is recommended to increase access to ART
eligibility towards elimination of new HIV infections in children
by 2015.
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E83 - International trade law and
intellectual property
WEAD0405
Methodology to determine the patent status of key ARVs
and other essential medicines: a strategy to reduce cost of
treatment
M. Dhaliwal1, T. Avafia2, J. O’Malley2, B. Konstantinov1, B. Milani3,
C. Oh4 and UNDP HIV/AIDS Practice
1United Nations Development Programme, BDP, HIV/AIDS Group,
New York, United States. 2United Nations Development Programme,
New York, United States. 3Medecins Sans Frontieres, New York,
United States. 4Independent, New York, United States
Background: Evidence has emerged linking the lack of readily
available accurate information of the patent status of key ARVs with
high prices in some countries. Despite their similar socio-economic
circumstances, it shows that countries often pay significantly
different prices for the same ARVs. Greater cost savings can be
achieved if organizations and officials involved in the national
procurement have more transparent information regarding the
patent status of key ARVs.
Methods: UNDP has co-sponsored the development of a methodol-
ogy written by Barbara Milani and Cecilia Oh that can be used by
officials involved in procuring ARVs and other essential medicines in
low and middle income countries to determine their patent status
and ascertain whether and when generics can be freely imported
into their country.
Results: The methodology was preliminarily tested in Canada, China,
India, and South Africa in 2006 and proved to be effective in
determining the patent status of ARVs. An updated and expanded
version of the methodology is being finalized and will be launched
before the AIDS Conference in July 2012.
Conclusion: In light of the decrease in AIDS funding and growing
need for countries to lower treatment cost, the methodology can be
used by officials and organizations involved in procurement to
ensure that generic ARVs are imported legally, and by low and middle
income countries to facilitate the use of other flexibilities, where
necessary, if valid patents for key ARVs are hampering the
procurement of more affordable equivalents of comparable quality.
WEAE0103
Understanding voluntary licensing: an analysis of current
practices and key provisions in antiretroviral voluntary
licenses
C. Park1, S. Moon2, E. Burrone1, P. Boulet3, S. Juneja1 and E. ‘t Hoen1
1Medicines Patent Pool, Geneva, Switzerland. 2Harvard University,
Boston, United States. 3Independent Consultant, Geneva,
Switzerland
Presenting author email: cpark@medicinespatentpoo.org
Background: Voluntary licensing has gained increased attention as a
potential policy measure to improve access to generic versions of
widely-patented antiretroviral (ARV) medicines in developing coun-
tries, particularly in relation to the Medicines Patent Pool, an
international voluntary licensing mechanism. This study offers a
description of ‘‘baseline’’ voluntary licensing practices before UNI-
TAID’s decision to establish the Pool in 2009, analyzes the evolu-
tion of licensing practices since then, and highlights the types of
license provisions with the most important implications for public
health.
Methods: We compiled data on all publicly-announced voluntary
licenses between major ARV patent-holders and generic firms, and
analyzed various provisions covering: geographic scope for produc-
tion and sales; degree of competition enabled for end products and
active pharmaceutical ingredients; royalty rates; freedom to co-
formulate into fixed-dose-combinations and pediatric formulations;
technology transfer; regulatory data; and various other provisions
with public health relevance.
Results: There is wide variation in voluntary licensing practices, with
geographic scope ranging from one to 112 countries; number of
licensees ranging from one to unlimited; royalty rates ranging from
0% to 5% of the generic price; freedom to co-formulate ranging from
none to unlimited; and access to technology transfer and regulatory
data ranging from minimal to extensive. Other terms and conditions
may have important public health impact, but the lack of transpar-
ency on the text of licenses limits the scope of the analysis.
Conclusion: Voluntary licenses offer one potential route to improving
access to low-cost, generic ARVs in a predictable, sustainable manner.
However, attention must be paid to license provisions that can limit
access to generic medicines, restrict competition, create onerous
burdens, or otherwise reduce the public health benefits of licensing.
Increased transparency in licensing practices, critical analyses of
license provisions, and improved license terms are necessary to
maximize the potential public health benefit of this policy tool.
WEAE0104
Panorama of the pharmaceutical patenting and sanitary
registration of ARVs drugs in Brazil: implications to access
and to health industrial complex
P. Villardi
Associação Brasileira Interdisciplinar de AIDS, Rio de Janeiro, Brazil
Presenting author email: pedro@abiaids.org.br
Background: In Brazil the number of patents and patent applications
has increased, making it difficult to place generic drugs in the
market. At the same time, it is fundamental that the pharmaceutical
companies-either innovators or generic-register their drugs, formula-
tions or combinations in the National Agency Sanitary Surveillance-
ANVISA (acronym in Portuguese) so that the general population to
access is their sanitary registration.
Methods: This study was conducted between April 2010 and April
2011 and it was funded by the Brazilian Ministry of Health. The
research resulted in two methodological outcomes: 1) an ARV patent
and sanitary registration database; 2) research methodology aimed
at overcoming one key difficulty faced in Brazil in this area of
investigation, which is that patents are not automatically linked to
their corresponding final products. The methodology was designed
for Brazil, but it may be adapted to other countries. Regarding to
sanitary registration of ARVs, ANVISA provides an online database of
granted and not granted sanitary registrations.
Results: Patents and registration for 23 single-drug medicines and 8
combinations were reviewed. The study identified 96 patents or
patent applications related to these drugs and combinations, which
account for more than 3 patents/drug. One study result is that the
granting of a secondary patent delays the entry of generic
medication in the market. In the case of darunavir, the first patent
will expire in 2016, but if the last patent application is granted (for
Tibotec), the patent applicant, will benefit from a monopoly until
2025.
Conclusion: The results of the research led to the following policy
recommendations: 1: Wide application of the Bolar Exception and
rigid standards for patent examinations; 2: Incentives for pre and
post-grant oppositions; 3: A possible solution for the non-transparent
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nature of the patent system in Brazil is the compulsory publication of
granted patents.
E85 - Role of multilateral agencies and
donors
THPDD0105
Conflict-affected displaced persons need to benefit more
from HIV Global Fund grants and national strategic plans
P. Spiegel1, H. Hering2, E. Paik3 and M. Schilperoord1
1UNHCR, Division of Programme Support and Management, Geneva,
Switzerland. 2UNHCR, Cairo, Egypt. 3Independent Consultant, Paris,
France
Presenting author email: spiegel@unhcr.org
Background: Access to HIV programmes for refugees and internally
displaced persons (IDPs) is a human rights issue and a public health
priority for affected and host populations. Primary source of funding
for HIV programmes for many countries is the Global Fund. This
article analyses the current HIV National Strategic Plans (NSPs) and
Global Fund approved proposals from rounds 18 for countries in
Africa hosting populations with refugees and/or IDPs to document
their inclusion.
Methods: The review was limited to countries in Africa as they
constitute the highest caseload of refugees and IDPs affected by HIV.
Only countries with refugee and/or IDP populations of 10,000
persons were included. NSPs were retrieved from primary and
secondary sources while approved Global Fund proposals were
obtained from the organisation’s website.
Results: Majority of countries did not mention IDPs (57%) compared
with 48% for refugees in their HIV NSPs. A minority (2129%) of HIV
NSPs referenced and included activities for refugees and IDPs. The
majority of countries with 10,000 refugees and IDPs did not
include these groups in their approved HIV proposals (61%83%).
Conclusion: Besides legal obligations, Governments have a public
health imperative to include these groups in NSPs and funding
proposals. Governments may wish to add a component for refugees
that is additional to the needs for their own citizens. The inclusion of
forcibly displaced persons in funding proposals may have positive
direct effects for host populations as international and UN agencies
often have strong logistical capabilities that could benefit both
populations. Given recent developments in the Global Fund and HIV
funding in general, the HIV funding situation for forcibly displaced
persons may worsen. It is essential for their inclusion to occur if we
are to reach the stated goal of universal access and the Millennium
Development Goals.
E87 - International assistance and
funding mechanisms
WEPDE0203
Its ‘dark ripple’ effect: competing narratives of PEPFAR and
sex work in southern Africa
M. Ditmore1 and D. Allman2
1Urban Justice Center Sex Workers Project, New York, United States.
2Dalla Lana School of Public Health, University of Toronto, Toronto,
Canada
Presenting author email: mhd-iac@taumail.com
Background: The President’s Emergency fund for AIDS Relief (PEPFAR)
is the largest donor in Southern Africa, spending over US $6 billion
since 2004 and supporting ARV treatment for 1.5 million people.
However, since the introduction of PEPFAR conflicting narratives
have appeared regularly. These conflicting narratives often tend to
differently describe and interpret the content, intent, impact and
outcome of PEPFAR policies, particularly with regards to prostitution.
Methods: This analysis utilized a competing narrative approach to
identify recurrent and conflicting narratives relating to PEPFAR and
its implementation among organizations and populations in southern
Africa. A competing narrative methodology allows the identification
and comparison of differing interpretations of phenomena. Here
narratives found in published, ethnographic and interview sources
from sex work and public policy communities in Southern Africa and
elsewhere were analyzed and similarities and differences in these
communities’ interpretations of the PEPFAR policy compared.
Results: The presentation and discussion of PEPFAR’s anti-prostitu-
tion clause vary widely, and have varied over time. Sex worker
communities and organizations have spoken of PEPFAR’s "dark ripple
effect"-the incremental phase-out of sex worker-accessed services,
the increasing isolation of sex workers, and fears about disseminating
and sharing information about sex work programs and funding. In
contrast, public policy communities have been slow to acknowledge,
publicly, the policy’s suggested failures, or to provide clarifying
guidance or response to proposed shortcomings.
Conclusion: Among the two often-opposing communities, conflicting
narratives about PEPFAR and its implementation were found. Evident
were narratives of PEPFAR’s suggested harms and the lack of
response to it. This analysis builds on earlier work to suggest that
fostering improved dialogue between sex work and US funding
communities would help to better broad understandings of PEPFAR’s
impacts, while potentially translating to improved HIV service access
for sex workers.
E89 - Financial sustainability of the
response to HIV and AIDS
MOAE0304
Ensuring the financial sustainability of the national AIDS
response in a low-middle income country with the growing
HIV epidemic: is it feasible in the next few years in Ukraine?
A. Shakarishvili1, K. Sharapka1, G. Gotsadze2, A. Ilnitski1, N. Nizova3
and O. Zhyhinas3
1UNAIDS, Kiev, Ukraine. 2Curatio International Foundation, Tbilisi,
Georgia. 3Ukrainian AIDS Centre of the Ministry of Health of Ukraine,
Kiev, Ukraine
Presenting author email: shakarishvilia@unaids.org
Background: Ukraine is a lower-middle income country with
the most severe and growing HIV-epidemic in Europe (1.1%
estimated adult prevalence), concentrated among people who
inject drugs (PWID), sex workers (SWs) and men who have sex
with men (MSM). Ukraine’s financial needs for the adequate
HIV response are dramatically increasing while it continues to
highly depend upon external funding. The major challenge is to
sustain financing of the HIV response while the global financial
crisis prompts uncertainty of the level and scope of future donor
support, especially for middle-income countries. We aimed to
examine the financial sustainability of Ukraine’s HIV response, and
make recommendations for its mid- and long-term financing
strategies.
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Methods: We analyzed trends in the annual expenditures using the
National AIDS Spending Assessments; financing needs for 20112015
using the 20112013 National Operational Plan and the gap analysis
for 20142015; future domestic and external funding allocations;
policy environment, and implications of all those on future financial
sustainability.
Results: The HIV expenditures dramatically increased since
2004 (USD3.3M) with external and non-governmental resources
comprising 4248% of the USD 65.472.8M in 20092010. Despite
the increasing future funding allocations from all sources,
the financial gap remains substantial estimated at USD 138M in
2015. All HIV care and prevention services remain free through
public and community-level settings regardless of the funding
source.
Conclusion: While domestic investments for treatment increase, HIV
prevention especially for key populations is almost fully funded
externally. Allocation of a larger proportion of governmental
resources is critical, along with policy initiatives aimed at reduction
of costs per client through efficient service delivery modalities,
including HIV service integration into primary and other care. While
donor-funding commitments will be still required for the next few
years, establishment of alternative modalities like financing HIV from
a national health insurance, introducing cost-sharing arrangements,
and facilitating private-public partnerships will be needed.
Table 1. Annual expenditures on HIV (in USD) by programme areas and sources of financing  20092010
2009 2010
HIV expenditures Domestic governmental External and NGO Demestic governmental External and NGO
Prevention tor PWID 169 373 3 292 357 146 772 3 625 771
Prevention, for other MARPs 191 793 1 278 826 56 743 1 540 867
PMTC 4 951 137 420 194 5 410 734 437 383
Other prevention 4 857 170 3 875 473 4 015 743 4 717 556
Treatment 23 196 773 3 911 843 22 537 044 7 884 386
Care and support 564 399 2 179 320 962 890 2 701 316
Organizational and administrative support 4 121 960 12 386 875 4 924 272 13 877341
Total 38 052 604 27 344 888 38 054 198 34 784619
GRAND TOTAL 65 397 492 72 838 817
Table 2. Annual estimated financing needs by HIV programme areas, future financing allocations for HIV by sources and financing
gap (in USD)  20122015
HIV financing needs 2012 2013 2014 2015
Prevention 51 319 632 56 318 716
Treatment 100 366 043 117 037 132
Care and support 17 789 487 22 175 823
Organizational and administrative support 13 460 978 16 703 643
TOTAL 182 936 140 212 235 315 250 437 671 295 516 452
Sources of future financial allocation 2012 2013 2014 2015
Governmental 47 330 859 63 627 783 63 627 783 63 627 783
Other domestic 2 000 000 2 000 000 2 000 000 2 000 000
External (Global Fund) 71 420 140 44 052 919 64 668 346 69 911 446
External (other) 23 686 808 23 750 000 21 750 000 21 750 000
TOTAL 144 437 807 133 430 702 152 036 129 157 289 229
Financial gap 2012 2013 2014 2015
TOTAL 38 498 333 78 804 613 98 401 542 138 227 223










ART with 1st line
ARVs ART with 2st line ARVs
Unit cost 55 62 51 23 928 (incl. USD 843 for
ARVs)
1716 (incl. USD 1631
for ARVs)
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E91 - AIDS: taking a long-term view and
developing more positive and sustainable
outcomes
WEPDE0104
Evaluating the costs of implementing a more sustainable
response: a study of PEPFAR support to Kenya’s PMTCT
program, 20052010
A. Dutta1,2, N. Wallace1,2, P. Savosnick3, J. Adungosi4, U. Kioko2,5,
S. Stewart6, M. Hijazi6 and B. Gichanga7
1Futures Group International LLC,Washington, United States. 2Health
Policy Initiative Costing Task Order, Nairobi/Washington, Kenya.
3Elizabeth Glaser Pediatric AIDS Foundation, Nairobi, Kenya. 4FHI
360, Nairobi, Kenya. 5University of Nairobi, Nairobi, Kenya. 6Office of
HIV/AIDS USAID, Washington, United States. 7USAID Kenya, Nairobi,
Kenya
Background: The President?s Emergency Plan for AIDS Relief
(PEPFAR) in its second phase (200914) has an increased emphasis
on promoting the sustainability of the HIV/AIDS response. Such
sustainability is related to greater country ownership, local capacity,
and strengthened health systems. Investments promoting sustain-
ability can compete for resources with the rapid delivery of services.
There is need to measure the costs associated with an increased
emphasis on sustainability.
Methods: The USAID HPI Costing Task Order evaluated the cost of
PEPFAR support to service delivery and sustainability for the PMTCT
program in Kenya. Data were analyzed from two implementing
partners: FHI360 and the Elizabeth Glaser Pediatric AIDS Foundation.
Data sources included implementation and financial records as well
as interviews with partner staff. From this data, unit costs of PEPFAR
support per mother receiving ARV-based prophylaxis and per
infection averted were calculated for the study period, 20052010.
Results: The average unit cost across EGPAF and FHI360 of PEPFAR
support (excluding commodity costs) per HIV-positive mother
provided antiretroviral-based prophylaxis declined by 52% from
$567 to $271. PEPFAR support for commodities and supply chain
added $48 to the latter cost in 2010. The unit cost of PEPFAR support
per averted mother-to-child infection declined by 66% from $7,117
to $2,440, excluding commodity costs. The sustainability-related
proportion of the unit cost of support to PMTCT increased from 12 to
33% over the study period. Investment into sustainability has grown
in proportion and complexity while overall unit costs of support have
declined.
Conclusion: Investing in sustainability did not inhibit the expansion
of PMTCT services. Such investments build long-term viability and
enhance the prospect of a transition from reliance on donor support.
We do not see a trade-off between scaling-up services and investing
in sustainability. Rather, investment in sustainability is critical to
service delivery scale-up and an effective, affordable use of PEPFAR
resources.
E92 - Global recession and funding
cutbacks: unleashing new challenges for
sustainability
WEAE0106
The ‘middle-income’ curse: should global aid and treatment
access decisions be based on national economic criteria?
K. Bhardwaj
Independent Lawyer (HIV, Health and Human Rights), New Delhi,
India
Background: Of late, donors adjusting their funding policies and
companies and agencies working on treatment access initiatives
have included World Bank set economic criteria in their decision
making. What has been the impact of these new parameters in HIV
funding and treatment access in so-called "middle income" coun-
tries?
Methods: The analysis looks at 1) Changes in Global Fund funding
criteria; 2) Changes in price discounts by MNCs on ARVs and 3) The
coverage of the Medicines Patent Pool licence announced in 2011.
The situations of India, China, Argentina, Botswana and Namibia are
examined in particular.
Results: The study finds that in all three cases, economic criteria are
now playing a key role in determining the level and extent of
assistance in relation to funding and treatment access. While the
Global Fund funding criteria attempts to balance the economic status
of a developing country with its disease burden, in the other two
situations, the use of economic criteria appears motivated only by
private interests in profits.
Conclusion: The use of GDP to determine access to HIV funding and
treatment has gained acceptance in part because of the impression
that the "middle income" status of a country indicates the ability of
the country or its people to fund HIV programmes or HIV treatment.
The GDP does not however reflect actual situations in country or the
fact that several HIV programmes with marginalized communities are
only in existence because of neutral, evidence based funding from
the Global Fund. Such an approach undermines the very basis of
Universal Access and is likely to be counterproductive both in the
short term (with countries hesitating from adopting evidence of
treatment as prevention into policies) and in the long term (as HIV
programmes in these countries shrink or are shaped by national
priorities and prejudices including in relation to marginalized
groups).
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Patient outcomes in Lubumbashi, Democratic Republic of
Congo after disruption in HIV care and treatment due to
decreased Global Fund appropriations
A. Freeman1, M. Kiumbu2, B. Mwamba3, J. Atibu2, L. Kalenga3,
H. Mukumbi4, T. Ntambwe3, R. Ramazani3, J. Mafutamingi3,
C. Mwepu3, B. Kalindula3, V. Mbuya3, L. Mwila3, C. Cummiskey5,
K. Stolka6, J. Newman6 and J. Hemingway-Foday6
1RTI International, Statistics and Epidemiology, Research Triangle
Park, United States. 2Kinshasa School of Public Health, Kinshasa,
Democratic Republic of the Congo. 3AMO-Congo, Lubumbashi,
Democratic Republic of the Congo. 4AMO-Congo, Kinshasa,
Democratic Republic of the Congo. 5RTI International, Washington,
United States. 6RTI International, Research Triangle Park, United
States
Presenting author email: afreeman@rti.org
Background: The worldwide financial crisis has forced The Global
Fund to scale-down funding for HIV programming, particularly in
Sub-Saharan Africa. There are few documented reports of patient
outcomes when decreased Global Fund appropriations lead to
disruption of HIV care and treatment.
Methods: We conducted a cross-sectional survey to assess transfer
behavior, care satisfaction, ART treatment and adherence, and
disease progression among patients experiencing unexpected dis-
ruption of HIV services in Lubumbashi, Democratic Republic of
Congo. A systematic random sample (n1,000) was selected from
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HIV patients enrolled in the Central Africa International Epide-
miologic Databases to Evaluate AIDS (IeDEA).
Results: Of 1,000 patients, 363 were lost-to-follow-up, 36 deceased,
540 found and 61 have unknown status. Of the 540 patients who
were found, data are currently available from 299. Of these, 259
(87%) were formally transferred to another facility, predominately
government-run (95%). 91% (n231) of transferred patients pre-
sented at least once for continued care. Of those who continued
care, 20% received adherence counseling and 45% had CD4 testing.
87% of the 299 patients with available data were on ARVs at the time
of clinic closure. Among these, 78% continued taking ARVs after
transfer, 1% started second line therapy, 7% started a new ART
regimen, and 2% stopped taking ARVs. 24% of patients on ARVs
reported non-adherence to one or more drug. Prior to transfer, 25%
of the patients were WHO stage I/II and 75% were stage III/ IV,
compared to 28% in WHO stage I/ II and 72% in stage III/ IV one year
after the disruption.
Conclusion: When faced with disruption of care, patient retention
is jeopardized. Many countries with grave HIV epidemics
have experienced reductions in Global Fund appropriations.
A better understanding of the consequences of these reductions is
needed.
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